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1.  ABSTRACT  
 
Polycomb Repressive Complex 1 (PRC1) is an evolutionary conserved transcriptional 
repressive complex, fundamental for lineage fate decisions and maintenance during 
development. PRC1 acts by depositing a moiety of Ubiquitin on lysine 119 on histone H2A, 
promoting nucleosome compaction and transcriptional repression. Cell identity is a 
fundamental feature, not only during development, but it has to be maintained throughout 
the entire individual lifespan.  Importantly, loss of cell identity is associated with 
pathologies, primarily with cancer.  
We recently described that, in homeostatic condition, PRC1 loss of function in LGR5 
expressing intestinal stem cells, led to severe defects in tissue maintenance due to loss of 
stem cell identity and stem cell self-renewal. This places PRC1 as a fundamental complex 
in stem cell preservation. In this context, PRC1 is necessary to repress non-lineage specific 
transcription factors, whose upregulation not only perturbs the transcriptome of stem cells, 
thus leading to identity loss, but also impairs the transcriptional control of the WNT pathway 
that is essential for stem cell self-renewal.  
The landscape is even more complicated by the evidence that tissue context plays a critical 
role in protein function. In pathological conditions, primarily in cancer, several reports have 
described opposite roles for epigenetic players, including PRC1 subunits, depending on the 
cancer type. This highlights the importance of context dependency for the correct choice of 
the therapeutic approach. This opens up the possibility that PRC1 function, or PRC1 activity 
loss, could be different among different tissue types.  
To address this point we evaluated PRC1 activity and function in a different LGR5 
expressing stem cell populations that derives from a different embryonic layer, the hair 
follicle, analyzing the phenotype of loss of PRC1 activity in this context and comparing the 
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transcriptional outcomes in the different stem cell populations to describe the influence of 
context on PRC1-loss.  
Our data support a general role of PRC1 in stem cell identity maintenance, that is 
accomplished through the regulation of the same targets. However, we show that, differently 
from intestinal stem cells, PRC1 activity loss in the hair follicle leads to the activation of a 
specific epidermal program, showing that the pool of transcription factors present in different 
stem cell population alters the transcriptional outcome of PRC1 loss.  
To add a layer of complexity to the Polycomb field and to its role in identity maintenance, 
PRC1 is composed by several subunits that define at least 5 different biochemical sub-
complexes. These complexes are specified by 6 different mutually exclusive PCGF proteins 
(PCGF1-6) that determine the ancillary subunits composing the complexes. Their role in 
embryonic development is matter of several studies, however their involvement in adult 
tissue maintenance is still obscure. Exploiting different PCGFs conditional knock out mouse 
models we aim to address the specific role of different sub complexes in the maintenance of 
tissue homeostasis, in order to define the contribution of these Polycomb complexes in the 
phenotypic outcome observed in PRC1 loss of function intestinal and hair follicle LGR5 




2.1 POLYCOMB GROUP OF PROTEINS 
2.1.1  CELL IDENTITY  
Cell identity is an important cell feature in both the research field and clinic, due to its 
connection to homeostasis preservation and pathology development. Importantly, 
establishment and maintenance of the correct identity is critical for organism development 
and for whole tissue homeostasis in adult life. A single cell, the zygote, gives rise to all of 
the hundreds of cell types composing the human body in a spatially and temporally 
coordinated and precise manner during embryogenesis and later development (Mohammad 
and Baylin 2010, Mortimer, Wainwright et al. 2019).  
This process involves different regulatory elements and mechanisms, such as morphogens, 
transcription factors and epigenetic players, that cooperate to determine the correct cell fate. 
Among them, epigenetic regulators plays a fundamental regulatory role, by integrating 
different signals at the chromatin level, shaping DNA accessibility and dictating genes 
activation and repression, thus leading to a fine regulation of all cellular processes and 
ensuring that genetically identical cells acquire different identities (Cheung, Allis et al. 2000, 
Mortimer, Wainwright et al. 2019).  
 Remarkably, these mechanisms are also conserved in adulthood where they are necessary 
to control stem cells function and whole tissue homeostasis, highlighting the importance of 
epigenetic regulation of transcription throughout the entire lifespan (Rinaldi and Benitah 
2015). However, in recent years, several studies have shown that factors involved in 
chromatin regulation can act differently in adulthood compared to development.  
Throughout life, adult stem cells have to be carefully preserved due to their fundamental role 
in replenishing the tissue from dying and, importantly, damaged cells. In this view, it is clear 
that their identity has to be tightly regulated and preserved in order to maintain homeostasis 
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within the tissue. Intriguingly, different organs present dissimilar cell turnover and damage 
rate. Indeed, several mechanisms have evolved differently in adult stem cell to integrate 
different stimuli to ensure the maintenance of homeostasis (Rinaldi and Benitah 2015) 
highlighting the importance of studying homeostatic processes in vivo in different organs.  
Importantly, how adult stem cells retain their identity while self-renewing, or lose it while 
differentiating, during homeostasis is still largely unexplored. 
Due to epigenetic players strict relation with cell identity, it is indeed not surprising that their 
deregulation is involved in aging and in the pathogenesis of different diseases, primarily in 
tumors. Cancer is a heterogeneous disease and is considered a multistep process that 
gradually leads to the loss of cellular identity meanwhile acquiring typical cancer cell 
features (Hanahan and Weinberg 2000, Hanahan and Weinberg 2011). Epigenetic players 
are affected at different levels and in a highly context dependent manner, reaching almost 
half of the total altered proteins in different cancers (Vogelstein, Papadopoulos et al. 2013).   
 
2.1.2  EPIGENETIC  
The term epigenetic was coined to define “the heritable traits that are not linked to DNA 
sequence” but its definition has been modified over time and is accepted a more 
comprehensive meaning is accepted in which “epigenetic is used to describe the mechanisms 
by which chromatin-associated proteins and post-translational modification of histones 
regulates transcription” (Helin and Dhanak 2013). Genomic DNA is folded inside the 
nucleus by histones and non-histone proteins that constitute the chromatin. Based on the 
grade of compaction, two main forms of chromatin have been described: the 
heterochromatin, which is highly compacted and transcriptionally less permissive, and the 
euchromatin, which in turn is more relaxed and accessible. However, except for a few 
genomic regions, such as repeated and non-coding regions, centromeres and telomeres, that 
constitute the “constitutive heterochromatin”, the remaining DNA portions are not static and 
 17 
it is possible to switch between condensed “facultative heterochromatin” and decondensed 
euchromatin status by actively changing chromatin conformation (Trojer and Reinberg 
2007) with different mechanisms in order to obtain the activation or the repression of the 
genes needed.   
The nucleosome is the basic unit of chromatin and was described more than 40 years ago by 
Kornberg (Kornberg and Thomas 1974). It is composed by an octamer of histone proteins, 
whose core is made by a tetramer of histones H3-H4 and two dimers of histones H2A-H2B, 
around which are wrapped ~147 bp of left-handed DNA. This structure is stabilized by both 
protein-protein interaction, within the histone core, and several electrostatic and hydrogen 
bonds, among the DNA helix and the histones (Richmond and Davey 2003, Rohs, West et 
al. 2009). Beside the structured core of the histones, these proteins possess flexible tails that 
protrude outside the nucleosome core structure and are used as scaffold for other non-protein 
interactions. These tails can be post-translationally modified by different classes of 
epigenetic proteins, affecting histone-DNA and protein-protein interaction thus enabling 
chromatin modulation of its structure and functions.  
Nucleosomes are spaced from each other by free DNA that can be associated with the linker 
histone H1, that is attached outside the nucleosome core, where DNA exit and enter the 
nucleosome. Histone H1 is involved in chromatin compaction and is found to be present in 
the constitutive heterochromatin and in short discrete genomic regions that should be 
transcriptionally repressed, while transcribed regions are devoid of histone H1 (Trojer and 
Reinberg 2007).  
Indeed, this complex organization and its surrounding proteins interaction and modification 
is fundamental to tightly regulate gene expression. Chromatin plays an important regulatory 
role as an integrative platform for several different signaling pathways, that ultimately 
converge on histones, regulating all the cellular processes. This transcriptional fine tuning 
requires rapid rearrangements of the chromatin to allow or impede DNA accessibility 
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(Cheung, Allis et al. 2000). Four are the principal mechanisms of epigenetic controls: 
Chromatin remodeling, histone variants, DNA modification and Histones modification (Fig 
2.1). 
 
This dynamic reorganization of nucleosomes is achieved through the activity of different 
remodeling proteins and complexes which rely on the use of adenosine triphosphate (ATP) 
as source of energy to disrupt nucleosome-DNA contacts, move the nucleosome on the DNA 
filament and remove or substitute the nucleosomes. Based on protein homologies, chromatin 
remodeling players can be divided in at least 4 major families. All these proteins share the 
ATPase domain, and are characterized by unique domains, within or adjacent to the catalytic 
residues, that guarantee tissue specific expression patterns, as well as a large variety of 
different peculiar functions (Hargreaves and Crabtree 2011). Overall their function results 
in a fine regulation of nucleosome occupancy along the DNA, causing both increased or 
reduced accessibility of a genomic site, thereby affecting the transcriptional outcome 
(Sudarsanam and Winston 2000, Levine and Tjian 2003). 
Figure 2.1 Chromatin and Epigenetic modifications 
Schematic view of chromatin structure and compaction. In the figure are represented 
different epigenetic modifications and chromatin associated proteins and structures. 
Image from (Aranda, Mas et al. 2015). 
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Another epigenetic mechanism that regulates the transcriptional control is the incorporation 
of different histone variants within the nucleosome core. In eukaryotes several histones 
variants exist, all resembling the canonical counterpart but exhibiting differences both in 
expression patterns and in their genomic recruitment and organization (Szenker, Ray-Gallet 
et al. 2011). Canonical histone proteins are encoded by large gene clusters, containing 
multiple copies that lack introns and 3’PolyA and their mRNA ends with a stem-loop 
structure needed for their stability and translation during S-phase (Dominski and Marzluff 
2007, Talbert and Henikoff 2017). On the contrary, histone variants are more similar to a 
general mRNA, as they have introns and a polyadenylated 3’end. Typically histones are 
incorporated in the DNA during replication, by contrast their variants are deposited and 
substituted throughout the cell cycle (Marzluff and Duronio 2002, Talbert and Henikoff 
2017). The replacement of canonical histone forms alters the nucleosome distribution and 
the interacting proteins, for example chromatin remodelers and modifiers, thus affecting the 
chromatin landscape with different outcomes. Histone variants, like their classical 
counterparts, are subjected to several post-translational modification, that can be either the 
same as their replication dependent canonical histone, or can be newly acquired or lost 
(Szenker, Ray-Gallet et al. 2011, Talbert and Henikoff 2017) greatly increasing the range of 
possible transcriptional outcome. 
Overall the biochemical diversity introduced with histone variants shows the importance of 
histones, they represent not only a scaffold protein for DNA compaction, but also a fine tool 
for epigenetic regulation of gene transcription through different mechanisms.  
 
Together with histones, DNA covalent modifications are the most influential epigenetic 
alteration that is able to affect the association and the downstream function of factor that 
binds DNA. Four different DNA modification have been described: 5-methyl cytosine 
(5mC), 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC) and 5-carboxylcytosine 
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(5aC) (Rothbart and Strahl 2014). However, the most studied and represented in the genome 
is the DNA methylation that occurs primarily at the 5-position of cytosine residues (5mC) 
in the context of CpG dinucleotides. 5mC is widespread throughout the mammalian genome 
approximately marking the 70-80% of total CpG. However, CpG island (CGIs), which are 
CpG-rich regions that are mainly found in gene promoters, are particularly refractory to this 
modification, indeed they are generally unmethylated (Illingworth and Bird 2009). DNA 
methylation is performed by specialized enzymes named DNA-methyltransferases 
(DNMTs). Two types of DNA methylation exist: one is associated with DNA-replication, 
necessary to maintains the correct methylation pattern in the newly formed cells, and the 
second, that ensures “de novo” methylation deposition, (Okano, Xie et al. 1998, Okano, Bell 
et al. 1999). Both are fundamental for the correct organism development (Okano, Bell et al. 
1999, Li 2002). Importantly, DNA methylation is a crucial epigenetic modification and its 
deregulation leads to several different pathologies including cancer  (Helin and Dhanak 
2013). 
 
Beside all the histone forms, nucleosomal proteins encounter several different covalent 
modification occurring not only on various residues on their tails, but also in their globular 
domain, thus enormously increasing the number of regulatory epigenetic signals (Jenuwein 
and Allis 2001, Rothbart and Strahl 2014). Lysine acetylation, Lysine/Arginine methylation 
and Serine/Threonine/Tyrosine phosphorylation are the best characterized histone 
modifications. However several others modification exists, such as Ubiquitination, 
Sumoilation, and Succinylation which are less abundant and their roles have been started to 
be elucidated (Arnaudo and Garcia 2013). 
Histone modifications are deposited by different proteins families called “chromatin 
writers”.  These post-translational modifications can either act directly or indirectly 
(Kouzarides 2007). The deposition of acetylation and phosphorylation can directly influence 
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the chromatin structure altering the histone positive charge and leading to a more accessible 
chromatin status. Also, the addition of the large molecules such as ubiquitin can induce a 
change in chromatin conformation by itself. Moreover, the deposited histone modification 
can be recognized by other specialized proteins called “chromatin readers” that can recruit 
to the genome Transcription Factors (TFs) and cofactors needed for the transcriptional and 
epigenetic regulation. Histone covalent modification can be actively removed by the 
“chromatin erasers” proteins, creating a complex network of proteins and histone 
modifications that ultimately lead to the precise control of transcription (Kouzarides 2007). 
Additionally, more than one modification can be present on the same histone, and can 
influence the deposition or the stability of the other histone marks and the binding affinity 
of readers and TFs in several ways creating a real histone code for transcriptional regulation 
(Jenuwein and Allis 2001, Kouzarides 2007).  
 
All of these mechanisms contribute to create a powerful platform necessary to integrate the 
cellular and extracellular signal and to promptly respond to environmental changes and their 
correct function must be accurately preserved, to prevent epigenetic and transcriptional 
deregulation that ultimately can lead to pathologies such as cancer.  
  
2.1.3  POLYCOMB PROTEINS 
Among all the epigenetic modifiers Polycomb Group of Proteins (PcG) are the most widely 
studied. Polycomb proteins are essential epigenetic regulators of embryonic development 
and cell fate differentiation. They regulate this process by repressing gene transcription of 
developmental and differentiation genes in a highly precise spatial and temporal manner.  
PcG were discovered almost 70 years ago in Drosophila melanogaster, where they control 
the expression of Homeotic (Hox) genes during development and differentiation. In 1942 a 
single male fly with ectopic sex combs present on each of its six legs was observed, which 
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led to the identification of the first PcG mutant, extra sex combs (esc). A few years later P.H. 
Lewis named another heterozygous mutant with extra sex comb that were lethal in 
homozygous conditions Polycomb (Pc), and in the following years other mutants were 
discovered (Poynter and Kadoch 2016). However, it was only years later that the function of 
PcG genes was fully appreciated, when in Pc mutant embryos drastic homeotic 
transformations of thoracic and abdominal segments which were posteriorly shifted  were 
observed (Lewis 1978, Poynter and Kadoch 2016). This phenotype was shown to antagonize 
mutations in BX-C, a gene cluster encoding for Hox genes, suggesting that Pc plays a role 
as BX-C inhibitor, a theory confirmed by later studies (Poynter and Kadoch 2016, 
Schuettengruber, Bourbon et al. 2017). Years later from PcG discovery, other regulators of 
Hox genes were discovered. Their mutation caused embryonic segments transformation into 
a more anterior ones, thus antagonizing the Polycomb phenotype. This new set of genes 
where named Trithorax group of proteins (TrxG) (Ingham 1983, Ingham 1985, Ingham 1985, 
Struhl and Akam 1985, Kennison and Tamkun 1988). Crosstalk among PcG and TrxG 
ensure the correct establishment of segmentation along the anteroposterior axis of drosophila 
melanogaster body.  
PcGs function in the regulation of developmental genes trough repression, is also strongly 
conserved in mammals (Morey and Helin 2010). Moreover, in the last few decades 
Polycomb proteins were found to be implicated in several different processes including 
control of cell cycle progression, senescence, X-chromosome inactivation, stem cell 
differentiation and, importantly, pathologies such as cancer (Morey and Helin 2010). 
Mammalian orthologues of fly PcGs began to be acknowledged in early 90’s with the 
identification of Bmi1 (Psc in Drosophila) and its role in cancer development (Haupt, 
Alexander et al. 1991, Haupt, Bath et al. 1993). Based on biochemical purification in 
drosophila melanogaster, PcG proteins were divided into two different complexes Polycomb 
Repressive Complex 1 and 2 (PRC1 and 2). This division is maintained also in mammals 
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where the PRCs possess additional subunits and their structures and composition became 
more complex and context dependent (Aranda, Mas et al. 2015). 
 
PRC1 and PRC2 have specific catalytic functions and mediate transcriptional repression via 
modification of histones tails and chromatin compaction. PRC1 catalyzes the deposition of 
a moiety of ubiquitin on lysine 119 of histone H2A (H2AK119Ub1) while PRC2 is 
responsible for the deposition of mono-, di-, tri-methylation on lysine 27 of histone H3 
(H3K27me1/me2/me3) (Cao, Wang et al. 2002, Muller, Hart et al. 2002, Cao, Tsukada et al. 
2005, Stock, Giadrossi et al. 2007). 
 
In line with their essential role in drosophila also during development, mammalian PcGs 
plays a fundamental role in development also. PRC2 complex ablation results in early 
embryonic lethality and the same is true for the loss Rnf2/RING1B for PRC1 subunit (Faust, 
Schumacher et al. 1995, O'Carroll, Erhardt et al. 2001, Voncken, Roelen et al. 2003, Pasini, 
Bracken et al. 2004). Of note, it is increasingly evident that genes important for development 
largely overlap with those that govern adult renewal potential and identity of stem cells 
(Mohammad and Baylin 2010), emphasizing the importance of Polycomb regulation of 
developmental genes also in adult tissue. In the last few years the characterization of PRCs 
composition, structure, functions and regulation has started to take place, not only for the 
importance of these complexes in development, but also for the evidence of their 
involvement in human disease including cancer.  
 
2.1.3.1  POLYCOMB REPRESSIVE COMPLEX 2 
Drosophila PRC2 core is composed by Enhancer of Zeste (E(z)), Suppressor of Zeste (Su(z)) 
and Extra sex combs (Esc). In mammals the subunits composing the core complex are well 
conserved, and it is composed of either EZH1 or EZH2 (homolog of E(z)), SUZ12 (homolog 
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of Su(z)) and EED (Embryonic Ectoderm Development, homolog of Esc) (Pasini, Bracken 
et al. 2004, Morey and Helin 2010, Poynter and Kadoch 2016). EZH1/2, which are mutually 
exclusive within the complex, exert the catalytic activity through their SET domain 
performing al the three methylation status of H3K27 (Margueron, Li et al. 2008), while the 
SUZ12 and EED scaffold proteins are necessary for the enzymatic activity of the complex 
(Cao and Zhang 2004, Pasini, Bracken et al. 2004). In particular, the EED subunit, through 
its WD40 domain, is able to recognize H3K27me3, thus establishing a positive feedback 
loop that enhance the PRC2 activity up to 7-fold suggesting a mechanism for PRC2 mark 
level maintenance throughout the cell cycle (Margueron, Justin et al. 2009). These three 
subunits are present in a 1:1:1 stoichiometry within the complex and constitute the minimal 
composition for the catalytic activity of PRC2 (Smits, Jansen et al. 2013) (Fig 2.2).   
The mutually exclusive catalytic subunits are the only two core proteins that are paralog. 
Interestingly EZH2 loss causes early embryonic lethality, while EZH1 knock out mice are 
viable, fertile and shows a normal phenotype, meaning that EZH2 can fully compensate for 
EZH1 activity. On the contrary, EZH1 can only partially complement EZH2 in H3K27 
methylation. Moreover, the two proteins show dissimilar expressions patterns. EZH1 is 
ubiquitously expressed at constant levels during the cell cycle, whereas EZH2 seems to be 
more expressed in actively dividing cells (Margueron, Li et al. 2008). Their expression 
patterns are also different at temporal and differentiation levels, in fact, while EZH2 
decreases during cell differentiation, EZH1 increases (Margueron, Li et al. 2008, Mousavi, 
Zare et al. 2012, Xu, On et al. 2015). Moreover, although both EZH1 and EZH2 have H3K27 
methylation ability, EZH2 shows 20-fold greater ability in mark deposition, compared to 
EZH1 that, in turn, seems to be more efficient in chromatin compaction. EZH1 and EZH2 
shows only partial redundancy also in terms of catalytic activity. EZH1 seem to be associated 
to H3K27 mono-methylation on region of active transcription, while EZH2 is commonly 
associated to di- and tri-methylation deposition in transcriptional repressed genomic loci 
(Mousavi, Zare et al. 2012, Xu, On et al. 2015).  These evidences imply a non-redundant 
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functionality for the two different PRC2 complexes, increasing the complexity of PRC2 in 
mammalian organism. 
Histone methylation plays a key role in transcriptional regulation by acting through different 
mechanisms. Overall it can influence the chromatin architecture leading to a differential 
modulation and interaction with TFs and proteins involved in the transcription initiation and 
elongation (Wagner and Carpenter 2012, Helin and Dhanak 2013).  
Remarkably, in contrast to other histone modifications, methylation does not have an 
univocal effect and, depending on the methylation degree, it can result in either active or 
repressive transcription (Bannister and Kouzarides 2011). Historically, PRC2 functionality 
has been associated only to H3K27me3 and gene repression, however it sequentially deposits 
all the three methylation-status on H3K27 with different specific outcome (Ferrari, Scelfo et 
al. 2014). H3K27me3 is preferentially deposited in correspondence of CpG-rich promoter 
region of silenced genes, H3K27me2, is associated to large transcriptional silenced regions 
and H3K27me1 is deposited throughout all the gene bodies of actively transcribed genes. 
Figure 2.2 Schematic representation of Polycomb repressive complex 2 
In the cartoon, taken from (Margueron and Reinberg 2011), are shown PRC2 core 
and ancillary subunits with their putative interaction with chromatin. 
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Significantly, combinatorial patterns provide an important regulatory platform to regulate 
expression. In the case of H3K4me3, deposited by the COMPASS complexes (Shilatifard 
2012), and H3K27me3 concomitant modifications, found together in murine Embryonic 
Stem Cells (mESCs) at the so called “poised” or “bivalent” genes. These genes are typically 
related to development, which, owning both active and repressive status, are able to be 
promptly switched on and off when needed during differentiation (Brookes, de Santiago et 
al. 2012, Voigt, Tee et al. 2013). In differentiated cells these domains tend to disappear, 
retaining only active or repressive marks depending on their role in specific tissue (Ku, 
Koche et al. 2008), however new bivalent genes are formed (Mikkelsen, Ku et al. 2007, 
Mohn, Weber et al. 2008, Oguro, Yuan et al. 2010, Jadhav, Nalapareddy et al. 2016, Cohen, 
Zhao et al. 2018, Pivetti, Fernandez-Perez et al. 2019).      
PRC2 core is associated with several accessory subunits, that are dispensable for its 
enzymatic activity, but participate in the regulation of its histone modification deposition, 
by modulating the catalytic activity or the complex association to the genome. Among all, 
the most important are the histone chaperone RbAp48/46 (retinoblastoma associated 
proteins 48/46) which are required for catalytic activity in vivo (Ketel, Andersen et al. 2005), 
AEBP2 which enhance KTM activity in vitro (Cao, Wang et al. 2008), three different 
Polycomb-like proteins (PCLs; PHF1, MTF2, PHF19) that through their TUDOR domain 
recognize the H3K36me3 mark, suggesting a role in silencing initiation of active gene 
(Ballare, Lange et al. 2012), and JARID2 that recognizing the GC-GA rich DNA elements 
is involved in PRC2 recruitment at genes for proper ESC differentiation (Pasini, Cloos et al. 
2010). 
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2.1.3.2  POLYCOMB REPRESSIVE COMPLEX 1 
Polycomb repressive complex 1 (PRC1) is composed by numerous subunits and these 
proteins form several different subcomplexes that are biochemically different among each 
other and are potentially different in terms of biological function (Gao, Zhang et al. 2012). 
In Drosophila melanogaster PRC1 core is composed by Polycomb (Pc), Polyhomeotic (Ph), 
Posterior sex combs (Psc) and Sex comb extra (Sce, also known as dRING) (Morey and 
Helin 2010). In mammals, the situation is extremely more complicated. For each subunit at 
least two homologues have been discovered. Mammalian PRC1 core is composed by one 
catalytic subunit that deposits a single molecule of ubiquitin on lysine 119 of histone H2A, 
mutually exclusive among Really Interesting New Gene 1A and 1B ( RING1A and RING1B,  
Sce homolog), one out of six different Polycomb Group Ring Finger protein (PCGF, Psc 
homolog) (Fig 2.3) and one out of three Polyhomeotic-like protein (PHC1, PHC2 and PHC3, 
Ph homolog) (Morey and Helin 2010). PRC1 complex then can be further subdivided into 
two major classes of complexes named “canonical” and “non canonical” PRC1 based on the 
presence respectively of the CBX subunit (Chromobox, Pc homolog) or its mutually 
Figure 2.3 Schematic representation of Polycomb repressive complex 1  
In the cartoon, modified from (Aranda, Mas et al. 2015), are shown PRC1 core and 
ancillary subunits with respect to the specific PCGFs associated to the complex and 
their recruitment specificity oh chromatin. 
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exclusive counterpart, RYBP, that determines the mechanisms of PRC1 recruitment to 
chromatin. Moreover, in mammals several different CBX paralogues exist (CBX2,4,6,7,8) 
and RYBP can be substitute by YAF2 (Morey and Helin 2010, Gao, Zhang et al. 2012). 
Accordingly to mass spectrometry analyses performed in mammalian cells by Gao and 
colleagues (Gao, Zhang et al. 2012), at least 5 different biochemical, and probably 
functional, PRC1 sub-complexes exist. Each of these sub-complexes can interact with 
specific proteins that can direct the complex to specific targets.  
All of these complexes catalyze for H2AK119 Ubiquitin (Ub) deposition, that is a 76-
aminoacid protein conserved among all eukaryotic organisms, implicated in several 
mechanisms including protein degradation, cell cycle, protein trafficking and transcriptional 
regulation (Zhang 2003). Ub is attached to a lysine residue through an isopeptide bond, and 
this addition is a complex process involving three different enzymes:  E1 activating protein, 
E2 conjugating enzyme and lastly an E3 ligase, that is responsible for target recognition and 
catalyze the binding reaction (Pickart 2001), that in PRC1 complex are either RING1A or 
RING1B. This modification is implicated in transcriptional regulation and is associated with 
gene repression and chromatin compaction (Ogawa, Ishiguro et al. 2002, Cao, Tsukada et 
al. 2005, Zhou, Zhu et al. 2008, Zhou, Wang et al. 2009). As for other modifications, histone 
ubiquitination is reversible, and several specific deubiquitinating enzymes exist (DUBs).  
Polycomb protein BAP1 has been identified as H2A-specific histone DUB and its loss 
significantly increase the levels of H2AK119Ub1 on PRC1 targets (Scheuermann, de Ayala 
Alonso et al. 2010). However, DUBs roles are poorly investigated. Importantly, BAP1 is 
commonly found to be mutated in mesotheliomas and uveal melanomas (Carbone, Yang et 
al. 2013, Murali, Wiesner et al. 2013), highlighting the importance of maintaining the correct 
epigenetic mark deposition to prevent neoplastic pathology.   
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Based on Gao’s and coworker’s data, the minimal canonical PRC1 complexes contains either 
RING1A or RING1B, Mel18/ PCGF2 or Bmi1/ PCGF4 and one CBX subunit (Gao, Zhang 
et al. 2012).  
The different CBXs proteins are mutually exclusive within the complex, and their inclusion 
in PRC1 seems to be regulated during development. CBX7 seems to be the main component 
in ESCs and is substituted by CBX2 and CBX4 in differentiated cells (Morey, Pascual et al. 
2012, O'Loghlen, Munoz-Cabello et al. 2012). CBX subunit is considered the determinant 
for canonical PRC1 recruitment on the chromatin (Aranda, Mas et al. 2015) in fact through 
its Chromobox domain, is able to recognize and bind H3K27me3 PRC2 deposited mark, 
thereby recruiting PRC1 on PRC2 targets, where the two complexes cooperate in silencing 
the target locus. This mechanism is supported by the large overlap between PRC2 and 
RING1B targets and by the loss of RING1B from the chromatin in absence of PRC2 activity.  
However, in recent years a new paradigm arise, and by ChIP-seq analyses performed by Gao 
and colleagues, and in accordance with other studies, emerged that RING1B peaks only 
partially overlap with H3K27me3, all of which colocalized with Mel18/ PCGF2 or Bmi1/ 
PCGF4 and CBX proteins, suggesting distinct role for CBX- and RYBP (Boyer, Plath et al. 
2006, Pasini, Bracken et al. 2007, Trojer, Cao et al. 2011, Gao, Zhang et al. 2012). Moreover, 
it is important to know that upon loss of PRC2 activity, the global H2AK119Ub1 levels 
remains largely unaffected, suggesting that PRC1 activity does not require PRC2 (Tavares, 
Dimitrova et al. 2012).  
Non canonical PRC1 complexes incorporate RYBP (Ring and YY1 Binding protein) or 
YAF2 (YY1 Associated Factor 2) instead of CBX. These complexes lack the subunit that 
recognize PRC2 mark, meaning that they are tethered to chromatin in a PRC2 independent 
manner (Tavares, Dimitrova et al. 2012). Moreover, RYBP containing complexes, beside 
the classical PRC1-PRC2 targets, can binds different subsets of targets, suggesting that 
PRC1 possess other mechanisms for its recruitment on the genetic material and can regulate 
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different cellular processes (Morey, Aloia et al. 2013). Differently from canonical 
complexes, where only Mel18/ PCGF2 and Bmi1/ PCGF4 can bound CBX subunit, all 
PCGFs proteins are able to interact with RYBP and YAF2 (Gao, Zhang et al. 2012). 
PCGFs proteins are mutually exclusive within the complex, defining different non canonical 
complexes core, that associate with different ancillary proteins.    
PRC1 containing PCGF1/NSPC1 (also named PRC1.1), is the homolog of dRAF complex 
in Drosophila. A fundamental subunit of the complex is the histone H3K36 demethylase 
KDM2B, that, through its CxxC domain, drives the complex on CpG rich DNA regions 
(Blackledge, Zhou et al. 2010, Barrero and Izpisua Belmonte 2013, Scelfo, Piunti et al. 
2015).  
PCGF3 and PCGF5 have been found to bind the same interactors, thereby defining two 
biochemically redundant complexes. AUTS2, together with FBRS and FBRSL1, which has 
no previous association with PRC1, have been recovered in Mass spectrometry analyses for 
the two PcG proteins (Gao, Zhang et al. 2012, Scelfo, Piunti et al. 2015). Interestingly, in a 
study in central nervous system development, AUTS2 is able to tether PCGF5 to chromatin 
where it can activate transcription via CK2 and P300 recruitment, opening a new field on 
active transcription and polycomb complexes (Gao, Lee et al. 2014). Moreover, a recent 
work carried out in our laboratory in ES cells define a novel interaction of PCGF3 with USF1 
transcription factor and demonstrated that this interaction is necessary for PCGF3 chromatin 
localization, thus introducing a novel player in polycomb recruitment field (Scelfo, 
Fernandez-Perez et al. 2019).   
Lastly, PCGF6/MBLR can associate with several different proteins defining a huge complex 
containing E2F6, DP1, MGA, MAX, WDR5 and L3MBTL2. In the past years, it has been 
demonstrated that PRC1.6 occupies E2F6 binding sites and recently that MGA mediates 
PRC1.6 recruitment on chromatin on T-box sequences (Trojer, Cao et al. 2011, Gao, Zhang 
et al. 2012).  
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Despite all these new advances our PRC1 knowledge about the biology and the molecular 
functions is still largely not understood.   
 
2.1.4 POLYCOMB RECRUITMENT 
Polycomb complexes must be recruited on chromatin to exert their function. In Drosophila 
Melanogaster PcG recruitment is mediated by Polycomb Responsive Elements (PREs), as 
demonstrated at Hox genes (Busturia and Bienz 1993, Sengupta, Kuhrs et al. 2004). PREs 
are distal cis-regulatory elements, few hundred bp long, that are devoid of nucleosomes and 
can be present upstream or downstream of their target promoter, in introns or in the majority 
of cases close to the transcriptional start site (TSS). 
In mammal the recruitment represents a major issue. Despite PRCs core are well conserved, 
mammals lack PRE- binding proteins and PRE-elements remains elusive in the genome. In 
general, mammalian PcGs preferentially bind non methylated CpG rich promoters of their 
target genes and CpG-rich sequence itself mediates PRC2 recruitment (Mendenhall, Koche 
et al. 2010, Lynch, Smith et al. 2012, Riising, Comet et al. 2014). 
The classical model of Polycomb recruitment is a two-step mechanism: first PRC2 is 
recruited on its targets and mediates the methylation of histone H3K27, which is recognize 
by CBX subunit that subsequently tether PRC1 complex on the chromatin where RING1B 
ubiquitinates the K119 of histone H2A. These two modifications lead to chromatin 
compaction and transcriptional silencing.  
However, with the new discovery of CBX lacking non canonical PRC1 complexes, this 
model remains valid only for canonical complexes targets.  
Moreover, it has been demonstrated that H3K27me3 distribution does not completely fit the 
binding of PRC1, and example of PRC1 peaks devoid of H3K27me3 exist (Gao, Zhang et 
al. 2012, Tavares, Dimitrova et al. 2012). Furthermore, H2AK119Ub1 deposited by PRC1 
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has been suggested to play a key role in PRC2 recruitment (Schwartz and Pirrotta 2014), 
shedding a new light on the complexity of Polycomb recruitment on chromatin. 
Since PRC1 and PRC2 core component do not have DNA binding properties, several 
alternative recruitment mechanisms have been proposed for their engagement to the 
chromatin that includes the association with other ancillary proteins (such as PCL1-3, 
AEBP2, JARID2, KDM2B…) or with specific transcription factors, the influence of 
chromatin signatures (apart from CpG-island also histone variants and histone 
modifications), the interaction with long non-coding RNAs and the status of Polymerase II 
(PolII). 
PRC1.1 component BCOR (BCL6 Co-repressor) is able to recruits PCGF1 containing 
complex on BCL6 targets (Morey and Helin 2010), and KDM2B demethylase is able to 
tether PRC1.1 on H3K36 methylated histones (Barrero and Izpisua Belmonte 2013 , He, 
Shen et al. 2013, Xu, On et al. 2015). On the other hand, PRC1.6 associate with several 
proteins and it has been demonstrated that either MGA, E2F6 and L3MBTL2 can drive 
PCGF6 localization on chromatin (Stielow, Finkernagel et al. 2018, Scelfo, Fernandez-Perez 
et al. 2019). Last, PCGF5 has been reported to interact with AUTS2, that mediates it 
recruitment on DNA. Moreover, our laboratory has demonstrated that PCGF3 is able to 
interact with USF1 that mediates PCGF3 tethering on the chromatin on its specific E-box 
motifs (Scelfo, Fernandez-Perez et al. 2019).   
PRC2 can be targeted to the DNA through JARID2 protein that have been shown to binds 
most of PcG target genes and to be necessary for binding. This interactor protein contains 
an AT-rich interaction domain (ARID) and a Zn-finger domain, both with the potential to 
bind DNA. Despite some studies have shown that JARID2 is necessary for PRC2 binding, 
inhibition of JARID2 has only minor effect on H3K27me3 and Jarid2 KO mice shows a 
milder effect on development compared to PRC2 KO ones, indicating that other mechanisms 
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can regulates PRC2 genomic targeting (Ku, Koche et al. 2008, Li, Margueron et al. 2010, 
Pasini, Cloos et al. 2010).  
As previously mentioned, other mechanisms can recruit Polycomb complexes on the 
chromatin. It has been reported that both long non-coding RNA HOTAIR, expressed in 
HOXC cluster and necessary for efficient silencing of HODX locus (Rinn, Kertesz et al. 
2007), and, Xist non-coding RNA, that initiate the process of X Chromosome inactivation, 
can directly recruit PRC1 on the genes or chromosome that should be inactivated 
(Schoeftner, Sengupta et al. 2006). Also, the phosphorylation status of Polymerase II has 
been shown to affect PcG occupancy. PolII can be modified within its carboxyl-terminal 
domain and exclusive phosphorylation of Serine 5 in ESCs, is associated with developmental 
genes that are in a poised status, with transcription ready to be initiated or repressed upon 
differentiation stimuli and PRC1 and PRC2 marks co-occurrency (Brookes, de Santiago et 
al. 2012, Voigt, Tee et al. 2013, Ferrai, Torlai Triglia et al. 2017). 
From 2010 many groups focused on a deep characterization of PRC1 subcomplexes 
molecular mechanisms and functions and their interdependency with PRC1 and PRC2. It 
has to be mention that accordingly to new studies non canonical PRC1 complexes can 
localizes on active chromatin, with roles that can be different from the classical Polycomb 
transcriptional repression (Cohen, Zhao et al. 2018, Fursova, Blackledge et al. 2019, Pivetti, 
Fernandez-Perez et al. 2019, Scelfo, Fernandez-Perez et al. 2019) and that, least for PCGF3 
and PCGF5, their involvement in active transcription has been validate (Zhao, Huang et al. 
2017, Scelfo, Fernandez-Perez et al. 2019).  
 
2.1.5 POLYCOMB BIOLOGY 
mESCs derive from the inner mass of the pre-implantation embryos at the stage of blastocyst 
and represent an excellent model system to study the mechanisms for establishing the correct 
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cell-fate acquisition and transitions, in fact they are pluripotent cells that when cultured in 
the correct environment can self-renew or can be induced to differentiate, recapitulating in 
vitro the three embryonal layers found in vivo (Aloia, Di Stefano et al. 2013). Polycomb 
complexes are highly expressed in ESCs where they are bound preferentially to CpG-rich 
promoters of genes encoding for developmental factors (Boyer, Plath et al. 2006, Bracken, 
Dietrich et al. 2006). Generally, ESCs possess an open chromatin structure with low levels 
of DNA methylation and high levels of activating histone modification that must be finely 
regulated to balance self-renewal and pluripotency, and differentiation (Orkin and 
Hochedlinger 2011). Upon differentiation the chromatin shift from a more open status to a 
more closed one with the concomitant accumulation of H3K27me3.  
For these reasons ESCs, are widely used in Polycomb field to perform mechanistic and 
biological studies. Moreover, both straight and conditional KO mouse models have been 
developed to study phenotypes arising from PcG loss, during embryogenesis and later 
development. Importantly, only in recent years Polycomb complexes started to be 
investigated in adulthood, thus only little is known about PRCs roles in adult tissue 
maintenance. 
PRC2 core subunits are necessary for early step of embryogenesis in vivo and straight KO 
mice for these subunits died early in post-implantation stages (Faust, Schumacher et al. 1995, 
O'Carroll, Erhardt et al. 2001, Pasini, Bracken et al. 2004). Notably, deficient mESCs can 
be derived from KO mice blastocysts. These mESCs do not display self-renewal impairment 
despite the loss of H3K27me2/3 and a pervasive activation of genes related to differentiation 
(Richly, Aloia et al. 2011). On the contrary ancillary proteins Jarid2 deletion cause defects 
in neural tube formation (at 15.5 dpc), and Pcl2 (Mtf2) results in loss of left-right symmetry 
in chicken embryos but results dispensable in mouse (Takeuchi, Yamazaki et al. 1995, 
Wang, Wang et al. 2004, Wang, He et al. 2007). Nevertheless, PRC2 plays an important role 
in embryonic and adult hematopoietic stem cells (HSCs). Ezh2 loss impairs embryonic HSCs 
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self-renewal but does not affect adult stem cell function in the bone marrow, except for 
lymphopoiesis. By contrast, in line with the different expression pattern of EZH1 and EZH2 
which are more expressed in differentiated and undifferentiated status respectively, Ezh1 
depletion highly affect adult HSCs total numbers, impairing HSCs self-renewal and 
quiescence, alleviating the repression of Ink4a/Arf locus and Bmp2 (Margueron and 
Reinberg 2011, Mousavi, Zare et al. 2012, Aloia, Di Stefano et al. 2013, Xu, On et al. 2015). 
Regarding PRC1, loss of RING1B activity results in embryonic lethality due to gastrulation 
arrest, while Ring1a KO mice are viable (de Napoles, Mermoud et al. 2004). Ring1b 
deficient ESCs shows reduced levels of H2AK119Ub1 and the deregulation of some target 
genes but maintain the expression of pluripotency markers (Richly, Aloia et al. 2011). 
Notably depletion of both PRC1 catalytic subunits severely impairs ES self-renewal (Endoh, 
Endo et al. 2008). 
In later development, mice in which Ring1b, Ezh2 or Eed is depleted in central nervous 
system shows impairment of this transition leading to an incorrect neuronal development 
(Hirabayashi, Suzki et al. 2009). Moreover, it has been demonstrated that RING1B is 
required for maintenance of neural stem cell in an undifferentiated status (Roman-Trufero, 
Mendez-Gomez et al. 2009).    
In accordance with the dispensability of PRC1 subunits, except for RING1B in mouse 
development, single PCGFs depletion in ESCs does not affect self-renewal properties, 
however it affects cell differentiation. This is the case for PCGF1 which is dispensable for 
ES colony formation and maintenance but PCGF1 KO cells fail to repress stem cell markers 
upon induction of differentiation (Yan, Zhao et al. 2017). Moreover, it has been 
demonstrated that PCGF1 is needed in HSCs to repress HoxA gene promoter in order to 
terminate self-renewal program in progenitor cells (Ross, Sedello et al. 2012). 
Mel18/ PCGF2 and Bmi1/ PCGF4 KO have been studied for long time, and their single 
genetic ablation results in defects in anterior-posterior specification of skeleton, while the 
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concomitant deletion of both canonical PCGFs results in a more severe developmental 
defects that results in mice death at 9.5 dpc (van der Lugt, Domen et al. 1994, Alkema, van 
der Lugt et al. 1995, Akasaka, Kanno et al. 1996). Moreover, Bmi1/PCGF4 has been largely 
investigated in hematological pathology and in hematopoietic stem cells (HSCs). It has been 
reported to inhibit the Ink4a/Arf locus, that encodes for p16 and p19 cell cycle inhibitors, 
and mice depleted for Bmi1 in HSCs show a reduced postnatal population of stem cells and 
impaired self-renewal (Park, Qian et al. 2003). Moreover, Bmi1 loss causes an aberrant 
activation of Ebf1 and Pax5 developmental genes that promotes a premature lymphoid 
lineage specification (Oguro, Yuan et al. 2010).  Interestingly, even though is reported as 
BMI1 paralog, Mel18 has been proposed as tumor suppressor via BMI1 downregulation 
(Zhang, Sheng et al. 2010), while in other cancer it can act as oncogene (Wiederschain, Chen 
et al. 2007), highlighting again the extreme variability of PRCs proteins among different 
contexts.   
Endoh and colleagues investigated the role of PCGF6 in mESCs and found that Pcgf6 KO 
affects the rate of cell proliferation without affecting the morphology of cells. Moreover, 
according to MAX ablation in ESCs, PCGF6 depletion leads to the ectopic expression of 
meiosis-related and germ-cell related genes. They also reported that ablation of Pcgf6 results 
in viable and fertile mice, although not at normal mendelian ratio. Lethality was observed at 
blastocyst stage of embryonic development and in post-implantation stages. Moreover, one 
third of embryos at 10.5 dpc exhibit growth retardation (Endoh, Endo et al. 2017).  
Lastly a role for PGF3/5 in correct ESCs development have been reported. Indeed loss of 
Pcgf3/5 results in a pronounced decrease of mesoderm markers, thus implying an active role 
in transcription of PCGF3 and PCGF5, as suggested by other reports (Gao, Zhang et al. 2012, 
Zhao, Huang et al. 2017, Scelfo, Fernandez-Perez et al. 2019).  
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Polycomb proteins have been shown to act also in skin development and maintenance. 
Interestingly, Ezh2 loss during embryonic skin development accelerates the differentiation 
process by transcriptionally upregulating epidermal-related genes, without affecting other 
PcG pathways. However, by birth, PRC2 histone mark reappears, shedding light on the 
possible compensatory effect of EZH1 postnatally. Importantly, loss of both Ezh1 and Ezh2 
affects general skin development, in two opposite ways: Hair follicles appendages, which 
derives from epidermal progenitors, shows a compromised formation and maintenance, in 
contrast the epidermis is hyperproliferative and survives long-term engraftment (Ezhkova, 
Pasolli et al. 2009, Ezhkova, Lien et al. 2011). Among the two complexes, PRC1 exert a 
major role in skin compartment. It has been reported recently that during epidermal 
development, PRC1 ablation in epidermal progenitors leads to fragile skin phenotype, with 
tissue thinning and mechanical stress susceptibility (Cohen, Zhao et al. 2019). Moreover, 
impaired hair follicle formation during epidermal development has been recently reported 
also for PRC1 ablation (Cohen, Zhao et al. 2018). 
Adult tissues are maintained by stem cells that sustain the cells renewal. Intestinal tissue are 
renewed in 5 days and stem cells located at the bottom of the tissues sustain this regeneration 
(Barker, van Es et al. 2008). PRC1 and PRC2 accomplish two different roles during adult 
intestinal homeostasis, as demonstrated by their respectively KOs in intestinal epithelium 
and intestinal stem cells (Chiacchiera, Rossi et al. 2016, Chiacchiera, Rossi et al. 2016, 
Chiacchiera and Pasini 2017). PRC1 depletion in intestinal stem cells (ISCs) leads to loss of 
stem cell identity and stem cell exhaustion affecting ISCs self-renewal potential, 
independently from Ink4a/Arf. On the contrary PRC2 is necessary to maintain the correct 
balance among secretory and absorptive lineage in the intestinal epithelium. Moreover, 
PRC2 ablation does not affect ISCs maintenance but is required for regeneration of the tissue 
upon irradiation.  
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Taken together this study highlight the extreme context dependency of PcGs and the need to 
deeply investigate these complexes in other models and in several tissues. Additionally, a 
deep knowledge about Polycomb roles in adult stem cell homeostasis and in their role in 
regeneration upon damage is still missing.   
 
2.1.6 POLYCOMB DEREGULATION AND CANCER 
Due to Polycomb role in development and differentiation regulation is not surprising that 
their deregulation frequently occurs in several cancer (Jones and Baylin 2007). 
Overexpression of PcG genes have been observed in either hematological malignances and 
solid tumors including Medulloblastoma and tumors originating from colon, liver, lung, 
breast and prostate (Raaphorst 2005). Moreover Polycomb genes have been shown to be 
recruited on chromatin by interacting with multiple chimeric fusion proteins such as PLZF-
RARA and TMPRSS2-ERG (Boukarabila, Saurin et al. 2009, Yu, Yu et al. 2010).  
Compare to PRC2, PRC1 seems to be less affected in cancer development probably for its 
fundamental role in stem cell maintenance, however some subunits have been found 
important in cancer development. Bmi1/PCGF4 collaborate with c-Myc oncogene in 
lymphomagenesis (Haupt, Bath et al. 1993), and is aberrantly expressed also in solid tumors 
including squamous cell carcinoma (Sparmann and van Lohuizen 2006). Bmi1/PCGF4 role 
as oncogene is further confirmed by its enhanced expression correlation with poor prognosis 
(Mohty, Yong et al. 2007, Shafaroudi, Mowla et al. 2008). Its oncogenic function has been 
mainly attributed to Ink4a/arf locus repression, however its paralog Mel18/PCGF2 shows 
tumor-suppressor features being frequently lost in cancer (Zhang, Sheng et al. 2010, 
Schwartz and Pirrotta 2013). However, as mentioned above, these differences are context 
dependent and Mel18 acts as oncogene in some cancer type. The same duality is maintained 
also for CBX7 that have been proposed as both oncogene and tumor suppressor in solid and 
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hematological tumors (Scott, Gil et al. 2007, Forzati, Federico et al. 2012, Klauke, Radulovic 
et al. 2013, Shinjo, Yamashita et al. 2014). 
 
PRC2 components are more involved and compromised in cancer. EZH2, SUZ12 and PCL3 
are frequently overexpressed in different tumors (Sparmann and van Lohuizen 2006). EZH2 
overexpression has been linked to aggressive and advanced metastatic stages of the 
pathology and is typically associated poor prognosis (Kleer, Cao et al. 2003). 
However, recent studies suggest a complex scenario for EZH2, which can act both as 
oncogene and tumor suppressor depending on the cellular context. For this reason, either 
activating or inactivating mutations can be found for EZH2. Interestingly, its overexpression 
seems to correlate more with solid tumors, while hyperactivating and inactivating mutation 
with hematological malignances (Ernst, Chase et al. 2010, Morin, Johnson et al. 2010, 
Sneeringer, Scott et al. 2010, Ntziachristos, Tsirigos et al. 2012).  
Of note, PRCs are involved in the regulation of pathways implicated in the emergence of 
cancer stem cells, such as Hedgehog, WNT and Notch pathways. Due to this role Polycomb 
deregulation has important implications. As an example, it has been demonstrated that WNT 
pathways is a major factor in colorectal cancer development (Zhao, Chen et al. 2009, 
Vermeulen, De Sousa et al. 2010, Takebe, Harris et al. 2011). Of note PRC1 depletion 
studies in murine intestinal epithelium has underly the necessity of a functional PRC1 for 
WNT driven intestinal cancer (Chiacchiera, Rossi et al. 2016).        
 
2.2 THE HAIR FOLLICLE 
The skin is the largest organ of the body and is the first barrier protecting animals against 
several insults, such as UV radiation, pathogens, dehydration and is constantly subjected to 
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several traumas (Fuchs 2016). In adults the tissue is maintained by stem cells that provides 
new cells to substitute the older and damaged ones.  
The skin is composed by two major compartments: the Interfollicular Epidermis (IFE) and 
the hair follicles (HFs), with its associated appendage, the Sebaceous Gland (SG).  
The IFE, or epidermis, is a stratified epithelium whose innermost layer, that is called Basal 
Layer (BL), is attached to a basement membrane, a structure composed by extracellular 
matrix and that is rich in growth factors. Among all the different layers that compose the 
epidermis, only the BL has the ability to proliferate. Once a cell divides, it detaches from the 
BL and migrate upward while differentiating. The outermost layer is composed by dead 
keratinocytes, the cells that compose the vast majority of the epithelium, that forms flattened 
scales that are sloughed from the skin and replaced continuously by the underlying 
keratinocytes (Fuchs 2016). 
 
Most mammals have hairs that guaranties warmth and protection (Fuchs 2016). Differently 
from IFE the hair follicle does not regenerate continuously. Instead, it encounters cyclical 
bouts of proliferation and hair growth (Anagen), followed by the destruction of exceeding 
cells (Catagen) and finally the quiescent phase (Telogen). Due to their abundance in mouse 
and their peculiar cycle, which stages are well characterized (Paus, Muller-Rover et al. 1999, 
Saxena, Mok et al. 2019), it emerged as one of the best systems to explore homeostasis and 
stem cells of adult tissue, with the possibility to explore both quiescent and resting phase of 
the stem cells and their differentiation.  
Murine HFs are specified during late embryogenesis and mostly develops after birth in a 
synchronized process called morphogenesis, that start the first cycle. By the end of the 
morphogenesis, approximately 16 days after delivery (Postnatal day 16, P16), the follicles 
are formed, and after catagen and telogen a new synchronized hair cycle begins at P28 (Paus, 
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Muller-Rover et al. 1999, Muller-Rover, Handjiski et al. 2001). This is the last synchronized 
wave of hair regeneration during mouse life and ends with a long quiescent phase named 
“long telogen” that last at least four weeks (from week 7, or from P49). After the long telogen 
phase, mouse fur starts to regenerate in an asynchronous way, forming patches of anagen, 
telogen and catagen follicles (Muller-Rover, Handjiski et al. 2001). However, it is possible 
to re-synchronize the hair cycle by waxing mouse back-skin and forcing the hairs to re-enter 
the anagen phase, that occurs normally without differences respect to spontaneous anagen 
(Muller-Rover, Handjiski et al. 2001).  At each cycle a new hair shaft is formed and the older 
one is eventually shed, for the vast majority of time in an active process called exogen 
(Schneider, Schmidt-Ullrich et al. 2009).        
Mature hair follicle is composed by several specialized parts that can be divided in two 
compartments: the first, that constitute the upper part of the HF, remains static throughout 
the cycle, and it is composed by the infundibulum, that is a transition zone between HF and 
Figure 2.4 Schematic representation of Hair follicle 
In the figure, taken from (Morgan 2008), are represented HFs during the proliferating (anagen) and 
resting (telogen) phase, showing the different cellular population within the HF.  
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IFE, the isthmus, where the arrector pili muscle is inserted, and the HF associated sebaceous 
gland; the second, the lower part of the hair follicle, changes during the cycle and actively 
participate to this process, and its composition changes during the different cycle phases 
(Schneider, Schmidt-Ullrich et al. 2009) (Fig 2.4). The quiescent follicle presents, in its 
lower part, the bulge, that houses stem cells and melanocytes, and the secondary hair germ, 
or hair germ (HG), that contains other stem cells, that will be discussed in the next sections. 
Anagen induces many changes in this lower follicle part, that greatly extend downward in 
the subcutis forming the bulb, that contains all the proliferating cells, the matrix 
keratinocytes and the HF pigmentary units that cooperate to form the new hair shaft. Also 
the bulge participate in this processes, although it do not change in morphology and 
positioning. Anagen phase will be discussed in detail in the following sections. 
Outside the HF structure an important associated mesenchymal structure is the Dermal 
Papilla (DP) that is composed by mesenchymal cells that cluster together forming a defined 
structure. Its role is to sustain anagen progression through the production and diffusion of 
signaling molecules, such as Fgf7 and Fgf10, that stimulate proliferation in the associated 
HF (Greco, Chen et al. 2009, Driskell, Clavel et al. 2011). 
 
2.2.1  MORPHOGENESIS  
Hair follicle cycle does not create new follicles, but only regenerate the hairs. HFs are 
specified in late embryonic development in a temporally and spatially tightly controlled 
process called morphogenesis (Paus, Muller-Rover et al. 1999, Saxena, Mok et al. 2019), 
that leads to the creation of adult HFs.    
Historically, the guide written by Paus and colleagues in 1999 dictated the basis for 
morphogenesis stage recognition (Paus, Muller-Rover et al. 1999). However, in the last 20 
years advanced mouse genetics, molecular and imaging methods have enabled numerous 
studies that increased our knowledge at phenotypical, functional and molecular levels, that 
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have been summarized by Saxena and coworker this year (Saxena, Mok et al. 2019). 
Morphogenesis requires the formation of two important structures, the placode (PC), in the 
developing epidermis, and the dermal condensate (DC) in the underlying mesenchymal 
subcutis. These two structures necessitate the activity of the WNT pathway to be specified, 
as demonstrated by the glabrous phenotype of mice depleted for WNT signaling mediator 
Wintless (Wls) in the epidermal progenitors and by beta-catenin ablation in the dermis 
(Zhang, Tomann et al. 2009, Chen, Jarrell et al. 2012). Before morphogenesis begin, at stage 
0, epidermis is a uniform layer of cells without any morphological signs or molecular 
specification of HFs formation. What is known is the presence of a widespread WNT 
signaling activity in the upper dermis, which is critical HF specification signal, called “first 
dermal signal”, that is still not identified (Zhang, Tomann et al. 2009). Absence of WNT 
signaling, either in epidermis or in the dermal compartment, results in absence of pre-PC in 
the epidermis (Saxena, Mok et al. 2019). During the first stages, the unknown dermal signal 
induces the specification of the pre-PC, that is morphologically undistinguishable from the 
epidermis, that still present a peculiar molecular pattern with active WNT signaling 
(Huelsken, Vogel et al. 2001, Andl, Reddy et al. 2002, Zhang, Tomann et al. 2009), Edar 
(Barsh 1999, Headon and Overbeek 1999, Schmidt-Ullrich, Tobin et al. 2006) and Fgf20 
(Huh, Narhi et al. 2013) expression. This specification induces the gradual formation of the 
DC that enlarge while the PC, that appears thicker and composed by tightly packed vertically 
oriented cells, starts to move downward in the underlying dermis. This invagination is 
concomitant with the expression of a master regulator of hair follicle cycle, Shh (Huelsken, 
Vogel et al. 2001, Rhee, Polak et al. 2006, Zhang, Tomann et al. 2009, Tomann, Paus et al. 
2016). Particularly, asymmetric division creates 2 layers of PC, the upper one expressing 
Sox9 and with diminished WNT signaling, that will specify for bulge-HFSCs, and the lower 
one that maintain Shh expression and active-WNT pathway that will specify for matrix (Mx) 
cells, and, at the end of morphogenesis for a second HFSCs population (Nowak, Polak et al. 
2008). At later stage hair peg is similar to an adult HF. Basal PC cells continue to express 
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Shh and Pcad, while the Outer Root Sheath (ORS) is starting to differentiate (Saxena, Mok 
et al. 2019) and the inner Mx start to produce the Inner Root Sheath (IRS) that develop the 
hair. In the next stages, the hair shaft is elongating and will exit from the hair canal emerging 
from the epidermis.  
After morphogenesis, the anagen hair follicles enter the first catagen phase. The ORS and 
the IRS shrink due to programmed apoptotic events. However, not all cells are lost during 
this process, but some ORS cells will constitute the HG that, together with the bulge, houses 
the HFSCs populations (Jaks, Barker et al. 2008). 
 
2.2.2  ADULT HAIR FOLLICLE: ANAGEN AND TELOGEN 
Anagen hair follicle is an elongated structure composed by several different concentric 
layers. The bulge characterizes the end of the permanent non-cycling region and is separated 
from the anagen bulb by a long stretch of suprabulbar epithelium. The bulb is composed by 
the Mx cells that rapidly proliferates to give rise to all the differentiated cells of the hair 
shaft. Full anagen hair follicle is composed by eight different concentric layers, each one 
expressing a peculiar keratins pattern (Schneider, Schmidt-Ullrich et al. 2009). At the 
outermost part of the HF it is identifiable the ORS, marked by LGR5 expression.  Deeper in 
the HF, the IRS is composed by the companion layer, Henle’s layer, Huxely’s layer and IRS 
cuticle. In the middle of the follicle reside the new hair shaft that is composed by the hair 
cuticle, the cortex, and finally the medulla (Schneider, Schmidt-Ullrich et al. 2009, 
Genander, Cook et al. 2014). To date, many molecular markers of HFs lineages have been 
discovered: among them, Gata3, Cut1 and BMPs are important for IRS formation, while 
Sox9 and Shh for ORS maintenance and formation (Schneider, Schmidt-Ullrich et al. 2009).     
 
Telogen can last up to several weeks. During this phase HFs are at their minimal size and 
comprises only quiescent stem cells in the bulge and in the HG, which is in close contact 
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with the DP. To date most of the transcriptomic studies on telogen follicles have been 
performed in bulk on the whole population of HFSCs, or on subsets of cell enriched for 
specific markers. However, recently, Joost and coworkers profiles the whole epidermis and 
the hair follicle at single cell level (Joost, Zeisel et al. 2016). This work revealed that telogen 
HFs are extremely heterogenous and different subpopulation can be identified within the 
follicle, confirming already known markers and expression gradients, but also discovering 
new markers and new cell populations. 
 
Hair follicle stem cells can be divided in two populations: a quiescent population in the bulge 
region, and a primed population in the lower bulge and in the HG (Hsu, Li et al. 2014). 
Stem cells in the bulge are characterized by the expression of K15 and CD34 surface marker 
(Cotsarelis, Sun et al. 1990, Trempus, Morris et al. 2003, Blanpain, Lowry et al. 2004, 
Morris, Liu et al. 2004) and shows the potential to retain histone labels over a long period 
(Braun, Niemann et al. 2003, Tumbar, Guasch et al. 2004). Initial studies, led to the creation 
of the “bulge activation hypothesis” model that foresaw, at the anagen onset, the activation 
of a subset of stem cells and their progeny-derived migration that ultimately creates the 
matrix (Cotsarelis, Sun et al. 1990, Oshima, Rochat et al. 2001, Cotsarelis 2006).  
In 2008, Jaks and colleagues identified a stem cell population marked by LGR5 expression, 
an orphan receptor previously identified as WNT target gene in colon cancer (Barker, van 
Es et al. 2007, Barker, van Es et al. 2008, Jaks, Barker et al. 2008). Through in vivo lineage 
tracing analyses carried out in Lgr5-CreERT2-Rosa26-LoxSTOPLox-LacZ mouse strain, 
the authors demonstrated that this population resides in the lower bulge area, where it 
partially overlaps with CD34 expressing cells, and in the HG. This population forms the 
ORS in anagen follicle, and part of these cells are maintained after catagen constituting the 
new lower bulge and HG (Ito, Kizawa et al. 2004). Moreover, they described that LGR5-
HFSCs are the first cells that proliferates during anagen and expresses genes indicative of 
an active Hedgehog pathway, such as Gli1 and Gli2, and importantly also Shh itself. In 
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contrast with the previous literature, CD34 or Bulge-HFSC population do not actively 
participate to anagen progression and they remain in the bulge area while anagen progress 
(Jaks, Barker et al. 2008). Importantly, bulk RNA-seq analyses revealed that bulge-HFSCs 
and HG-HFSCs are transcriptionally largely indistinguishable and interchangeable (Greco, 
Chen et al. 2009, Rompolas, Mesa et al. 2013). 
 
During anagen onset and progression LGR5-HFSCs are the first cells to respond to the 
proliferation stimuli, and importantly they have been shown to be necessary for hair follicle 
regeneration, and their loss impair HF cycle. However, CD34 bulge-HFSCs are able to 
reconstitute LGR5-HFSCs population, restoring HF cycle (Hoeck, Biehs et al. 2017), further 
demonstrating that LGR5 stem cells are necessary for anagen progression. 
The molecular detail of stem cell activation still remains unknown. However, telogen phase 
set a critical threshold for anagen induction that anagen-promoting factors must overcome 
to start a new hair cycle (Blanpain, Lowry et al. 2004, Lin, Chudova et al. 2004, Morris, Liu 
et al. 2004, Tumbar, Guasch et al. 2004, Rendl, Lewis et al. 2005). During telogen, BMP 
and WNT inhibition by TCF3 and DKKs impede stem cell activation. Cycle start when WNT 
activation, and consequently beta-catenin stabilization, combined with focal expression of 
BMP inhibitors in the DP is reached. Nevertheless, is not known how WNT signal is initiated 
(Fuchs 2007, Fuchs 2008), but it has been demonstrated that waves of BMP signals occurs 
in the telogen dermis, thus defining high BMP telogen phases, during which HFs are 
refractory to proliferation, and low BMP telogen phases which render HFs competent to 
anagen induction (Plikus, Mayer et al. 2008). At the anagen onset, HG promptly proliferates 
as first (Greco, Chen et al. 2009, Lien, Polak et al. 2014), develops into the Mx, a pool of 
Transient Amplifying cells (TACs) that rapidly proliferate and terminally differentiate to 
form the IRS and the hair shaft. Lower bulge stem cells proliferate to form the ORS, that 
envelop the other HF structures (Hsu, Pasolli et al. 2011, Rompolas, Mesa et al. 2013). 
During early anagen phases, the upper bulge starts to cycle few times, induced by short-
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living progenitors derived from the lower bulge that start to express Shh, generating the new 
bulge for the next hair cycle and replenishing the niche, however, the bulge progressively 
moves away from the DP thus returning to quiescence (Hsu, Pasolli et al. 2011, Hsu, Li et 
al. 2014, Hsu, Li et al. 2014). Matrix cells, in contrast move downward engulfing the DP 
and continue to proliferate, sustained by active WNT and SHH pathways. Moving away, due 
to their division, from the proliferating part of the bulb and entering into the pre-cortical 
matrix, the cells start to terminally differentiate and to create the hair shaft (Schneider, 
Schmidt-Ullrich et al. 2009).     
 
During catagen, TAC undergoes apoptosis, however some ORS sparse cells remains, 
forming the new HG. Nevertheless, one inner layer of terminally differentiated K6 positive 
cells, the companion layer, remain in the telogen follicle, anchoring the hair and providing 
inhibitory signals to the HFSCs of both bulge and HG, through BMP6 and FGF18 expression 
(Hsu, Pasolli et al. 2011). 
 
2.2.3 PATHWAYS IN HAIR FOLLICLE STEM CELLS 
Several pathways are important for the correct maintenance of HF during all cycle phases. 
Among them the most important are Hedgehog pathway, specifically SHH, WNT/beta-
catenin and BMP-antagonist, that boost the cell cycle, and BMP and FGF that, conversely, 
induce cycle arrest or catagen (Hebert, Rosenquist et al. 1994, Paus and Foitzik 2004, 
Cotsarelis 2006). 
Hedgehog signaling pathway controls several different processes, among them cell growth, 
survival, cell fate, and pattern specification (Varjosalo and Taipale 2008). SHH molecule 
binds to its receptor Patched (Ptc) activating a signaling cascade that drive the activation of 
zinc-finger TFs GLI1-3, that in turn modulate the expression of their target genes. In the 
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absence of SHH, Ptc inhibit Smoothened (Smo) transmembrane proteins, that is required for 
GLI2 and GLI3 stabilization and Gli1 transcription (Cohen, Kicheva et al. 2015).   
 
In HF, SHH pathway is essential for its formation and its proliferation during anagen 
progression (St-Jacques, Dassule et al. 1998, Chiang, Swan et al. 1999). LGR5-HFSCs 
express high levels of GLI1 and GLI2, and importantly also present abundancy of Shh 
transcript level, addressing a possible autocrine function to reinforcing this pathway in 
LGR5-HFSCs (Jaks, Barker et al. 2008). In a recent work by Zhang and colleagues (Zhang, 
Tsai et al. 2016), in vivo depletion of Shh from K15 expressing cells, that specify for both 
bulge and HG stem cell population, shows the essential role of this pathway also in the 
flanking environment. Particularly, Shh deletion in K15 generates a TAC population 
deprived for this molecule that is impaired in proliferation, resulting in early anagen block.  
 
Another important player governing HFs development and adult cycle is the WNT pathway. 
This pathway is activated when WNT ligand engage its receptor complex Frizzled-LPR5-
LPR6. This binding inhibits beta-catenin destruction, continuously exerted by Adenomatous 
Polyposis Coli (APC) within the so called “destruction complex”, leading to beta-catenin 
nuclear accumulation. In the nucleus TCF/LEF family members, already localized on 
chromatin are repressed by Groucho binding. When beta-catenin enters the nucleus it is able 
to bind TCF/LEF protein unseating TLE/Groucho from the complex, thus leading to 
transcriptional regulation of beta-catenin targets (Nusse and Clevers 2017). As previously 
mentioned, WNT pathway exert a major role in HF development. Indeed, mice that 
ectopically express WNT inhibitor that impede LPR binding to Frizzled, shows a complete 
impairment of HFs morphogenesis, preventing the expression of PC molecular markers and 
its specification (Andl, Reddy et al. 2002).    
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Interestingly, mice expressing the non-degradable form of beta-catenin in epidermal 
progenitors shows an accelerated and excessive PC formation, however, most of the 
developing HFs failed to produce hair, suggesting that a tight regulation of beta-catenin in 
both proliferation and differentiation is needed (Narhi, Jarvinen et al. 2008).   
 
WNT pathway is counteracted by BMP inhibitory signal. Indeed, the balance between these 
two pathways set a critical threshold that has to be overcome to induce HF in anagen 
(Schneider, Schmidt-Ullrich et al. 2009).  
 
BMP belongs to the TGF-Beta family of secreted signaling molecules. BMP binds to its 
membrane receptor BMPRI or ALK2-6, activating the signaling pathway. This receptor-
ligand binding is followed by the recruitment of BMPRII which phosphorylate BMPRI 
leading to its activation, thus starting a cascade of phosphorylation events that involves 
receptor-regulated SMAD (R-SMAD1/5/8), that in turn activates SMAD4, the effector 
SMAD protein, that translocate into the nucleus and activates transcription of its target. 
 
BMP signaling is important to tightly regulate the resting phase of the HF cycle. During 
telogen BMP2/4 are expressed, thus making HFs refractory to growth stimulation 
(Schneider, Schmidt-Ullrich et al. 2009). Importantly when quiescent HFSCs are depleted 
for Bmpr1a they rapidly adopt features of activated HFSCs, progressing in the cell cycle, 
without the possibility to return to quiescence, however, these bulbs do not form any hair 
shaft and most of them transform in cyst structure, highlighting BMPs important role, not 
only in governing quiescence, but also in differentiation programs (Genander, Cook et al. 





2.2.4 POLYCOMB AND HAIR FOLLICLES 
 
The high grade of stem cell plasticity is tightly governed at epigenetic and transcriptional 
level. In 2009 Ezhkova and colleagues showed that lineage definition and progression of the 
hair follicle is governed, at least in part, by PRC2 complex, through the repression and the 
de-repression of chromatin (Ezhkova, Pasolli et al. 2009, Ezhkova, Lien et al. 2011). In the 
same year, Lien and colleagues analyzed the different chromatin states of various HFs 
populations: anagen HFSCs, quiescent HFSCs and the derived TAC (Lien, Guo et al. 2011). 
They identify some genes whose transcriptional repression change during lineage 
progression, as an example, matrix related genes are silenced in both quiescent and anagen 
HFSCs, while become activate in TAC population. On the contrary stemness genes are 
repressed in TAC and devoid of H3K27me3 PRC2 mark in both quiescent and anagen 
HFSCs, showing that epigenetics plays a fundamental role in tightly regulate lineage 
choices.  
Recently, it has been demonstrated that both PRC2 or PRC1 loss, severely affected HFSCs 
formation (Ezhkova, Lien et al. 2011, Dauber, Perdigoto et al. 2016, Cohen, Zhao et al. 
2018). Remarkably, these works were performed during morphogenesis, the process that 




Intestine is the second most extended epithelial tissue of the body (Gehart and Clevers 2019). 
Being an interface with the external environment, it accomplishes two main functions: it is 
deputed to nutrients uptake meanwhile guaranties protection against the harsh environment. 
Several insults from luminal content damage intestinal cells, inducing a high rate of cell 
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death every day. Thus, tissue must be renewed constantly throughout the entire life, without 
losing its absorptive and protective function, and it has been estimated that a new epithelial 
tissue is renewed and formed in 3 to 5 days. Intestine divides into two major parts: the small 
intestine, that exert the absorptive role, which is further subdivided in duodenum, jejunum 
and ileum, and the large intestine, which functions are water re-absorption and undigested 
contents compaction, and is composed by caecum, proximal and distal colon and rectum.  
The intestinal epithelium is structured in functional modules constituted by crypts-villus 
units (Barker 2014) (Fig 2.5). Absorptive function is mainly carried out by enterocytes that 
are present on the villi, that compose the differentiated part of the intestinal tissue. Villi are 
finger-like protrusion that spread from the intestinal surface toward the lumen, enormously 
increasing the absorptive surface of the epithelium. In the opposite direction, epithelial 
invaginations form the less differentiated and staminal part of the tissue, the intestinal crypts 
of Lieberkün, where the intestinal stem cells (ISCs) that sustain tissue regeneration are 
housed (Barker 2014). Each villus is surrounded by at least six crypts cooperating to 
maintain the villus cell population.  
Intestinal epithelium is composed by several different cell populations that are more or less 
represented in the tissue depending on the intestinal tract. 
Differentiated cells are located mainly along the villi and comprise: the Enterocytes, that 
accomplish the absorptive role; the Goblets cells, that produce the mucins, needed for 
modulating the interaction among intestinal epithelium and intestinal bacterial population 
and, in the last part of the small intestine, to help the passage of compact stools in the colon 
(Birchenough, Johansson et al. 2015); the Enteroendocrine cells, that produce hormones 
needed to regulates the digestive system (Worthington, Reimann et al. 2018). Rarer  
populations are the Tuft cells, which role is to rapidly increase in cell number and to 
promptly activate type 2 immune response during helminths inflammation (Howitt, Lavoie 
et al. 2016), the Cup cells, whose function is not known and the M cells, that reside on 
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lymphoid Peyer’s patches and transport antigens from the gut lumen to the underlying 
lymphoid tissue. 
 
At the crypts base, a high cycling stem cell population fuels tissue regeneration producing 
transient amplifying cells that are pushed upward in the luminal compartment and exit the 
crypt within two days. Paneth cells, the only differentiated cells in the crypts, contribute to 
protective role producing and secreting defensins and lysozyme to help the antimicrobial 
protective role (Bevins and Salzman 2011). Importantly, Paneth cells escape this upward 
migration and conversely migrate downward to re-occupy the crypt base where they can 
remain from 6 to 8 weeks (Scoville, Sato et al. 2008, Barker, van Oudenaarden et al. 2012) 
(Fig 2.5).  
As mentioned above, intestine encounters high damage rate and cell death. Therefore, crypts 
containing stem cells must be well protected from the harsh environment to minimize their 
damage. First, crypts are not in close contact with digestive and absorptive system, and they 
are connected to the lumen only with a 6um opening that limited the exchange. Secondly, 
mucus produced by Goblet cells, physically creates a barrier over this opening.  
 
Within the crypt, Paneth cells plays a fundamental role in ISCs protection. This cell type 
produces a wide variety of antimicrobial products such as lysozyme, defensins and 
phospholipase A2 that, not only protect the stem cells but are exported in the lumen as 
integral part of mucosal protection (Gehart and Clevers 2019). Despite the protective 
environment, stem cells can suffer mutations, toxins and other environmental factors. Stem 
cell competition provide another mechanism for tissue protection, limiting the ability of 
deteriorated cells to create their progeny. The limited space of the crypt creates this 
competition that stochastically leads to either loss or dominance of one clone in a single 
crypt. Cells that displays mutations that delay their division or provoke irregular cell cycle 
or enhance apoptosis, are displaced from the intestinal tissue, limiting the insurgence of 
 53 
neoplastic proliferation to those cells that can proliferate outside the stem cell niche (Gehart 
and Clevers 2019).    
Paneth cells are interspersed with ISCs, putting in close contact ISCs with at least one Paneth 
cell. At the crypt base, Paneth cells do not contribute only to stem cells and intestine defense, 
but they also provide nourishment for ISCs. Paneth cells are source of WNT ligand, 
epidermal growth factor (EGF) and Notch signaling (Sato, van Es et al. 2011). Recently it 
has been discovered that Paneth cells and ISCs has different metabolism: while stem cells 
depend on mitochondrial oxidative stress, Paneth cells undergoes glycolysis with lactate as 
end product (Rodriguez-Colman, Schewe et al. 2017). Importantly, lactate is used in ISCs 
as substrate for mitochondrial metabolism. Of note, oxidative metabolism is a source of 
DNA damage, however lactate has been shown to act as a radical scavenger and antioxidant 
in vitro, open the possibility that lactate can both boost ISCs metabolism and protect them 
from oxidative stress.  
Mesenchymal cells provide another important source of signals for stem cell niche 
specification and maintenance. Fibroblast, myofibroblast, pericytes, neural cells, vascular 
cells and smooth muscle, do not create only a physical and structural support for the tissue, 
Figure 2.5 Schematic representation of intestinal tissue 
In the figure, taken from (Gehart and Clevers 2019), the intestinal tissue, with enlargement on 
the crypts and villi structures. In the pictures are represented the major cell types constituting 
the differentiated and the undifferentiated compartment. 
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but they provide signals that help to regulates stem cell behavior (Gehart and Clevers 2019). 
Several studies have pointed out the important role of mesenchymal cells as source of WNT, 
R-Spondin, BMPs and BMP inhibitor, however, a deep characterization of cell population 
is still lacking. Importantly, also crypts influence the microenvironment through ligands 
secretion such as Sonic and Indian Hedgehog, that are important for smooth muscle 
maintenance in adult tissue.          
During homeostasis ISCs, also known as Crypt base columnar (CBCs) cells for their 
morphology, give rise to all differentiated cells types in the intestinal tissue meanwhile 
maintaining the ISCs population. To face the high rate of cell death and damage that occurs 
at the top of the villi, they proliferate every 24 hours, generating the transit amplifying (TA) 
progeny that localize in the middle of the crypts and that in turn divide every 12-16 hours to 
sustain the massive intestinal cells loss, migrating upward while differentiating (Barker 
2014, Leung, Tan et al. 2018).  
However, adult stem cells are crucial also for tissue regeneration after injury. In adult 
intestinal tissue two different stem cell population have been described: beside CBCs, 
committed precursors derived from columnar cells, the so called +4 cells, can dedifferentiate 
into a multipotent state and participate to intestinal regeneration. This mechanism requires a 
high rate of cell plasticity that is established and maintained through particular chromatin 
state that characterize intestinal crypts cells (Elliott and Kaestner 2015, Beumer and Clevers 
2016, Leung, Tan et al. 2018). This high plasticity give rise to two different models for tissue 
homeostasis: the “stem cell zone mode” and the “+4 model”. 
Initially, in 1977, the mapping of long-lived cells containing all cell lineages, drived the 
postulation of “+4 model” as stem cells governing tissue homeostasis. In this model stem 
cells were positioned just above Paneth cell at the +4 position from the crypt base (Potten 
1977). CBCs as intestinal stem cells were discovered in the same years by Cheng and 
Leblond (Cheng and Leblond 1974), however, it was only twenty years later that Bjerknes 
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and colleagues challenged the “+4 model” proposing the “stem cell model” where CBCs 
were identified as the intestinal stem cells (Bjerknes and Cheng 1999).  
Despite the great advance in intestinal stem cells identification, only in 2007 Barker and 
colleagues, provides, through genetic mouse model and lineage tracing analyses, the proof 
for CBCs stemness (Barker, van Es et al. 2007, Barker, van Es et al. 2008). As first, based 
on a study of WNT pathway in cancer cell lines, Lgr5 (Leucine-rich repeat-containing G-
protein coupled Receptor 5) was identified as one of the best targets of this signaling cascade. 
The generation of the mouse model Lgr5-CreERT2-Rosa26-LoxSTOPLox-LacZ, that 
enable the visualization of the progeny derived from LGR5 expressing cells, reveals that 
LGR5 is an effective marker of CBCs intestinal stem cells and that from these  proliferating 
cells, ribbons of LacZ marked cells progressively extend from crypts bottom to the villi tips 
(Barker, van Es et al. 2007, Barker, van Es et al. 2008). 
 However, other genetic studies, addressed +4 cells as a second long-term stem population 
within the crypts and in the last years new studies contributed to clarify the molecular 
identity of this stem cell reserve (Sangiorgi and Capecchi 2008, Montgomery, Carlone et al. 
2011, Takeda, Jain et al. 2011, Powell, Wang et al. 2012). Buckzaki and colleagues 
demonstrated that after a transient H2B-GFP expression, that is diluted and lost in several 
cell division, two distinct population retains GFP expression: Paneth cells and a cell 
population characterized by both Lgr5 and +4 markers expression. Additionally, these cells 
express markers of differentiated secretory cells and contribute to Paneth cells formation 
during physiological tissue renewal. However, after irradiation, these long-lived cells revert 
to a multipotent state regenerating the whole intestinal epithelium (Buczacki, Zecchini et al. 
2013). Further experiments demonstrated that upon LGR5 expressing cell loss, by irradiation 
or with genetic models to induce specific cellular death, CBCs are depleted from the tissue 
and the homeostatic regeneration is lost. Indeed, within few days after CBCs loss, LGR5-
expressing cells reappears and perfectly reconstitute the tissue. This regeneration is impaired 
if reappearance of LGR5 expressing cells is continuously blocked, meaning that CBCs are 
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essential for tissue regeneration (Dekaney, Gulati et al. 2009, Tian, Biehs et al. 2011, van 
Es, Haegebarth et al. 2012, Metcalfe, Kljavin et al. 2014). 
 
In this new model two coexisting stem cell populations participate to intestinal epithelium 
maintenance, the LGR5-CBCs expressing cells that replenish the intestinal tissue during 
homeostatic conditions, and long-lived cells serve as a stem cells reserve-pool in case LGR5-
ISCs are lost upon tissue damage or generally when needed (Tetteh, Farin et al. 2015).  
 
Still, this ability of dedifferentiate to drive tissue regeneration, seems to be wider than 
expected and other reports identified new precursors of both absorptive and secretory 
lineages as cells involved in stem cell pool and tissue regeneration after damage, highlighting 
the importance of dedifferentiation to ensure the tissue maintenance (Gehart and Clevers 
2019).    
 
2.3.1  PATHWAYS IN INTESTINAL TISSUE 
This elaborate organization is maintained throughout a complex network of interactions 
among different cell types.  
 
The most important and studied are Wingless integration site (WNT), Bone Morphogenetic 
Protein (BMP), NOTCH and Epidermal Growth Factor (EGF) pathways.   
To ensure tissue regeneration different pathways tightly regulates cells fate determination. 
The most important and studied are Wingless integration site (WNT), Bone Morphogenetic 
Protein (BMP), NOTCH and Epidermal Growth Factor (EGF) pathways.   
 
The WNT pathway is tightly correlated with stemness, in fact mutations in its components 
are the first cause of colorectal cancer onset and development. WNT ligands binds to 
Frizzled-LPR5-LPR6 receptor complex, that inhibit beta-catenin destruction, leading to 
 57 
nuclear accumulation and, upon binding with TCF/LEF family members, transcriptional 
regulation (Nusse and Clevers 2017). 
The role of WNT pathway during homeostasis has been intensively investigated with 
different approaches both in vivo and in vitro. A gradient of WNT ligands is established in 
intestinal compartment, starting from the crypt base, where it reaches the higher 
concentration, and being lost at the interface between crypt and lumen. Importantly, during 
development WNT is necessary for Paneth cells specification, that subsequently become the 
main source of WNT ligands (van Es, Jay et al. 2005). Inhibition of WNT signaling severely 
affects intestinal epithelium leading to stem cell loss and rapid animal death (Fevr, Robine 
et al. 2007, van Es, Haegebarth et al. 2012). Others important players in WNT signaling are 
R-Spondins soluble proteins. Despite the abundance of WNT ligands at the crypt base, their 
ability to activate the pathway rely on R-spondin binding to LGR5 receptor. This binding 
provokes the sequester of RNF3 or ZNRF3 E3 ligase that, when free, ubiquitinates the 
Frizzled receptor, thus leading to its degradation. Indeed, R-Spondin/LGR5 interaction 
results in increased sensitivity to WNT pathway (de Lau, Peng et al. 2014).     
 
BMP belongs to the TGF-Beta family of secreted signaling molecules, and the pathway is 
activated when BMP engages its membrane receptor BMPRI or ALK2-6, followed by the 
recruitment of BMPRII which phosphorylate BMPRI leading to its activation. A sequent 
cascade of phosphorylation events involves R-SMAD1/5/8, that activate the effector 
SMAD4, that translocate into the nucleus and activate transcription of its targets. Conversely 
to WNT, BMP restricts the stemness potential in the crypts, and its gradient is opposed to 
the WNT ones, starting from the villus and diminish reaching the crypt base. BMP signal 
cascade is able to negatively regulate the stem cell specific transcriptional program (He, 
Zhang et al. 2004, Qi, Li et al. 2017). 
 In the crypt, BMP inhibitor molecules, such as Noggin and Gremlin 1-2, tightly titrate the 
free BMP, thus impeding stem cell exhaustion.  
 58 
 
NOTCH pathway is one of the most direct form of cell-to-cell communication. The 
canonical transduction molecule involves a ligand, tethered on the cell membrane that binds 
the transmembrane receptor on the adjacent cell. In mammals five different ligands (DLL1, 
3, 4 and Jagged1, 2) and four notch receptors (NOTCH1-4) exist. Ligand-receptor binding 
induces Notch cleavage by gamma-secretase and the release of notch intracellular domain 
(NCID) that translocate into the nucleus. RBPJ is a transcriptional repressor in absence of 
signal, however, upon NCID binding, the dimers recruit MALM1-4 resulting in 
transcriptional activation of the target genes. NOTCH signaling is able to activate either 
proliferation, differentiation or cell death depending on the context. In the small intestine 
NOTCH ligands are expressed by secretory precursors and Paneth cells, while stem cells 
express NOTCH1 and 2. Genetic ablation of NOTCH 1 and 2 or their ligands DLL1 and 4 
induces stem cells and TA cells to differentiate toward the secretory lineage, severely 
impairing the absorptive ability of the intestinal epithelium (Sato, van Es et al. 2011, 
Guruharsha, Kankel et al. 2012, Sancho, Cremona et al. 2015). 
 
Last, EGF-ERBB pathway comprises four transmembrane receptor tyrosine kinases 
(EGFR/ERBB1, ERBB2-4) and 13 secreted ligands, all sharing the epidermal growth factor 
domain. Upon ligand binding, ERBB1 and ERBB4 can form homodimers or heterodimers, 
that activate the signaling cascade. Phospho-activated receptors can bind different adaptor 
proteins responsible for RAS GTPase recruitment and MAPK cascade activation.  
EGF signaling pathway promotes intestinal cell growth and proliferation, as demonstrated 
by mice lacking or defective for EGF pathway components (Miettinen, Berger et al. 1995, 





2.3.2  POLYCOMB AND INTESTINE 
Signaling pathways converge on chromatin to tightly regulate cell differentiation. Several 
are the TFs and the epigenetic players involved in this tight and complex network, and some 
of them shows fundamental roles.  
Secretory lineage specification is controlled by NOTCH signaling pathway through HES1, 
a direct NCID target. Hes1 is expressed in proliferating cells and is required for ISCs and 
TA cells maintenance (Kayahara, Sawada et al. 2003, Suzuki, Fukui et al. 2005). Loss of 
NOTCH signaling or Hes1 deletion leads to the upregulation of ATOH1 TF (Jensen, 
Pedersen et al. 2000, Ueo, Imayoshi et al. 2012), that can be considered the master regulator 
of secretory lineage, as demonstrated by the lethality due to the complete absence of 
secretory cells in Atoh1 deficient mice (Yang, Bermingham et al. 2001). On the contrary 
ATOH1 ectopic expression results in prenatal death due to the complete transformation of 
intestinal cells in secretory cells (VanDussen and Samuelson 2010). These data demonstrate 
that ATOH1 is necessary and sufficient to specify for secretory lineage, and its expression 
must  be strictly regulated.  
Epigenetic analyses of H3K27me3 PRC2 mark along the crypts-villus axis revealed that 
almost 40% of repressed genes in enterocytes are active in ISCs, among them Myc, Ascl2 
and Lgr5 (Jadhav, Nalapareddy et al. 2016). In non-secretory cells Atoh1 promoter is 
enriched for H3K27me3 and inhibition of NOTCH signaling correlates with PRC2 mark 
decrease and Atoh1 increase (Chiacchiera, Rossi et al. 2016). Accordingly, EED loss, 
leading to the disruption of PRC2 activity, increases Atoh1 levels and expand goblet and 
enteroendocrine cells populaitons, meaning that PRC2 activity is essential to maintain 
repressed Atoh1 in cells where it should be silenced. 
However, Polycomb plays other important role in intestinal tissue. PRC2 is required for 
intestinal regeneration when LGR5 population is lost, as upon irradiation, by repressing 
INK4A/ARF locus (Chiacchiera, Rossi et al. 2016). On the other hand, independently from 
p16 and p19 activation, PRC1 is strictly required to maintain stem cell identity, preserving 
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the correct transcriptional profile, by repressing non-lineage-specific genes. In PRC1 
deficient mice, the massive upregulation of genes belonging to other cell types, directly 
interfere with TCF4/beta-catenin binding, leading to stem cell loss (Chiacchiera, Rossi et al. 








2.4  AIMS  
Cell identity is an essential feature that is preserved, controlled and modulated throughout 
life. In this context, PcG proteins exert a critical role defining transcriptional identity during 
development as well as during adult tissue homeostasis. Our laboratory has previously 
demonstrated that PRC1 activity is fundamental for ISCs identity and for the integrity of the 
whole intestinal tissue. An important aspect of Polycomb biology, starting from its 
pathological behavior in cancer settings, suggest that PcG activity in adult tissue is highly 
context dependent. This may also involve the high biochemical heterogeneity that exist 
among Polycomb Repressive complexes with a particular emphasis on PRC1 activity that 
can exist in six distinct sub-forms. Therefore, taking advantage of LGR5-GFP-ires-
CreERT2/Ring1a-/-/Ring1bfl/fl/Rosa26Lox-stop-Lox LacZ mouse model, the major aim of 
this project is to investigate the role of PRC1 in a different stem cell compartment in which 
the LGR5 receptor is expressed: the hair follicle. This tool allowed us to compare two 
different adult cycling stem cells, that develop from different embryonic layers, during adult 
tissue homeostasis. This will provide understanding about PRC1functional similarities and 
specificities in these two stem cell populations at a molecular level, thus defining if and how 
cell identity and the associated environment are able to reshape Polycomb activity. 
Furthermore, since PRC1 activity is divided in six different biochemical complexes that are 
specified by the expression of the six distinct and mutually exclusive PCGFs paralogues, the 
second aim of my project is to translate the knowledge generated in our laboratory in more 
simple models such as embryonic stem cell in a more complex biological system like the 
intestinal epithelium. To achieve this, we decided to deeply investigate PCGFs biological 
function taking advantage of tissue-specific conditional KO mouse models to define the role 
of each PCGF protein, thus of PRC1 sub-complexes, respect to the general role that PRC1 






3. MATERIALS AND METHODS 
 
3.1  ETHIC STATEMENT 
Mice were maintained accordingly to the guidelines set out in Commission Recommendation 
2007/526/EC, 18 June 2007, on guidelines for the accommodation and care of animals used 
for experimental and other scientific purposes. All experiments were performed in 
accordance with the Italian Laws (D.L.vo 116/92 and following additions), which enforces 
EU Directive 86/609 (Council Directive 86/609/EEC of 24 November 1986 on the 
approximation of laws, regulation, and administrative provisions of the member states 
regarding the protection of animals used for experimental and other scientific purposes. 
 
3.2  MOUSE MODELS 
LGR5-specific conditional knockout mice were generated crossing a C57BL6 strain straight 
knockout for Ring1a (Ring1a-/-) through the insertion of a PGK-HPRT deletion cassette  (del 
Mar Lorente, Marcos-Gutierrez et al. 2000), and with LoxP sites flanking exons 3 to 5 of 
Ring1b (Ring1bfl/fl) (Cales, Roman-Trufero et al. 2008) with LGR5-GFP-ires-CreERT2 
(Barker, van Es et al. 2007). These mice were further crossed with Rosa26lox-stop-lox LacZ 
transgenic mice for in vivo lineage tracing (Barker, van Es et al. 2007). Specific PCGFs 
conditional KO mice, that allow the depletion of different exons of the various genes, were 
bred either with LGR5-CreERT2 and Rosa26lox-stop-lox Lacz or AhCre background 
strains, which are described below. The correctness of the genotype was confirmed by 
polymerase chain reaction (PCR) with specific primers performed on genomic DNA 
extracted and purified from tail or ear skin, as described in the next paragraph.  
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Cre-recombinase protein is an enzyme that directs recombination between two strands of 
DNA with specific sequences called loxP sites (“locus of crossover in Phage P1”) (Oumard, 
Qiao et al. 2006). Upon Cre activity, the removal of the genomic region between the loxP 
sites induces the deregulation of the target genes. Ring1b recombination elicits the start 
codon of the transcript thereby, inhibit the start recognition and consequently the 
transcription and the protein production. On the contrary, LacZ transcript is blocked by the 
presence of an upstream STOP codon that is removed by Cre cleavage, thus permitting beta-
galactosidase expression and translation.  
LGR5-GFP-ires-CreERT2 transgene constitutively expresses, only in LGR5-expressing 
cells, a Cre-recombinase protein fused to a modified fragment of the Estrogen Receptor, that 
Figure 3.1 Schematic representation of the mouse model used 
The mouse strain is homozygous straight knock-out for Ring1a gene and harbor floxables 
alleles for Ring1b genes. It has been further complemented with a lineage tracing construct, in 
homozygosity, that allows the expression of LacZ gene after the removal of a stop cassette 
inserted before the LacZ start codon.  
Cre Recombinase and GFP are under the LGR5 promoter that allows their expression only in 
cells where the receptor is expressed. Cre-ERT2 encodes for a cytoplasmic therefore inactive 
form of the enzyme that is translocated in the nucleus upon tamoxifen metabolites binding.  
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sequesters the enzyme in the cytoplasm, where it cannot exert its function. The estrogen 
receptor antagonists (i.e. Tamoxifen molecule) (Fig 3.1) binds the ERT2 fragment of the 
fusion protein, enabling its nuclear translocation where it can actively cleave loxP sites.  
Differently from LGR5-specific CreERT2 expression, Rosa26lox-stop-lox LacZ possess a 
more ubiquitous expression potential thanks to ROSA26 promoter, however beta-
galactosidase transcript can be expressed only upon Cre nuclear import, thus limiting LacZ 
expression only in LGR5 stem cells and their progeny in our mouse model.  
 Cre mediated recombination of LGR5-CreERT2 strains was induced by performing four 
intraperitoneal injection of Tamoxifen (Sigma-Aldrich) dissolved at 75mg/kg in corn oil.  
Tamoxifen is a prodrug that possess little affinity for the ER, indeed, to obtain the active 
molecule is metabolized in the liver by Cytochrome P450 to 4-hydroxytamoxifen (4-OHT) 
or N-desmethyl-4-hydroxytamoxifen (Desta, Ward et al. 2004). 
AhCre mouse model (Ireland, Kemp et al. 2004) mediate Cre recombinase expression upon 
CYP1A1 promoter which is highly activated by lipophilic xenobiotic binding. Induction of 
Cre transcription is obtained by 4 intraperitoneal injection of beta-naphthoflavone dissolved 
at 80 mg/kg in corn oil. This mouse model allows Cre expression in whole intestinal 
epithelium, with the only exception of Paneth cells.  
 
3.3  GENOTYPES 
Skin from tails or ears were conserved at RT for few days in 100% ethanol until the 
extraction. Ethanol was discarded and the samples were washed with 1X PBS to remove the 
remaining alcohol. Samples were digested in 200 L Digestion buffer (TRIS-HCl pH 7,5 10 
mM, EDTA pH8 10 mM, NaCl 10 mM, SDS 0,5%) with 0.5 mg/ml Proteinase K at 52°C 
for at least 5 hours or overnight shaking. Digested tissues were then purified by adding 1 
volume of each Guanidine thiocyanate solution (Guanidine Thiocyanate 0,345 g/ml, EDTA 
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pH8 10 mM, TRIS-HCl pH 7,5 10 mM, NaCl 10 mM) and 75% Ethanol. The mixture was 
vortexed, transferred to EconoSpinTM Spin Column for DNA (Epoch Life Science), fudge to 
13000 RPM for 3’ at RT and the flow-through was discarded. The column was then washed 
with 500 L of Washing Buffer (Ethanol 25%, 2-Propanol 25%, NaCl 100 mM, TRIS-HCl 
pH8 10 mM) and subsequently with 600 L of 75% Ethanol, removing the flow-through 
after each centrifugation. The column was dried fudging 5’ at 13000 RPM at RT and the 
DNA were eluted in 50 l of DNase-RNase free water.  
5 L of this DNA were used for each PCR.   
 
3.4  HAIR FOLLICLE PURIFICATION 
LGR5 positive stem cells were purified from back skin of treated mice at different time 
points according to the experimental plan. After mice were euthanized, the fur was removed 
with razor and back skin near the tail were lifted with tweezer and cut, gently peeling the 
skin from the underlying tissue. Back-skin obtained were washed in ice cold PBS, laid and 
pin, without over-stretching the tissue, with intern facing up. Under a stereomicroscope, 
subcutaneous fat and blood vessels were accurately removed to expose the hair bulbs, and 
the tissue were digested using Collagenase (0,8 g/L) in Dulbecco’s Modified Eagle’s 
Medium (DMEM) for 45 minutes at 37°C. After this incubation, back-skin were scraped off 
and the collected HFs were further digested to obtain a single cell suspension with 2.5% 
trypsin in PBS with the addition of Deoxyribonuclease 1 (DNse1: 1600 U/ml) for 10’ at 
37°C. Fetal bovine serum (FBS) was added to the single cell suspension to neutralize trypsin. 
Cells were pelleted at 2000 RPM at 4°C for 5 minutes and washed in ice-cold PBS to remove 
FBS and trypsin residues. To remove hairs and aggregates the single cell, suspension was 
filtered with a 70 m cell strainer. The obtained suspension, enriched for HFs single cells, 
were resuspended in the correct buffer depending on the application.   
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3.5  CRYPTS PURIFICATION 
Small intestine was taken from mice and immediately processed due to its fast degradation. 
Intestine was flashed with ice-cold PBS twice, opened longitudinally and the villi were 
manually removed by scraping the tissue. Intestine was then chopped into around 5mm 
pieces and incubated in 30 ml of cold PBS containing 2mM EDTA, and kept on ice for 15 
minutes. After this incubation, the falcon was inverted twice to move the mixture and release 
remaining villi in the supernatant, that was carefully removed. Intestinal pieces were further 
incubated with 5mM EDTA in PBS for 45 minutes rocking at 4°C, after which fragments 
were let sit on the falcon base and the supernatant was removed. Tissue containing crypts 
was resuspended in 20 ml of ice-cold PBS containing 1% of FBS and vigorously shacked 
ten times, and supernatant containing the released crypts were filtered using a 70 M cell 
strainer. This passage was performed twice with new 20 ml of PBS-FBS 1% solution. Crypts 
were pelleted at 1000 RPM at 4°C and washed with ice-cold PBS-FBS 1%, and pelleted at 
800 RPM at 4°C to clean the purification from small fragmented tissue.  
Obtained crypts were used for lysate preparation or processed for other techniques, or 
alternatively incubated for 15 minutes in DMEM solution containing Trypsin 0.1%, DNaseI 
800 U/ml and 10 M Rock inhibitor Y-27632 (Selleck chemicals) to obtain a single cells 
suspension. Dissociated cells were resuspended in the buffer needed for further analyses. 
 
3.6  VILLI PURIFICATION         
Villi that were manually removed during crypts extraction were collected in ice cold PBS. 
Once pelleted, the supernatant was removed, and the villi were carefully resuspended in 50 
mL of ice-cold PBS with 3mM EDTA. Villi were incubated 10 minutes rocking at 4° C and 
fudged at 1200 RPM at 4° C for 10 minutes. Supernatant was removed, and the villi 
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resuspended and washed in 50 mL of ice-cold PBS with 1% FBS, and passed through a 100  
M cell strainer, changing the strainer when mucus stuck the flow, in order to recover only 
villi. The purified villi were pelleted as previously described, and washed in PBS. Next, the 
pellet was lysed as described in the next paragraph. 
 
3.7  LYSATES PREPARATION AND WESTERN BLOTTING 
ANALYSES 
The obtained pellet, from either crypts or villi, was lysed with S300 extraction buffer (TRIS-
HCl pH 8 20 mM, NaCl 300 mM, Glycerol 10%, Igepal 0.2%) with protease inhibitors, 
sonicated to disrupt DNA, fudged at 13000 RPM for 30 minutes at 4° C. After the 
centrifugation, the supernatant was quantified. Lysate was then diluted and preserved with 
LAEMLLI buffer to 1x concentration to reach the desired protein concentration, usually 1 
or 2 g/L. 40ug of total lysate were separated on SDS-PAGE and transferred on 
Nitrocellulose membrane. The membranes were then saturated with 5% low-fat dried milk 
in TBS-Tween 0.01% and incubated with the specific antibody following time and dilution 
reported in Table1. 
After primary antibody binding membranes were washed in TBS-Tween 0.01% and 
incubated with the correct secondary antibody as reported in Table 2. Excess of milk and 
secondary antibodies were washed prior to signal revelation, which was carried out with 
Clarity™ Western ECL Substrate (Bio Rad) and acquired using ChemiDoc XRS+ (Bio Rad). 
 
3.8  TOTAL RNA EXTRACTION 
Total RNA extraction was performed lysing the cells with TriZol and following the Direct-
zol RNA MiniPrep protocol (Zymo research) and then retrotranscribed to obtain cDNA. 
Briefly, crypts were lysed in TriZol and an equal volume of 95% ethanol was added to the 
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lysate. RNA was applied to a Zymo-spin column and washed by centrifugation, and then 
DNA was removed by a short DNase I treatment directly on the column. Pure RNA was 
washed twice and recovered in a sterile collection tube and quantified at NanoDrop.  
500 to 1000 nanograms of purified RNA was used for each retro-transcription reaction. RT 
was performed with ImProm-II™ Reverse Transcriptase reagents, following Promega 
standard transcription protocol.  
Retrotranscribed cDNA was analyzed by RT-qPCR with Gotaq(r) Qpcr Master Mix 
(Promega) with the primers list described in Table 3. 
 
3.9  FLOW CYTOMETRY 
Single cell suspensions obtained following the protocol described above were fixed 10’ at 
RT, with 4% Paraformaldehyde (PFA) in PBS without Methanol to crosslink the cells 
avoiding damaging the membrane, and preventing GFP leaking from the cytoplasm. PFA 
were blocked by adding the same volume of Glycine solution (Glycine 0,1 M, NaN3 0,01% 
in PBS) to the crosslinking reaction, in order to saturate the crosslinker, pelleted by 
centrifugation at 2000 RPM for 5’ at RT and washed with PBS. Cells were then 
permeabilized with Triton buffer (Triton 0,25% in PBS) for 7’ at RT at dark, washed and 
blocked for 30’ at RT at dark, with a solution of 5% FBS in PBS to diminish antibody non-
specific binding.  
Cells were then pelleted, and primary antibody diluted in PBS were added to the cells 
according to Table 1. After primary antibody binding, cells were pelleted and washed with 
BSA 1% in PBS to remove any residual primary antibody, followed by incubation with 
secondary antibody (Table 2) performed at dark. Cells were finally washed to remove the 




3.10  FACS 
In order to obtain a pure population of HFSCs, we exploited the GFP expression of LGR5-
GFP-ires-CreERT2 mouse strain. Single cell suspensions obtained following the protocol of 
hair follicle purification were washed once in PBS and resuspended in Sorting Medium 
(DMEM, 1;100 Penicillin and streptomycin (17-602, Lonza), 1:100 L-Glutamine (17-605E, 
Lonza), Hepes, EDTA pH8 2 mM, DNase1 (800 U/mL) and Y27632 (selleck Chemicals) 20 
M)). Cells were further filtered with 40 M cell strainer prior Sorting. 
Single cells from intestinal purification were resuspended in Sorting Medium (Advanced-
DMEM, 1:100 Penicillin and Streptomycin (17-602, Lonza), 1:100 L-Glutamine (17-605E, 
Lonza), Hepes, EDTA pH8 2 mM, DNase1 (800 U/mL), Y27632 (Selleck Chemicals), N2 
50x, B27 200x and NAC (N-Acetyl Cysteine) 100x and further filtered with 40 M cell 
strainer prior Sorting.    
Single GFP positive LGR5-HFSC were FACS-sorted using either FACSMelody or 
FACSJazz cell sorters (BD Biosciences). To discriminate between living and dead cells, we 
added Propidium Iodide to a final concentration of 25 g/ml.  
  
3.11  IMMUNOFLUORSCENCE 
Back-skin from ctrl and dKO mice were harvested as described in the first passage of “Hair 
follicle purification” protocol. The back skin obtained were briefly fixed in 4% PFA for 3 
hours at 4°C covering all the skin and gently shaking. The materials were then incubated at 
least overnight in 30% Sucrose in PBS to cryopreserve the tissues and avoid freezing 
damages. Back-skins were then embedded in O.C.T (Tissue-Tek 4583), that is a water 
soluble mixture of glycols and resins that provides an optimal matrix for cryostat sectioning, 
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and stored at -80°C. Embedded tissue were cut at 7um and slides were collected and stored 
at -80°C until staining.  
Sections were prewarmed at RT for few minutes and washed twice with 0,1% Tween 20 in 
Tris-Buffered Saline (TBS-T) to eliminate the residual matrix, and blocked with 5% donkey 
serum in TBS-T for one hour at RT. Primary antibody were then incubated overnight at 4°C  
(specified in Table.1). The following day, slices were washed twice with TBS-T and 
incubated for 1 hour at RT with secondary antibody (specified in Table 2) and 4’,6-
diamidino-2-phenylindole dihydrochloride (DAPI, 32670, Sigma- Aldrich) and mounted 
with Mowiol 4-88 (81381, Sigma-Aldrich). Images of back-skin were taken with Leica SP8 
confocal microscope.   
 
3.12  PROXIMITY LIGATION ASSAY 
The proximity ligation assay (PLA) is a powerful technique that enables both the 
visualization of endogenous proteins, or proteins modification, and the protein-protein 
interactions directly in situ on histological section and with high sensitivity.  With the 
collaboration of another lab member we set up the following protocol to perform this assay 
on anagen induced pure HFSCs populations.  
Anagen-induced HF were purified as described and were sorted to obtain LGR5-HFSCs 
from Ctrl and dKO mice. Collected cells were spotted on a coverslip pre-coated with Cell-
Tak (Corning) adhesive, that is composed by polyphenolic proteins extracted from marine 
mussel (Mytilus edulis), that creates a not-charged adhesion matrix suitable for PLA which, 
in turn, requires the use of charged molecules. Briefly, the correct amount of Cell Tak 
adhesive was resuspended in a sufficient volume of filtered Sodium bicarbonate 0,1M pH 8 
necessary to overlay the coverslip lied down in a 24 wells plate, incubated for 30 minutes at 
RT, then the mixture was removed, and the coverslip washed with pure water.  
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Cells were pelleted after sorting and resuspended in 300 L of sorting medium, and gently 
applied to the coated coverslip. After 4 hours at 4°C, cells were efficiently anchored to the 
matrix and were fixed with 4% PFA in PBS for 10’ at RT, washed and permeabilized with 
Triton 0.1% in PBS. Excess of permeabilization buffer were washed out with fresh PBS and 
the cells were subjected to Sigma-Aldrich PLA protocol using Duolink In Situ Orange 
Starter Kit Mouse/Rabbit. Cells were incubated with 1 drop of Duolink Blocking Solution 
for one hour at 37°C in a humidity chamber (Figure 3.2 step 1). Blocked samples were then 
subjected to specific antibodies binding (Figure 3.2 step 2), diluting both primary antibodies, 
which were raised in different animals (Ring1B-Mouse and Bmi1 or Rybp-Rabbit), together 
in Duolink Antibody diluent, as specified in Table 2, and incubating cells in humidity 
Figure 3.2 Proximity ligation assay protocol 
Schematic workflow of PLA protocol highlighting the principal steps of the technique. 
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chamber for 1hours at RT. Primary antibody solution was then removed and the samples 
were washed twice to take away any antibody trace. To detect whether two different proteins 
can interact, PLA involves the usage of PLUS and MINUS charged PLA Probes, that are 
oligonucleotides-labelled secondary antibody that when in close proximity (less than 40nm) 
can interact (Figure 3.2 step 3). The probe binding requires one-hour incubation in pre-
warmed humidity chamber at 37°C followed by two washes to eliminate the residual probes. 
If the proteins are in close proximity, so that the DNA probes can interact, during the ligation 
step (Figure 3.2 Step 4), that is carried out for 30’ at 37°C in humidity chamber, Ligase 
enzyme is able to close the loop among the two probes. After ligation step, the enzyme and 
the reaction buffer were washed out. The circular loop created by the probes is a suitable 
platform for the Polymerase to work, and the loops are amplified several times during the 
reaction, that is carried out at 37°C and last 100 minutes, incorporating in the nascent 
concatenamer fluorescent oligonucleotides that amplify the ligation signal (Figure 3.2 Step 
5). The treated coverslips were the mounted on a slide with the mounting medium added 
with DAPI, to counterstain the Nuclei. Stained samples were acquired with Leica SP8 
confocal microscope and interactions a visualized as discrete dots in the cell nuclei.  
 
3.13  HISTOLOGY  
Back skin and intestinal tissues from treated mice were collected at the indicated time points 
depending on the experimental work. Isolated samples were immediately fixed overnight at 
4°C in Formaldehyde (FA), flattened in the inclusion cassettes without overstretching the 
tissue. Tissues were then dehydrated in Ethanol solution, at increasing concentrations, to 
substitute the water present in the tissue, incubated with Xylene and included in Paraffin. 
Embedded samples were then cut with microtome at 5  m thickness, and the slices were 
subjected to Hematoxylin\Eosin Y staining. Briefly, samples were rehydrated, tissue were 
stained with Hematoxylin (Harris Hematoxylin Solution, Sigma Aldrich) for 2’ at RT and 
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coloration excess were removed with EtOH/ 0.5% HCl and were fixed, after two washes, 
with Ammonium Hydroxide 0,2% in water for 15’ at RT. Cell cytoplasm were counter 
stained with Eosin Y, and the excessive coloration were removed with 95% Ethanol in water, 
and slices were then processed with ethanol 100% and Xylene. Stained sections were then 
mounted with Eukitt (Bio-Optica) and images were acquired with either Olympus BX51 or 
Leica DM6 widefield microscopes. 
 
3.14  LINEAGE TRACING: HAIR FOLLICLE 
Our mouse model LGR5-GFP-ires-CreERT2/Ring1a-/-/Ring1bfl/fl/Rosa26Lox-stop-Lox 
LacZ, thanks to Rosa26 Lox-stop-Lox Lacz transgene allows the tracing of LGR5 stem cell 
progeny through the production of Beta-galactosidase molecule. 
Freshly prepared back-skin of treated mice, collected at the time point, indicated in the 
experimental workflow, were prefixed for 30’ at RT in PBS containing Gluteraldehyde 
0.2%, NP-40 0,02% and PFA 2%. Tissues were washed three times for 10’ with fresh PBS, 
and incubated gently shacking for 30 minutes at RT in the equilibration buffer (MgCl2 2mM, 
NP-40 0,02% and Sodium Deoxycholate 0,1% in PBS). Equilibrated back-skin was then 
stained overnight at RT with 5 mM K3Fe(CN)6, 5 mM K4Fe(CN)6 and 1mg/ml X-Gal (5-
bromo-4-chloro-3-indolyl-beta-D-galactopyranoside) diluted in equilibration buffer. Cells 
that derive from stem cells in which CreERT2 was nuclear, will express beta-galactosidase, 
which in turn catalyzes the hydrolysis of X-Gal into galactose and 5-bromo-4-chloro-3-
hydoxyndolo. This latter compound is further oxidized into 5,5’-dibromo-4,4’-dichloro-
indigo, which possesses the characteristic blue color, providing a visual assay for lacZ 
activity. Stained samples were then washed abundantly in PBS at RT, and the skin were 
fixed overnight with 4% PFA in PBS before paraffin embedding, that is carried out as 
described in Histology section. Embedded tissue was cut at 5um section and rehydrated 
following the standard rehydration steps for histology, gradually decreasing the Xylene and 
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the alcohol in the tissue. Section were then counter-stained with Nuclear Fast Red solution 
for 10’ at RT under chemical hood, dehydrated and mounted. 
 
3.15  LINEAGE TRACING: INTESTINE 
Freshly recovered intestinal tissues were washed once in ice cold PBS, and prefixed for 2 
hours at 4°C in PBS containing Gluteraldehyde 0.2%, NP-40 0,02% and PFA 2%. Tissues 
were washed three times for 10’ with fresh PBS and incubated gently shacking for 30 
minutes at RT in the equilibration buffer (MgCl2 2mM, NP-40 0,02% and Sodium 
Deoxycholate 0,1% in PBS). Equilibrated intestinal tissues were stained overnight at RT 
with 5 mM K3Fe(CN)6, 5 mM K4Fe(CN)6 and 1mg/ml X-Gal (5-bromo-4-chloro-3-indolyl-
beta-D-galactopyranoside) diluted in equilibration buffer. The day after staining, intestinal 
tissue was abundantly washed with PBS and fixed over-night in 4% PFA. Before beginning 
the dehydration step, intestines were flattened and embedded as described in the Histology 
section.  
 
3.16  RNA-SEQUENCING 
Singlets of HFSCs, isolated from mice back-skin as previously described, were FACS-sorted 
thanks to GFP protein and collected in 0,5ml tubes, previously coated with 20% FBS in PBS. 
Cells were immediately processed in sorting tubes following Smart-seq2 protocol 
(Switching Mechanism at the 5’ end of the RNA Transcript) (Picelli, Faridani et al. 2014) 
with minor modification. This protocol is extremely useful, first because the amount of 
material needed is extremely small, compared to other RNA sequencing protocol, as it is 
designed to work with less than 1000 cells, and secondly allowing the operator to reduce the 
material waste, by coupling sample collection and processing without wash and fudge 
alternation. We collected 3000 cells per sample that were directly lysed in 2 L of Lysis 
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buffer composed of Triton X-100 0,2% and Ribonuclease inhibitor (4 U/L) in pure water. 
One microliter of each 10 mM oligo-dT30Vn and 10 mM deoxynucleotide triphosphate were 
added to the samples that were then incubated for 3’ at 72°C, to allow RNA unfolding and 
oligo annealing with the polyA end of messenger-RNA. After this step, Reverse 
Transcription coupled with Template switching was performed by adding to the sample a 
mix containing SuperScript III reverse transcriptase enzyme 100U/L (Invitrogen) and 
buffer, RNase Inhibitor 10U/L, Betaine 1M, DTT 5 mM, MgCl2 6 mM and TSO 1 M 
(Template Switching Oligo) (Fig 3.3) RT was performed following the published protocol. 
cDNA was then Pre-Amplified using KAPA taq HotStart enzyme working in High Fidelity 
buffer. To perform the Pre-amplification, 15 L of the preamplification mix (KAPA taq 
HotStart, KAPA HiFi Buffer, MgCl2 0,5 mM, dNTPs 0,3 mM, ISPCR primer 0,1 M) were 
directly added to the retro-transcribed samples and were incubated in the thermal cycler for 
14 amplification cycles following temperature of the published protocol (Fig 3.3). Samples 
were then purified with AMPure XP beads (Agencourt AMPure XP, Beckman Coulter) 
equilibrated at RT for at least 30 minutes. An equal volume of AMPure beads was added to 
pre-amplified cDNA and the mix was incubated at RT for 8’ to let the DNA binds the beads. 
Beads with DNA were immobilized with a magnet and were washed with 100 L of 80% 
Ethanol and dried for 10 minutes to remove any alcohol residue. cDNA was eluted with 20 
L of pure water and eventually stored at -20°C.  Eluted cDNA was quantified with Qubit 
colorimetric quantitation assay (Thermo Fisher Scientific, Q32854), and the quality was 
checked with High-sensitivity DNA assay of Bioanalyzer instrument (Invitrogen). Poor 
quality cDNA, presenting short DNA fragments at the Bioanalyzer, possibly derived from 
degraded RNA and was discarded. 2 nanograms of good quality pre-amplified cDNA were 
used for fragmentation reaction (Tagmentation) and library preparation (Fig 3.3). Smart-seq 
protocol enables DNA cutting and the ligation of adapters, needed for amplification of the 
library and the sequencing, at the same time. cDNA was tagmented with 100 ng of 
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homemade Tn5 enzyme pre-annealed with A/B-MEDS (Mosaic End Double-Stranded) 
oligonucleotides in working buffer containing TAPS-NaOH pH 8.5 5mM , PEG 8000 8%for 
5 minutes at 55°C. Immediately after tagmentation reaction, the samples were put in ice to 
inhibit the enzyme that were further stripped 5’ at RT with 5 l of SDS 0,2%. Enzyme and 
buffer were removed by a quick AMPure purification (AMPure beads 1:1 ratio, 8’ at RT for 
Figure 3.3 SMART-Seq2 library preparation protocol  
Brief and schematic workflow of SMART-seq2 protocol highlighting the principal steps for 
library preparation.  Figure from (Picelli, Faridani et al. 2014).  
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DNA binding, 5’ on the magnet (flow-through were discarded), 17,75 L of pure water for 
DNA elution).  PCR mix (KAPA HiFi buffer, KAPA Taq HotStart, dNTPs 0,3mM, Ad1 
Primer (i5 primer for Illumina sequencing Without Barcode) 2 M and Ad2.X Primer 2 M 
(i7 primer for Illumina sequencing containing different Barcodes) were directly added to the 
eluted tagmented DNA and were amplified following the program: 72°C 3’, 98°C 30’’, 14 
cycles of  three steps amplification 98°C 10’, 62°C 30’’, 72°C 30’’, followed by the final 
elongation at 72°C for 5’. Amplified library DNA were then purified with AMPure, as for 
the pre-amplification step, quantified by Qubit and the quality was checked with High-
sensitivity DNA assay for Bioanalyzer. Libraries that showed enrichment of DNA fragments 
that span around 200 and 800 bp length, were then sequenced using Illumina HiSeq 2000.    
 
3.17  RNA SEQUENCING ANALYSES 
The RNA sequencing analyses were performed by a bioinformatic of the lab. Reads were 
aligned to the mouse reference genome mm9 using TopHat v2.1.1 (Trapnell, Pachter et al. 
2009) with parameters --no-coverage-search and --library-type-fr-unstranded.  PCR 
duplicates were removed using Picard tool from Broad Institute 
(http://broadinstitute.github.io/picard/).  
Gene counts were calculated using HTSeq-count v0.8.0 (Anders, Pyl et al. 2015) with 
parameters --stranded=no --mode=intersection-nonempty using RefSeq mm9 annotation 
downloaded from the University of California, Santa Cruz (USCS genome browser). 
Differential expression analyses were carried out using R package DESeq2 v1.20 (Love, 
Huber et al. 2014) using default parameters. Genes with an absolute log2(fold change) of 1 
and false discovery rate of <0.1 were considered ad Differentially expressed and used for 
analyses. Gene enrichment analyses on down- and up- regulated genes were performed using 
DAVID 6.8 online tool (Huang da, Sherman et al. 2009). Pre-ranked Gene Set Enrichment 
Analyses (GSEA) (Subramanian, Tamayo et al. 2005) were performed using gene lists 
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(Signature Gene Lists) from multiple skin cell population obtained from (Rezza, Wang et al. 
2016). The analysis was performed using default parameters (weighted as enrichment 
statistic) and ranking the input gene list using log2(fold change) data obtained from DESeq2. 
To assess the expression of differentially expressed genes in dKO vs Ctrl HFSC in other 
mouse tissues, we used public RNA-seq data (Bam Files) deposited by ENCODE at 
https://hgdownload.soe.ucsc.edu/goldenPath/mm9/encodeDCC/wgEncodeLicreRnaSeq/. 
Bam files were processed with the pipeline described previously and RPKM (Read Per 
Kilobases of Million Mapped Reads) data were normalized with the function 
normalize.quantiles() from R package processCore 
(https://github.com/bmbolstad/preprocessCore). 
 
3.18  CHIP SEQUENCING 
LGR5 expressing HFSCs from anagen synchronized Ctrl mice were purified as described in 
“Hair follicle purification” and sorted for GFP expression. Intestinal cells were purified as 
described in “Crypts purification” and sorted for GFP expression in order to isolate only 
LGR5 stem cells. A total of 2.5 millions of sorted cells were used for each Chromatin 
Immuno-Precipitation (ChIP) and were crosslinked with 1% FA for 10’ at RT followed by 
5’ incubation with Glycine 0.125 M. Cells were then pelleted and resuspended in IP buffer 
( NaCl 100 mM, Tris-HCl pH8.6 100 mM, EDTA pH8.0 5 mM, NaN3 0.2%, SDS 0.3% 
Triton X-100 1,7%). 
Cells were lysed 20’ in ice, and then sonicated to brake DNA by Branson sonicator with 
10% of amplitude for 30’ for 4 times with 1-minute rest to preserve sample’s integrity.  
Sonicated cells were then pelleted, and the supernatant is used for immunoprecipitation. The 
correct amount of Antibody (listed in Table 1) was added to the lysate, and the IPs were 
performed over-night. The day after, the immunocomplexes were recovered with protein A-
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conjugated magnetic beads (Dynabeads,Life Technoligies) at 4°C for 3 hours rocking, and 
then washed 5 times with washing buffer containing 150 mM salt, and once with 500 mM 
salt (NaCl 150 or 500 mM, Tris-HCl pH 8.0 20 mM, EDTA pH 8.0 2 mM, SDS 0,1%, Triton 
X-100 1%). Samples were decrosslinked overnight in NaHCO3 0.1 M and SDS 1% at 65°C 
shacking. Decrosslinked DNA was purified with PCR purification Kit from Qiagen and 
sequenced with Illumina HiSeq2000.   
ChIP performed in crypts was carried out on 500/1000 g of total chromatin, following the 
same protocol as previously reported, but Protein A sepharose beads were used instead of 
the magnetic ones.  
 
3.19. CHIP SEQUENCING ANALYSES 
The ChIP sequencing analyses were performed by a bioinformatic of the lab. Sequenced 
reads were aligned to mouse reference genome mm9 using Bowtie v1.2.2 (Langmead, 
Trapnell et al. 2009) with default parameters and not allowing multimapping (-m1). PCR 
duplicates were removed using Picard tool (http://broadinstitute.github.io/picard/), and 
peaks were called using MACS2 v2.1.1 (Zhang, Liu et al. 2008) with parameters –g-mm –
nomodel –p 1e10 –B. 
Genomic peaks annotation was performed using R package ChIPpeakAnno v3.15 (Zhu, 
Gazin et al. 2010), considering the promoter region major or equal to 2.5kb around TSS 
(Transcription start site). Overlaps of ChIP-seq targets were performed as following: Genes 
with peaks in their promoter regions (+/- 2.5kb around TSS) were considered as targets. 
Then, the overlap between target gene lists were performed using the R package 
VennDiagram v1.6.20 (Chen and Boutros 2011). For heatmap representation of ChIP-seq 
signals, bigwig files, subtracted by input signal, were generated using function bamCompare 
from deepTools 2.0 (Ramirez, Ryan et al. 2016) with parameters –ratio subtract –bs 30 –
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extendReads200. To normalize for differences in sample library size, a scaling factor for 
each sample was calculated as (1/total mapped reads) x 1 milion, and applied during bigwig 
file generation with the parameter –scaleFactors from bamCompare.  
RING1B ChIP-seq targets were clustered in four groups according to their RPKM 
expression in Ctrl mice using the dplyr function ntile(). Tracks for H3K27me3 from ISC and 
HFSCs were obtained from (Chiacchiera, Rossi et al. 2016, Chiacchiera, Rossi et al. 2016)  
and (Lien, Guo et al. 2011) respectively, and processed with the pipeline described 
previously. 
  
3.20  ANTIBODIES 
Table 1 Primary antibody list 








\\ 10g \\ 
RING1B Home made \\ 
1:100 o/n 
4°C 
1:100 10g \\ 
PCGF4 Home made \\ \\ 1:100 10g 
1:1000; 5% milk 





\\ \\ 1:100 10g \\ 




\\ \\ \\ 5g \\ 
PCGF1 Home Made \\ \\ \\ 5g 
1:1000; 5% milk 
in TBS\T; Rabbit; 
o/n 4°C 
PCGF2 Home Made \\ \\ \\ 5g 
1:1000; 5% milk 
in TBS\T; Rabbit; 
o/n 4°C 
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PCGF3 Home Made \\ \\ \\ 5g 
1:1000; 5% milk 
in TBS\T; Rabbit; 
o/n 4°C 
PCGF5 Home Made \\ \\ \\ 5g 
1:1000; 5% milk 
in TBS\T; Rabbit; 
o/n 4°C 
PCGF6 Home Made \\ \\ \\ 5g 
1:1000; 5% milk 





\\ \\ \\ \\ 
1:20000; 5% milk 
in TBS\T; Mouse; 
o/n 4°C 
 
Table 2 Secondary antibody list 




























\\ \\ \\ 
1:5000 





\\ \\ \\ 
1:5000 
Milk 5% TBS\T 
 
3.21  PRIMERS 
Primers were designed with Primer3 Plus or Primer Blast with the following parameters: 
Amplicon length 100-150 bp; Primer size: 18-23; Primer Tm: 57°C -63°C; designed on two 
different exons, in order to avoid genomic recognition.  
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Table 3 List of qPCR primers 
Primer name Sequence 
PCGF1 Fw GGCTGAGTTCTGGCAAAGAC 
PCGF1 Rv GGAGCTGTACATGCTGTGGA 
PCGF2 Fw AATCACGGAGCTGAACCCTC 
PCGF2 Rv AGCGTACGATGCAGGTTTTG 
PCGF3 Fw TCCAGAGGAGAAGCCAAAGA 
PCGF3 Rv ACTGTGGTTGCGTCAATGAG 
PCGF4 Fw TGTCCAGGTTCACAAAACCA 
PCGF4 Rv CGGGTGAGCTGCATAAAAAT 
PCGF5 Fw CTGATCAAGCCCACGACAGT 
PCGF5 Rv TGAACTTGGTTGCCACACCT 
PCGF6 Fw TCCACCAGACTCAGCCTCTT 
PCGF6 Rv GGCTTGGGGACTTCTAGACC 
TBP Fw TGGAGATCACAACAGCCAAA 
TBP Rv CTTCTTCCGTTTTCCAGGTG 
Rplp0 Fw TTCATTGTGGGAGCAGAC 
Rplp0 Rv CAGCAGTTTCTCCAGAGC 
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4.1  HAIR FOLLICLE REGENERATION REQUIRES PRC1-
DEPENDENT H2AK119UB1. 
PRC1 is a well-established regulator of lineage identity in embryonic stem cells (Morey and 
Helin 2010) and recently we described a fundamental role in adult Intestinal Stem Cells 
maintenance (ISC) (Chiacchiera, Rossi et al. 2016). However, nothing is known about PRC1 
functions in other adult tissue homeostasis. Indeed, our goal was to unveil whether PRC1 
role and function is conserved among different adult stem cells or not. We took advantage 
of the mouse models LGR5-GFP-ires-CreERT2/Rosa26Lox-stop-Lox LacZ (hereof 
Ring1a/b ctrl after tamoxifen administration) and LGR5-GFP-ires-CreERT2/Ring1a-/-
/Ring1bfl/fl/Rosa26Lox-stop-LoxLacZ (hereof Ring1a/b dKO after tamoxifen 
administration) that was previously generated in our laboratory. This mouse model expresses 
both GFP and Cre-recombinase under the control of the LGR5 promoter, enabling the 
visualization and the excision of LoxP sites only in stem cells expressing LGR5 marker. Our 
mouse model was further crossed with the LacZ reporter gene whose expression is enabled 
only in cells where the Cre-recombinase enzyme is nuclear and active, tracing in this case 
LGR5 stem cells their progeny. Furthermore, our LGR5-GFP-ires-CreERT2/Ring1a-/-
/Ring1bfl/fl/Rosa26Lox-stop-LoxLacZ mice are straight Knock-Out (KO) for Ring1a gene 
and possess homozygous-floxable alleles for the Ring1b gene allowing for the complete loss 
of PRC1 functionality through the inactivation of the two catalytic subunits of the complex 
(Fig 3.1, Materials and Method).  
Due to the reported redundancy of Ring1a and Ring1b (del Mar Lorente, Marcos-Gutierrez 
et al. 2000; de Napoles, Mermoud et al. 2004; Roman-Trufero, Mendez-Gomez et al. 2009), 
we directly investigated the dKO mice. Moreover, during development and through adult 
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life, until tamoxifen injection, our mouse model, LGR5-GFP-ires-CreERT2/Ring1a-/-
/Ring1bfl/fl/Rosa26Lox-stop-LoxLacZ do not show any severe impairment in hair follicle 
morphogenesis and regeneration, as demonstrated by their ability to maintain the fur, 
suggesting that the deletion of Ring1a catalytic subunit does not affect the hair cycle. 
 
The LGR5 transgene is expressed in Hair Follicle (HF) in a long-lived stem cell 
subpopulation that is actively cycling during hair regeneration. In the non-proliferative stage 
of the hair cycle, LGR5 stem cells are located at the base of the HFs in the secondary hair 
germ and in the lower part of the bulge region. During regeneration, LGR5-HFSCs expand 
downward generating a single cell layer called Outer Root Sheat (ORS) and giving rise to 
Transient Amplifying matrix-cells (TAC) (Jaks, Barker et al. 2008) that will further 
differentiate in all hair structures. We use the described genetic model to acutely abrogate 
Figure 4.1 H2AK119 ubiquitin loss upon PRC1 activity abrogation 
A) Immunofluorescence analyses of hair follicle in Ring1a/b ctrl and dKO 
condition, showing the loss of H2AK119Ub1 modification in PRC1 
depleted mice. Green: GFP expressed by LGR5-HFSCs; Red: 
H2AK119Ub1; Blue: DAPI 
B) Quantification of the percentage of GFP-H2AK119Ub1 double positive 
cells on total GFP cells in HFs of both ctrl and dKO mice.  




PRC1 activity in 8-12 weeks old, sex-matched mice in LGR5-HFSC. We treated the mice 
with 4 daily IP injection of Tamoxifen, to induce Cre-recombinase nuclear localization and 
function, and we were able to obtain a great loss of PRC1 activity, as demonstrated by the 
loss of the H2AK119Ub1 histone mark in GFP+ cells of telogen HFs (Fig 4.1A, B), proving 
that our system works.  
Mice fur is maintained during the entire lifespan by HF regeneration. This process is 
regulated in a synchronous way during the first 10 to 11 weeks of age, however, after a long 
telogen (resting) phase the hair follicle start to gradually lose their synchrony without 
affecting their regenerating capabilities (Paus, Muller-Rover et al. 1999, Muller-Rover, 
Handjiski et al. 2001, Jaks, Barker et al. 2008). In order to investigate the role of PRC1 in 
adult LGR5-HFSCs in the process of HF regeneration we forced re-synchronization by 
means of follicle plucking. HF removing starts a signaling cascade that rapidly and 
synchronously induces cells to start cycling and to proliferate, thus entering the anagen phase 
Figure 4.2 PRC1 depletion severely affect hair follicle regeneraion 
A) Schematic representation of PRC1 depletion and anagen induction protocol. Mice 
back-skins were recovered at 12 days post wax. TAM: Tamoxifen  
B) Image showing mice back-skin at day 0 (post wax) and at the end of the 
experimental work, showing hair follicle regeneration impairment in dKO 
compared to ctrl mice. 
C) In vivo lineage tracing of LGR5-HFSCs progeny. Tissues were stained with X-
Gal. Wholemount images were taken before paraffin embedding and the obtained 
section were counterstained with neutral red.  
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(Muller-Rover, Handjiski et al. 2001). In order to abrogate PRC1 activity in the very first 
phases of HF regeneration, to explore its function in telogen to anagen transition, we 
administered Tamoxifen via IP injection in adult mice 1 day before waxing the back skin 
(Fig 4.2A) and we recovered it after 12 days from hair removal.  
 
Ctrl mice completely regenerate the hairs (Fig 4.2B, top panels), while in the absence of 
PRC1 activity, dKO mice presented severe defects in hair follicle regeneration (Fig 4.2B, 
bottom panel) showing a delayed hair follicle cycle.  
With the aim to better characterize this delayed hair growth phenotype we performed the 
same experiment following in this case the HFSCs progeny (lacZ positive staining) in 
presence or absence of PRC1 complexes. Our mouse model expresses the Rosa26-Lox-
STOP-Lox LacZ construct in all cells of the body, however LacZ production is inhibited by 
a STOP codon upstream to the gene, so that its expression is restrained only in cells where 
Cre-recombinase efficiently floxed the LoxP sites of the transgene. In our model, only LGR5 
expressing cells produce the enzyme, therefore leading to the expression of lacZ gene in 
stem cells and all their derived progeny. Indeed, chemical retrieval of beta-galactosidase 
allows the visualization of cell populations derived from floxed stem cells. Lineage tracing 
analyses further confirm our result and 12 days after waxing we obtained a marked reduction 
of the number of beta-galactosidase expressing HFs in Ring1a/b dKO animals, suggesting 
that the remaining hair growth is derived from wild-type HFs (Fig 4.2C). 
 
4.2 PRC1 LOSS AFFECTS HAIR FOLLICLE CYCLE AND ANAGEN 
ONSET  
With this first experiment, we showed that PRC1 loss is able to severely affect hair follicle 
regeneration process and anagen progression. To further characterize PRC1 activity in adult 
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HFs maintenance, we took advantage of different hair follicle cycles taking place during 
mouse life. Murine fur undergoes two synchronous proliferative boosts in the first 7 weeks 
of life, the morphogenesis and the first hair cycle. After these two proliferative events, HFs 
encounter a long resting phase, called the “long telogen” phase, that can last up to 4 weeks 
(Muller-Rover, Handjiski et al. 2001, Jaks, Barker et al. 2008). At the end of this long 
quiescent phase hair follicle start to regenerate in an asynchronous way. With the aim to 
elucidate whether PRC1 activity is necessary for entering into or to progress through the 
anagen phase we induced Cre-mediated recombination, with 4 consecutive tamoxifen IP 
injection, during long telogen phase at P49 (post-delivery day 49) in order to reach PRC1 
depletion when all HFs are in their resting phase. After two weeks from tamoxifen delivery 
we induce anagen in order to synchronize HFs entering in proliferative phase of the cycle 
and we recovered the mice back-skin at either 8 days and 12 days post-waxing to perform 
histological analyses and lineage tracing staining to follow stem cell progeny fate (Fig 4.3). 
8 days after waxing, we observed a substantial delay in hair growth of Ring1a/b dKO mice 
compared to ctrl (Fig 4.4A). It is reported that, during HFs regeneration, C57bl/6 mice back-
skin full of proliferative follicles becomes darker, due to the strict coupling of hair cycle 
progression and follicular melanogenesis (Slominski, Paus et al. 1991, Muller-Rover, 
Figure 4.3 Hair follicle cycles in mouse 
Schematic representation of the experiment. The temporal bar shows HFs 
morphogenesis, first telogen and first anagen, which are synchronized. At day P49 
(post-delivery) all follicles are in long telogen phase and PRC1activity were abrogated 
with 4 intraperitoneal injection of Tamoxifen (TAM). After 2 weeks anagen were 
induced by waxing mice back-skin and samples were recovered at both 8- and 12-days 
post wax and processed for IHC and Lineage tracing analyses.  
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Handjiski et al. 2001) (Fig 4.4A). While ctrl mice back-skin presented a grey black color 
(Fig 4.4A left image), at this time point, Ring1a/b dKO still remains pink, suggesting that 
follicles are at earlier anagen phases compared to PRC1 proficient mice. 
This delayed phenotype is further confirmed by histological analyses showing an altered 
morphology of hair follicle in Ring1a/b dKO mice (Fig 4.4B).  
Detailed observation of histological section reveals that Ring1a/b dKO mice shows shorter 
HFs (Fig 4.4B, top panel and Fig 4.5A), with a morphology that, according to the Müller-
Röver et al., classification (Muller-Rover, Handjiski et al. 2001) seems to be blocked in the 
early anagen phases (I and IIIA) compared to ctrl HFs. Moreover, at 8 days post waxing the 
total number of beta-galactosidase positive HFs are strongly reduced in Ring1a/b dKOs (Fig 
Figure 4.4 PRC1 is required for anagen onset and progression  
A) Picture showing defective HF regrowth in Ring1a/b dKO mice compared to 
ctrl mice after 8 days from anagen induction.  
B) Top panel: Hematoxylin/Eosin Y staining of paraffin embedded tissue from 
ctrl and dKO mice showing the drastic changes in HF morphology upon PRC1 
depletion. 
Bottom panel: back-skin from Ring1a/b ctrl and dKO mice were stained with 
X-gal prior paraffin embedding. Slices were counterstained with neutral red. 
Pictures shows the loss of LacZ staining in dKO mice compared to ctrl mice. 
Mice were treated as described in Figure 4.3 and back-skin was recovered at 8d post wax. 
Scale bars 250 m.  
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4.4B, bottom panel and Fig 4.5B). Since LacZ is expressed in stem cell progeny, this staining 
defect suggested an impairment of LGR5-HFSCs proliferation. 
Several different layers constitute the skin. Under the epidermal tissue, the presence of 
hypodermal fat guarantees thermal isolation, functions as an energy reservoir and plays a 
role in mechanical protection and skin wound healing (Rosen and Spiegelman 2014). In the 
process of HFs regeneration it is well established that the hypodermal adipocyte layer 
fluctuates in thickness according to the different stages of hair cycle (Muller-Rover, 
Handjiski et al. 2001, Festa, Fretz et al. 2011, Foster, Nicu et al. 2018), and in particular this 
specialized tissue increases during anagen phase and reduces throughout catagen to reach a 
resting phase until a new hair cycle begins. Looking at histological sections, it is evident that 
Ring1a/b dKOs display a clear imbalance between hypodermis fat (Fig 4.5C) and dermis 
thickness (Fig 4.5D) despite the skin having a similar width among ctrl and dKOs conditions 
(Fig 4.5E), reinforcing the evidence that PRC1 loss severely affects HF regeneration.     
Figure 4.5 Measurement of HFs length and tissue morphology 8 days post wax  
A) Quantification of hair follicle length after 8 days from anagen induction. 
Measurements were taken with ImageJ software from the bulb base to the 
surface-exposure of follicular channel. 
B) Quantification of beta-gal positive follicles in Ring1a/b ctrl and dKO mice after 
8 days from anagen induction.  
C) Quantification of hypodermal fat. Measurements were taken with ImageJ 
software from the lowest part of the dermis to the panniculus carnosus. 
D) Quantification of dermal height in Ring1a/b ctrl and dKO mice. Measurement 
were calculated with ImageJ software from the upper part of the subcutis to the 
lowest part of epidermis.  
E) Total sections heights were measured from the lowest part of the subcutis to the 
upper part of the dermal compartment.  
All p-values were calculated with two side t test. N.s., not significant. Box plot graphs 
were generated with Prism software. 
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This phenotype was confirmed and more evident 12 days after waxing when Ring1a/b ctrl 
mice fully regenerate the fur, while dKO mice failed to correctly progress through HF 
proliferative phase, resulting in a severe hair regeneration delay (Fig 4.6A). 
Hematoxylin/eosin staining highlights drastic morphological HFs defects that ultimately 
results in defective regeneration (Fig 4.6B top). According to Müller-Röver et al. 
classification (Muller-Rover, Handjiski et al. 2001), Ring1a/b ctrl mice showed all features 
of full anagen follicles (anagen phase VI) (Fig 4.6B), while Ring1a/b dKO still resembled 
primary stages of anagen follicles and they seems to be slowly proceeding to anagen phases 
II and III (Fig 4.6B).  
Lineage tracing experiments on mouse back-skin 12 days after anagen induction revealed a 
marked reduction in Ring1a/b dKO of LGR5-HFSCs derived progeny, as demonstrated by 
the severe loss of beta-galactosidase staining compared to Ring1a/b ctrl mice (Fig 4.6B, 
bottom panel and Fig 4.7A). Consistently with 8 days post waxing, hair follicles showed 
Figure 4.6 PRC1 is required for anagen onset and progression  
A) Picture showing defective HF regrowth in Ring1a/b dKO mice compared to ctrl 
mice after 12 days from anagen induction.  
B) Top panel: Hematoxylin/Eosin Y staining of paraffin embedded tissue from ctrl 
and dKO mice showing the drastic changes in HF morphology upon PRC1 
depletion. 
Bottom panel: back-skin from Ring1a/b ctrl and dKO mice were stained with X-
gal prior paraffin embedding. Slices were counterstained with neutral red. Pictures 
shows the loss of LacZ staining in dKO mice compared to ctrl mice.    
Mice were treated as described in Figure 4.3 and back-skin were recovered at 12d post wax. 
Scale bars 250 m.  
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reduced follicle length (Fig 4.7B) as well as for the imbalance among hypodermis and dermis 
Figure 4.7 Measurement of HFs length and tissue morphology 12 days post wax  
A) Quantification of beta-gal positive follicles in Ring1a/b ctrl and dKO mice after 12 
days from anagen induction. 
B) Quantification of hair follicle length after 12 days from anagen induction. 
Measurements were taken with ImageJ software from the bulb base to the surface-
exposure of follicular channel. 
C) Quantification of hypodermal fat. Measurements were taken with ImageJ software 
from the lowest part of the dermis to the panniculus carnosus. 
D) Quantification of dermal height in Ring1a/b ctrl and dKO mice. Measurement were 
calculated with ImageJ software from the upper part of the subcutis to the lowest part 
of epidermis.  
E) Total section heights were measured from the lowest part of the subcutis to the upper 
part of the dermal compartment.      
All p-values were calculated with two side t test. N.s., not significant. Box plot graphs were 
generated with Prism software. 
 
Figure 4.8 PRC1 dKO impairs HFs progression during anagen 
A) Quantification of hair follicle length after 8 and 12 days from anagen induction. 
Measurements were taken with ImageJ software from the bulb base to the surface-
exposure of follicular channel. Red line indicates the increase in hair follicle length in 
Ring1a/b ctrl and dKO mice. 
B) Quantification of total section height in Ring1a/b ctrl and dKO condition showing no 
differences in skin thickness. 
C) Quantification of hypodermal fat. Measurements were taken with ImageJ software 
from the lowest part of the dermis to the panniculus carnosus. Red line indicates the 
increase in hair follicle length in Ring1a/b ctrl and dKO mice. 
D) Quantification of HF number per mm in Ring1a/b ctrl and dKO mice showing that 
PRC1 depleted mice display a reduced number of follicles.  
All p-values were calculated with two side t test. N.s., not significant. Box plot graph were 




 Comparing 8 and 12 days, it is clear that the differences of follicle length (Fig 4.8A) and 
dermis-hypodermis thickness unbalance are further increased (Fig 4.8B-C) during time, with 
a similar reduction in the number of HFs (Fig 4.8D). Taken together these data suggest that, 
rather than impair anagen entry, PRC1 activity loss severely affects the regenerative 
potential of LGR5-HFSCs and anagen progression.    
 
4.3  CONSERVED PRC1-REPRESSED TRANSCRIPTIONAL 
PROGRAMS ARE REQUIRED TO MAINTAIN HFSCs AND ISCs.    
These newly obtained data suggests that PRC1 loss in HFSCs induces similar phenotypic 
outcomes that was previously generated and observed by our lab in Intestinal Stem Cells 
(ISCs) (Chiacchiera, Rossi et al. 2016). With the aims to better define whether PRC1 loss of 
activity leads to an analogous phenotype through similar or different processes, we decided 
to deeper investigate the molecular effects of Ring1a/b dKO in two stem cells population 
that shares different common features despite arising from different embryonic layers (de 
Santa Barbara, van den Brink et al. 2003, Liu, Zhang et al. 2013). Even though ISC 
continuously regenerate the tissue while LGR5-HFSCs encounter cycles of proliferation and 
resting, both stem cell population are characterized by LGR5 receptor and rapidly divides to 
regenerate the tissue during their own proliferative phase, providing a perfect tool to study 
PRC1 mechanism in different context.  
To investigate the transcriptional changes induced by PRC1 loss of function in anagen-
activated LGR5 expressing stem cells, we collected both Ring1a/b ctrl and dKO mice back-
skins 8 days after hair plucking (Fig 4.9A). HFs were isolated from the tissue, reduced to 
single cells and 3000 LGR5-HFSCs per sample were isolated by Fluorescence Activated 
Cell Sorting (FACS), thanks to LGR5-GFP expression. The remaining sample was stained 
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for H2AK119Ub1 PRC1 mark and analyzed by FACS, demonstrating that tamoxifen 
treatment results in >70% loss of PRC1 activity in LGR5 expressing cells (Fig 4.9B).  
 Sorted cells were processed with SMART-seq2 (Switching Mechanism at the 5’ end of the 
RNA Transcript) protocol to perform RNA sequencing. This protocol published by Picelli 
et al in 2014 (Picelli, Faridani et al. 2014) allows us to perform RNA-sequencing starting 
from low material amount, performing the Retro-transcription step directly in lysed cells, 
minimizing the steps critical for material waste. The library was obtained with transposase 
5 that simultaneously cuts the amplified cDNA and adds two DNA primers for sequencing 
Figure 4.9 PRC1 loss induce a massive gene upregulation 
A) Schematic view of the experimental procedure to induce anagen and perform 
PRC1 ablation in HFSCs. Mice back skins were recovered after 8 days from 
anagen induction. 
B) Quantification of GFP-H2AK119Ub1 positive cells in Ring1a/b ctrl and dKO 
HFs. Single cell suspension was stained with H2AK119Ub1 antibody and 
analyzed by FACS.  
C) Correlation plot of RPKM values of detected genes from two independent 
biological replicates of Ring1a/b ctrl samples. 
D) Correlation plot of RPKM values of detected genes from two independent 
biological replicates of Ring1a/b dKO samples. 
E) Volcano plot showing deregulated genes in Ring1a/b dKO vs ctrl cells. (tresholds: 
p-value < 0.05, absolute log2(fold change)>1). 
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index addition. In order to minimize the biological variance among different mice, we 
purified and processed 2 independent biological replicates for Ring1a/b ctrl and dKO mice 
and both the replicates correlated well (Fig 4.9C and D).   
Consistently with the general role of PRC1 complex as transcriptional repressor, RNA-seq 
analyses revealed a >5-fold bias in genes up-regulation (1066 up-regulated genes versus only 
187 down-regulated genes) also in HFSCs compartment (Fig 4.9E). To elucidate which 
category of transcript was mostly affected by PRC1 loss, we first analyzed the Differentially 
Expressed Genes (DEG) with David Tool (Huang da, Sherman et al. 2009) to obtain the list 
of deregulated processes and pathways in our samples.  
Gene ontology analyses (GO) on upregulated genes revealed that they are associated with 
general developmental processes (Fig 4.10A) such as multicellular organism development 
and embryonic limb morphogenesis that are linked to PRC1 classical function during 
Figure 4.10 PRC1 loss induces upregulation of developmental genes and 
downregulation of lineage-related ones 
A) GO-term analyses of upregulated genes in Ring1a/b dKO HFSCs compared to ctrl. 
Top: Bar plot shows the genes-related pathways affected upon PRC1 depletion. 
Bottom: representative genomic view of RNA-seq tracks for one upregulated gene. 
B) GO-term analyses of downregulated genes in Ring1a/b dKO HFSCs compared to ctrl. 
Top: Bar plot shows the genes-related pathways affected upon PRC1 depletion. 
Bottom: representative genomic view of RNA-seq tracks for one upregulated gene. 
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development, such as IGF2 (Fig 4.10A bottom panel) and some HOX clusters genes. In 
contrast, down-regulated genes were specifically enriched for hair follicle morphogenesis 
and hair follicles related processes (Fig 4.10B). Among these down-regulated mRNAs we 
found the Sonic Hedgehog gene (SHH) (Fig 4.10B bottom panel) that is a well know 
regulator of HF anagen promotion and progression (St-Jacques, Dassule et al. 1998, Hsu, Li 
et al. 2014). SHH is upregulated in LGR5 and LGR5-derived matrix cells and is necessary 
to progress through anagen (Greco, Chen et al. 2009, Zhang, Tomann et al. 2009, Rompolas, 
Figure 4.11 PRC1 loss induces deregulation of non-lineage specific homeobox TFs 
A) GO-term analyses of upregulated genes in Ring1a/b dKO compared to ctrl. Bar plot 
shows the class of genes affected upon PRC1 depletion.   
B) Box plot showing the expression of downregulated (top panel) and upregulated genes 
(bottom panel), in Ring1a/b dKO compared to ctrl, among different tissues, organs and 
cell lines, showing that downregulated genes are specific for HFSCs while upregulated 
genes are already expressed in several different cell types.  
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Mesa et al. 2013) Its downregulation is in line with our block in the early phases of anagen, 
where matrix cells are emerging from LGR5-HFSCs, providing a possible explanation for 
the proliferative arrest of Ring1a/b dKOs HFs.  
Functional annotation analyses further revealed that DNA binding TFs, in particular 
homeotic and development-related transcription factors, were enriched in Ring1a/b dKO up-
regulated genes (Fig 4.11A) suggesting a massive deregulation of different TFs involved in 
developmental processes. To investigate whether these deregulated transcripts belong to 
specific tissues or were expressed in various compartments we decided to compare 
transcriptional data obtained from several different tissues (ENCODE) with up- or down- 
regulated genes in our LGR5-HFSCs. Ring1a/b dKO down-regulated genes (Fig 4.11B, top 
panel) are primarily expressed (Dark green box) in HFSCs compared to other tissues (White 
boxes), further confirming that down-regulated genes were essential to maintain HFSC 
identity.  
In contrast, upregulated genes, that were lowly expressed in HFCS ctrl cells (Dark green 
box), were already expressed in many tissue types, highlighting that loss of PRC1 activity 
results in massive upregulation of non-lineage-specific genes.     
In agreement with our previous finding obtained in ISCs (Chiacchiera, Rossi et al. 2016), 
these data strongly support a central role of PRC1 in maintaining lineage identity in stem 
cells of adult tissues.  
However, whether this involves common or specific mechanism still remains an open 
question.  
To elucidate this mechanism, we searched for common classes of genes that could be 
potentially involved in the regulation and the maintenance of lineage identity in ISCs and 
HFSCs upon PRC1 inactivation.    
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We compared RNA-seq profiles in adult LGR5 stem cells from intestine and anagen HFs 
and we found that none of the downregulated genes were in common between the two 
populations, in accordance with the role of these genes in maintaining the distinct identity 
Figure 4.13 PRC1 dKO upregulates development-related TFs 
A) Genomic snapshots of ZIC1, ZIC4 and ZIC5 showing RING1B binding and the gene 
transcription upon PRC1 depletion. 
B) Genomic snapshots of SOX7, HOXA10 and HOXB13 showing RING1B binding and the 
gene transcription upon PRC1 depletion. 
Figure 4.12 Common upregulated genes are development related genes 
A) Venn-diagram showing the overlap of downregulated genes, upon PRC1 loss 
of activity, among LGR5-HFSCs and ISCs.  
B) Venn-diagram showing the overlap of upregulated genes, upon PRC1 loss of 
activity, among LGR5-HFSCs and ISCs. 
C) GO-term analyses of common upregulated genes (255genes) between LGR5-
HFSCs and ISCs showing their role in development and differentiation.  
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of the two different stem cell populations (Fig 4.12A). On the contrary, we found that among 
the up-regulated genes (Fig 4.12B), approximately one-fourth (255 genes) are common 
between ISCs and HFSCs.  We performed a GO-term analyses of this common set of genes 
and they result to be for the vast majority homeobox containing TFs related to the regulation 
of developmental processes (Fig 4.12C). Among these genes we found several ZIC (zinc 
finger protein of cerebellum) TFs, such as Zic1, Zic4 and Zic5 (Fig 4.13A), as well as Sox7, 
Hoxa10 and Hoxb13 (Fig 4.13B), that are known regulators of development in several 
different tissues (Grinberg and Millen 2005, Mallo and Alonso 2013). These data suggest 
that PRC1 is able to repress and to prevent the activation of common non-lineage specific 
homeobox-containing TFs in different stem cells populations.  
 
4.4 PRC1 GUARANTEES STEM CELL IDENTITY MAINTENANCE 
BY REPRESSING A SUBSET OF CANONICAL PRC1 TARGETS.  
Two major classes of PRC1 have been recently described (Gao, Zhang et al. 2012), based 
on their biochemical composition. PRC1 complexes core contains RING1A or RING1B and 
one out of six mammalian Polycomb Group Ring Finger Protein (PCGF) (Gao, Zhang et al. 
Figure 4.14 different PRC1 subunits are expressed in LGR5-HFSCs 
A) Heatmap showing expression levels of PRC1 canonical and non-canonical 
subunits of two independent biological replicates of HFSCs from Ring1a/b ctrl 
mice. 
B) Immunofluorescence analysis of RING1B in a pure population of sorted 
Ring1a/b ctrl and dKO HFSCs. 
Scale bars 5um.  
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2012). Canonical PRC1 complexes contains CBX proteins, which are responsible for PRC1 
tethering on the chromatin, recognizing the H3K27me3 histone mark, deposited by PRC2, 
thus resulting in a PRC1 recruitment on its targets that is PRC2-dependent. Of note only 
PCGF2/Mel18 and PCGF4/Bmi1 are found to take part in PRC1 canonical complexes. On 
the other hand, all PCGFs can be part of non-canonical PRC1 complexes, that do not contain 
the CBX subunit and are recruited to chromatin independently from PRC2. These complexes 
are characterized by the presence of either RING1 and YY1 Binding Protein (RYBP) or YY1 
Associated Factor 2 (YAF2). Different components both of canonical and non-canonical 
PRC1 complexes are expressed in HFSCs (Fig 4.14A), suggesting the presence of all the 
existing subcomplexes. 
To investigate the ability of RING1B to form both canonical and non-canonical 
subcomplexes in LGR5-HFSCs, we decided to perform the Proximity Ligation Assay (PLA) 
in sorted anagen induced-HFSCs, from Ring1a/b ctrl and dKO mice (Fig 4.14B). PLA is a 
powerful technique that enable the visualization of proteins interactions directly in situ, 
exploiting the use of secondary antibodies conjugated with DNA probes that can be 
amplified, with Fluorescent labelled nucleotides, only if they are in proximity (less than 
40nm) to each other. We used this technique to evaluate the ability of RING1B to interact 
with RYBP (non-canonical PRC1, Fig 4.15 A, B) and Bmi1 (canonical PRC1, Fig 4.15 C, 
D) in our stem cells 
PLA-foci formation indicates that, in LGR5 expressing HFSCs, both canonical and non-
canonical complexes are formed and the deletion of both PRC1 catalytic subunits results in 
the disruption of PLA foci. Indeed, the phenotype observed upon Ring1a/b depletion could 
be ascribed to an impaired activity of both canonical and non-canonical complexes. 
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To identify the common mechanisms through which PRC1 regulates cell fate determination 
in different stem cell population we performed chromatin immunoprecipitation followed by 
sequencing analysis (ChIP-seq) for RING1B in HFSCs.  
We collected FACS-sorted activated LGR5-HFSCs after 8 days from anagen induction from 
Ring1a/b crtl mice (Fig 4.16A, B). A total amount of 2.5M cells were fixed in 1% 
Formaldehyde, resuspended in the IP buffer (refer to material and methods), sonicated to 
fragment the genomic DNA and used for a single immunoprecipitation. 
RING1B ChIP-seq analyses identified nearly 3900 RING1B peaks that were mainly 
associated to promoter regions (Fig 4.16C), resembling the chromatin association 
distribution of RING1B in ISCs (Fig 4.16D) and in accordance with other cellular system 
(Scelfo, Fernandez-Perez et al. 2019).  
Figure 4.15 Both canonical and non-canonical PRC1 are present in LGR5-
HFSCs 
A) PLA between RING1B and RYBP on Ring1a/b ctrl and dKO sorted LGR5-HFSCs 
B) Quantification of RING1B-RYBP dots per cell in Ring1a/b ctrl and dKO HFSCs 
C) PLA between RING1B and RYBP on Ring1a/b ctrl and dKO sorted LGR5-HFSCs 
D) Quantification of RING1B-RYBP dots per cell in Ring1a/b ctrl and dKO HFSCs 
Scale bars 5 m. All p-values were calculated with two side t test. N.s., not significant. Box 
plot graphs were generated with Prism software. 
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Between the two stem cells population RING1B is able to bind different sets of genes (Fig 
4.16E), as demonstrated by the overlapping peaks-related genes, however the common ones 
are related to development and differentiation (Fig 4.16F), highlighting that the classical role 
of PRC1 is maintained in different adult stem cells.   
Since PRC1 can form both canonical and non-canonical complexes, that are functionally 
distinct and can localize differently along the genome (Gao, Zhang et al. 2012) we decided 
to map the genomic localization of RING1B, in both stem cells population, comparing them 
with H3K27me3 deposition in order to define the PRC1 repressed domains (Lien, Guo et al. 
2011, Chiacchiera, Rossi et al. 2016). We took advantage of published data of H3K27me3 
Figure 4.16 PRC1 preferentially binds promoters in different stem cell population 
A) Schematic view of the experimental workflow for LGR5-HFSCs collection. 
B) FACS analyses of GFP expression in anagen hair follicle of C57BL/6 and Lgr5-GFP 
CreERT2 mice.  
C) Pie chart showing the percentage of RING1B peaks on Promoters, Distal intergenic 
regions, Gene body and Downstream gene regions in anagen LGR5-HFSCs.  (Total 
peaks = 3917) 
D) Pie chart showing the percentage of RING1B peaks on Promoters, Distal intergenic 
regions, Gene body and Downstream gene regions in ISCs. (Total peaks = 1293) 
E) Venn diagram showing overlapping HFSCs ChIP-seq Peaks respect to ISCs.   
F) GO analyses on genes related to the common ChIP peaks in HFSCs and ISCs. 
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ChIP-seq performed in anagen HFSCs (Lien, Guo et al. 2011) and our previous obtained 
data in ISC (Chiacchiera, Rossi et al. 2016). We found that the extent of overlap with 
canonical Polycomb-repressed domains was restricted to only 20% of RING1B peaks in 
HFSCs (Fig 4.17A left) and 10% in ISCs (Fig 4.17A right), thus suggesting that a large 
fraction of RING1B activity does not require prior PRC2 mark deposition.  
H3K27me3 repressive mark can be present within the same histone decorated with 
H3K4me3 transcriptional activatory modification. In ESCs, these two histone modifications 
together are enriched at promoters of development-related genes, defining the “bivalent” or 
“poised” status (Bernstein, Mikkelsen et al. 2006). These concomitant modifications are 
resolved when ESCs are triggered to differentiate by the acquisition of totally active 
(H3K4me3 only) or repressed (H3K27me3 only) state. Stem cells give rise to all cell 
populations in the tissue and should be able to efficiently switch on and off gene transcription 
in response to different stimuli. For this reason, we investigated the status of H3K4me3 of 
PRC1 repressed domain, and we found that, while only 30% of H3K27me3 sites in LGR5-
HFSCs are poised (Fig 4.17B left), this proportion reaches the 80% of RING1B-H3K27me3 
sites in ISCs (Fig 4.17B right). We also observed a large fraction of RING1B-bound sites 
Figure 4.17 PRC1 preferentially binds active genes promoters in different stem cell 
population 
A) Quantification of LGR5-HFSCs and ISCs RING1B promoter peaks that contains the 
H3K27me3 histone modification.  
B) Quantification of LGR5-HFSCs and ISCs RING1B-H3K27me3 promoters peaks that are 
decorated by H3K4me3 modification. 
C) Quantification of LGR5-HFSCs and ISCs RING1B promoter peaks that contains only 
H3K4me3 histone modification. 
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which are devoid of H3K27me3 but decorated with H3K4me3, suggesting in this context, 
an involvement of PRC1 in active transcription (Scelfo, Fernandez-Perez et al. 2019).  
Among all PRC1 subcomplexes, non-canonical subcomplexes are described to binds 
actively transcribed genes while canonical PRC1 is more linked to repression (Scelfo, Piunti 
et al. 2015, Zhao, Huang et al. 2017, Scelfo, Fernandez-Perez et al. 2019). As we know that 
PRC1 in LGR5-HFSCs is able to form both canonical and non-canonical complexes, to 
discern which PRC1 subtype binds promoters with the two different histone marks, we 
performed ChIP against the discriminating subunits CBX8 and RYBP respectively. 
We observed that in HFSCs, nearly 70% of RYBP peaks colocalize with RING1B (Fig 
4.18A). However only a small fraction of co-occupied peaks (11%) also harbor 
H2AK119Ub1 (Fig 4.18B). We also observed that those regions that are occupied by both 
RING1B and H2AK119Ub1, are also characterized by the presence of H3K27me3 PRC2-
deposited histone mark (Fig 4.18C) and by the presence of CBX8 subunits, specifying these 
sites as targets of canonical PRC1 complexes.    
Figure 4.18 H2AK119Ub1 is preferentially deposited at canonical PRC1 sites 
A) Quantification of LGR5-HFSCs RYBP peaks overlap with RING1B. (Total RYBP 
peaks = 811) 
B) Quantification of LGR5-HFSCs RYBP-RING1B promoters peaks that are decorated 
with H2AK119Ub1  
C) Quantification of LGR5-HFSCs RING1B- H2AK119Ub1 promoters peaks that 
harbor the H3K27me3 PRC2 mark. 
D) Quantification of LGR5-HFSCs CBX8 peaks that contains RING1B and the 2 
modification H3K27me3 and H2AK119Ub1. 
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These data suggest that both canonical and non-canonical PRC1 activities could possibly 
contribute to maintenance of stem cell identity by acting on both repressed and active genes.  
To discern the complexes involvement in this crucial regulation, we decided to analyze 
ChIP-seq data relating gene expression differences in Ring1a/b ctrl and dKO mice. 
We ranked all RING1B target promoters based on their expression in wild type stem cells 
from both HF and intestine. This analysis identified 4 clusters of genes each containing a 
quartile of gene expression. This divides all promoters in four groups: repressed, medium 
low, medium high and high expressed genes; that we used to determine transcriptional 
changes upon PRC1 loss of function in both HFSCs and ISCs (Fig 4.19A and Fig 4.20A). 
Repressed genes in Ring1a/b ctrl samples defined cluster 1 genes and were transcriptionally 
activated upon Ring1a/b dKO in both HFSCs and ISCs (Fig 4.19A and Fig 4.20A). Clusters 
2 and 3 comprised genes with intermediate expression, that in turn does not shows significant 
changes or slightly decreased their expression in PRC1 depleted stem cells counterpart (Fig 
4.19A and Fig 4.20A). The last group (Cluster 4) is composed of highly expressed genes that 
were slightly downregulated upon PRC1 depletion (Fig 4.19A and Fig 4.20A). Heatmaps of 
normalized ChIP signal around TSS (Fig 4.19B and Fig 4.20B), divided according to the 
previous identified expression clusters, shows that Cluster 1 transcripts belongs to gene that 
are fully silenced through canonical PRC1 complexes, as demonstrated by the concomitant 
presence of H2AK119Ub1, H3K27me3 and the relatively low presence of H3K4me3 active 
marks (Fig 4.19A and Fig 4.20A). Furthermore, the CBX8 canonical PRC1 subunit is 
localized only in this first gene cluster, thus providing additional evidence of canonical 
PRC1-mediated repression (Fig 4.19B).    
H3K4me3 signal is enriched in all the other 3 clusters and colocalized with a sharper 
RING1B signal, proving that PRC1 is able to localize at active transcription sites on 
chromatin (Fig 4.19B and Fig 4.20B).  This cluster also showed an intense signal of RYBP 




Figure 4.19 Genomic distribution of PRC1 binding in HFSCs 
A) Quartile-based gene expression clustering performed using Ring1a/b ctrl RNA-seq data, 
showing expression variations between Ring1a/b dKO and ctrl HFSCs. 
B) Heatmap representing normalized RING1B, H3K27me3, H3K4me3, H2AK119Ub1, CBX8 
and RYBP ChIP-seq intensities of +/- 8Kb from TSS of RING1B target genes in HFSCs. 
C) GO analyses of genes belonging to HFSCs cluster 1 
D) Venn- diagram showing the overlap between up-regulated genes in Ring1a/b dKO mice with 
total RING1B/H3K27me3-enriched regions. 
E) GO analyses of genes belonging to HFSCs clusters 2,3 and 4 
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Accordingly to transcriptomic data and their related ontology analyses, we found that genes 
involved in development and differentiation were over-represented only in cluster 1 (Fig 
4.19C and Fig 4.20C), which is characterized by the presence of canonical PRC1 and PRC2 
Figure 4.20 Genomic distribution of PRC1 binding in ISCs. 
A) Quartile-based gene expression clustering performed using Ring1a/b ctrl RNA-seq data, 
showing expression variations between Ring1a/b dKO and ctrl ISCs. 
B) Heatmap representing normalized RING1B, H3K27me3, H3K4me3 and H2AK119Ub1 
ChIP-seq intensities of +/- 8Kb from TSS of RING1B target genes in ISCs. 
C) GO analyses of genes belonging to ISCs cluster 1 
D) Venn- diagram showing the overlap between up-regulated genes in Ring1a/b dKO mice 
with total RING1B/H3K27me3-enriched regions. 
E) GO analyses of genes belonging to ISCs clusters 2,3 and 4 
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marks and the respective components. While the remaining 3 clusters showed enrichment in 
more general processes such as transcription, translation and cell cycle regulation (Fig 4.19E 
and Fig 4.20E). 
These data support a prominent role of canonical PRC1 activities compared to non-canonical 
ones in the maintenance of stem cell identity in both HFSCs and ISCs. However, it is 
important to stress that only a subset of RING1B /H3K27me3 double positive targets are 
derepressed upon PRC1 loss in stem cells from HFs and intestine (Fig 4.19D and Fig 4.20D). 
This suggests that H3K27me3 is largely sufficient to prevent TF accessibility and the 
consequently activation of canonical Polycomb targets and that only a small proportion of 
PRC1-PRC2 target genes contributes to the observed phenotypes, underlying the complex 
crosstalk and interdependency of the two complexes.  
 
4.5  LOSS OF PRC1 ACTIVATES AN EPIDERMAL-SPECIFIC 
PROGRAM IN HFSCs         
To elucidate the direct mechanism by which PRC1 prevents differentiation of stem cells, 
maintaining their identity, we analyzed the RING1B targets that became derepressed upon 
Ring1a/b dKO. HFs derives from a single layer of embryonic epidermis, that under the 
correct stimuli is able to differentiate into a new tissue that is then maintained throughout 
life by CD34-HFSCs and LGR5-HFSCs that are necessary to regenerate all hair structures 
(Jaks, Barker et al. 2008, Saxena, Mok et al. 2019). To understand the role of PRC1 in the 
suppression of interfollicular epidermis related genes and the maintenance of HF lineage, 
we decided to look at genes that were implicated in skin specification in PRC1 depleted 
HFSCs. Among these genes we found Achaete-Scute family BHLH Transcription Factor 2 
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(ASCL2) (Fig 4.12) that was previously shown to be sufficient and required for epidermal 
differentiation (Moriyama, Durham et al. 2008).  
 
We decided to investigate whether an epidermal specific program is initiated upon PRC1 
loss of activity and we performed a Gene Set Enrichment Analyses (GSEA) a bioinformatic 
a priori analyses that is able to determine whether a gene set list or database is enriched or 
not in the ranked gene list used as query. In our analyses we decided to compare signatures 
Figure 4.22 PRC1 activity depletion activates an epidermal program differentiation  
Gene set enrichment analyses (GSEA) performed on Ring1a/b dKO HFSCs using 
signature specific for 14 major skin and HF cell population s (Rezza, Wang et al. 2016)   
 Figure 4.21 Ascl2 is repressed by PRC1 in HFSCs 
A) Genomic snapshots of Ascl2 gene, showing RING1B binding. 
B) Genomic snapshots of Ascl2 gene showing gene transcription upon PRC1 depletion. 
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from different cells belonging to distinct skin compartments (Rezza, Wang et al. 2016) with 
Ring1a/b dKO vs ctrl transcriptional outcome in HFSCs.  
This analysis pointed out that, together with stem cell signature (Fig 4.22 left panel, HFSC), 
genes related to epidermis (Fig 4.22 right panel, EPI) were enriched in our sample. Among 
this signature we confirm that some genes such as, Krtdap, Calm5, Itgam and Gdpd2, 
together with Ascl2, were activated and highly upregulated in depleted HFSCs compared to 
ctrl ones (Fig 4.23A and B).  
 
Given the fact that Polycomb group proteins are epigenetics modifiers, and not TFs, that 
could actively start target genes transcription, removal of PRC1 suppression could be 
insufficient to activate gene transcription. To better characterize the mechanism of epidermal 
differentiation we decided to scan Ascl2 promoter with LASAGNA-search 2.0 in order to 
find TFs that could be responsible for its activation.   
Interestingly we found in the promoter of Ascl2, several binding motifs that are recognized 
by ZIC TFs family (Fig 4.24). Of note, we previously demonstrated that upon PRC1 loss of 
activity, several ZIC TFs, that are also directly bound by PRC1, are transcriptionally 
 Figure 4.23 PRC1 depletion upregulates different Epidermal related genes 
A) Heatmap representing epidermal-specific genes differentially regulated in Ring1a/b 
dKO LGR5-HFSCs (Log2 fold change). 
B) Genomic snapshots of RNA-seq for Calm5 and Itgam gene showing gene transcription 
upon PRC1 depletion. 
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upregulated (Fig 4.13A), possibly establishing a positive feedback loop for Ascl2 activation 
and driving an epidermal differentiation program.  
 
 
These results support a model in which PRC1 directly suppresses an epidermal-specific 
transcriptional program via suppression of master regulators of lineage specification thus 





Figure 4.24 ZIC TFs binds Ascl2 promoter 
Genomic snapshot of Ascl2 gene showing the binding sequences for ZIC family member in its 
promoter region.  
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4.6  PCGFs PROTEINS LOCALIZE DIFFERENTLY IN 
INTESTINAL CRYPTS. 
Loss of both PRC1 catalytic subunits, Ring1a and Ring1b, leads to a severe phenotype in 
intestinal and hair follicle tissues. However, Polycomb Repressive Complex 1 is composed 
by several different subcomplexes defined by a Polycomb Group Ring Finger protein 
(PCGF1-6) (Gao, Zhang et al. 2012, Scelfo, Piunti et al. 2015). Their mutual incorporation 
in the complex gives rise to at least 5 biochemically different PRC1 subcomplexes that could 
govern different cellular processes.  
In recent years, PCGFs proteins became a central focus in the field of Polycomb research, 
however their characterization has been performed mostly in-vitro, in mESC, and during 
murine embryonic development. Remarkably, a deep characterization of PCGFs proteins 
Figure 4.25 Schematic representation of PCGFs construct for conditional KOs 
The figure shows the murine constructs for different PCGFs conditional KOs. These strains 
have been crossed with LGR5-CreERT2-Rosa26-LSL-LacZ to induce the KO specifically in 
stem cells, and with AhCre that allows for deletion in the intestinal epithelium.  
The figure presents all the translated and non-translated exons for each PCGF gene and the 
ones that are delete upon Cre-mediated cleavage. 
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biochemical and molecular functions in adult tissue homeostasis and adult stem cell 
maintenance is still lacking.  
With the aim to better characterize PCGFs functions in adult tissue and to address their 
contribution in the phenotype driven by PRC1 loss of activity, we obtained all the genetic 
models for conditional deletion of specific PCGFs in mouse (Fig 4.25). Due to the presence 
of redundant complexes, we breed PCGF1 and PCGF6 alone, while PCGF2/4 and PCGF3/5 
together to create the double KO.  
To carry out this phenotypical and molecular analysis of PCGFs function in vivo, we first 
moved back to intestinal epithelium, a field where the laboratory has more expertise, to 
complement the analyses previously performed in Ring1a/b dKO. However, in order to 
understand if the different molecular outcome of PRC1 loss in HFs arise from different 
PCGFs functions in another stem cell compartment, the analyses will be further expanded in 
the hair follicle stem cell compartment.    
 
We first assessed PCGFs expression within the intestinal tissue. Since commercial 
antibodies were not all available, we took advantage of antibodies risen against murine 
PCGFs, produced in our laboratory, which were tested for the major molecular analyses such 
as Western Blot, Chromatin Immuno-Precipitation and Immuno-Precipitation used in our 
laboratory (Scelfo, Fernandez-Perez et al. 2019).  
Small intestines were harvested from Wild-type (WT or ctrl) mice and processed to isolate 
intestinal crypts and the villi.  
 
Proteins and RNA were extracted and the different levels of PCGFs were compared among 
undifferentiated and differentiated cells. PCGF1 and PCGF5 proteins seems to be more 
expressed in the differentiated compartment of intestinal epithelium, while the remaining 
four PCGFs are more expressed in the staminal compartment of the crypt, suggesting a role 
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for these PcG proteins in cell differentiation programs. Importantly, also PCGF1 and PCGF5 
are also expressed in the undifferentiated compartment, although their expression seems to 
increase in the villi, suggesting a role also in the maintenance of differentiated tissue (Fig 
4.26A, B). 
 
Within PRC1, PCGFs proteins dictate the ancillary proteins that will be recruited to assemble 
the final complex. This different composition leads to diverse chromatin localization of the 
subcomplexes, as previously demonstrated in mESCs and cell lines (Gao, Zhang et al. 2012, 
Scelfo, Piunti et al. 2015, Fursova, Blackledge et al. 2019, Scelfo, Fernandez-Perez et al. 
2019). 
In order to discover specific set of genes bound by the complexes, we map the different 
PRC1 sub-complexes binding sites along chromatin in the adult intestinal epithelium, we 
performed ChIP-seq experiments against all PCGFs protein from intestinal crypts 
compartment. With the exception of ChIP for PCGF1, purified crypts were fixed with 1% 
FA and sonicated to disrupt genomic DNA prior immuno-precipitation. Since the 
conventional crosslinking method with FA, which has a crosslinking radius of only ~2A and 
Figure 4.26 PCGFs expression in crypts and villi 
A) Schematic picture of the intestinal differentiated (villi) and undifferentiated (crypts) 
and relative protein abundance of different PCGFs.  
B) Relative mRNA expression of different PCGFs in Crypts (Green) and Villi (Red)  
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does not always conserve protein-DNA interaction, was not successful for the PCGF1 ChIP, 
we tried a different cross-linking protocol. This complex was recovered in purified crypts 
subjected to a double crosslinking protocol with dissucinimidyl glutarate (DSG) molecule, 
that has a radius of 7.7A and acts by crosslinking the primary amine of proteins, followed 
by protein-DNA fixing with FA.  
 
   
We found that, as expected, canonical PRC1 complexes, containing PCGF2/Mel18 and 
PCGF4/Bmi1, localized on classical target genes, such as HOXD cluster and ZIC genes (Fig 
4.27). Particularly, HOXD cluster seems devoid of any other PCGFs, that in turn binds 
discrete genes, demonstrating that PCGF proteins targets different genes, possibly regulating 
their transcription and governing different processes during intestinal tissue homeostasis. 
Of note, PCGF2/Mel18 and PCGF4/Bmi1 among all PCGFs displays the widest peaks length 
(Fig 4.28A), spanning from hundreds of bp in length to 5000 bases, settling to a median of 
1kb. On the other hand, non-canonical PCGFs showed narrower peaks, that are around 
Figure 4.27 PCGFs localization in intestinal crypts 
Genomic snapshots of ChIP-sequencing tracks for all the different PCGFs proteins in 
intestinal crypts and their relative RT-qPCR analyses of selected genes, showing the 
percentage of enrichment on the input.  
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500bp (Fig 4.28B), except for PCGF3 that shows even sharper peaks, probably due to it 
binding to specific target sequences.    
 
Unfortunately, PCGF5 immunoprecipitation was not efficient in intestinal crypts. Probably 
this is due to the low abundance of this protein expression that is consistent with the few 
peaks that we have detected along the genome, and localized on promoters (33 out of 56). 
Thus, we did not include PCGF5 in our genomic analyses.   
In order to dissect the possible complementarity among the different PCGFs, we analyzed 
ChIP seq by performing a heatmap analysis of PCGF peaks (Fig 4.29). We found that overall 
the different PCGFs localize differently on the genome, and only a partial overlap exists, in 
particular among PCGF2/Mel18 and PCGF4/Bmi1 containing PRC1, consistently with their 
ability to form similar complexes. Surprisingly, we found a good overlap of PCGF2/4 targets 
with PCGF1-containing complexes.  
A partial overlap of PCGF6 and PCGF3 also exist, but it is still restricted to few genes, due 
to low peaks number in the PCGF3 ChIP-seq. Remarkably, we ran a motifs enrichment 
analyses on promoters bound by PCGFs proteins and we found that, consistently with 
Figure 4.28 PCGFs genomic peaks shows differences in their length 
Box plot representing the width of the different PCGFs peaks on their genomic targets. 
(Total Peaks: PCGF1= 2114; PCGF2= 1064; PCGF3= 64; PCGF4= 1303; PCGF5= 
56; PCGF6= 1900)     
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mESCs literature, PCGF6 is found on E-box binding motif, that is also bound by c-Myc 
oncogene, and T-box sequences, that in turn is recognize by MGA, which is part of the 
Figure 4.29 Different PCGFs shows partial overlaps on gene promoters 
Heatmap showing the quantification of ChIP seq signals over PCGFs bound promoters (+/- 4kb 
from TSS) showing the grade of overlaps among PCGF1, PCGF2 PCGF3, PCGF4 and PCGF6.  
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PRC1.6 complex. Moreover, PCGF3 motif enrichment discovery shows that, also in 
intestinal crypts it is able to bind another BHLH motif, similar to c-Myc E-box, that is 
recognized and bound by the newly described USF1 partner discovered by our laboratory 
(Scelfo, Fernandez-Perez et al. 2019).   
 
To define the classes of genes possibly regulated by PCGFs proteins, we performed a GO 
term analyses on genes-related peaks for every PCGFs (Fig 4.30). We found that PCGF2 
and PCGF4 largely overlap, governing genes involved in development and cell fate 
commitment. 
Remarkably, also PCGF1 seems to bind genes related to development and differentiation, 
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Figure 4.30 GO-Term analyses of PCGFs gene target reveals functional overlap among 
PCGF1, PCGF2 and PCGF4 
Gene ontology analyses of PCGFs bound genes, showing their involvement in different cellular 
processes. PCGFs promoter peaks number are displayed in brackets. 
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PCGF2/Mel18 and PCGF4/Bmi1, opening the possibility that PCGF1 is involved in 
canonical-gene regulation. On the other hands, PCGF3 and PCGF6 seems to regulate 
different cellular functions related to transport, and cell cycle/metabolism respectively.     
  
In HFSCs, and accordingly to the recent literature (Morey, Aloia et al. 2013, Zhao, Huang 
et al. 2017, Cohen, Zhao et al. 2018, Fursova, Blackledge et al. 2019, Scelfo, Fernandez-
Perez et al. 2019), we showed that PRC1 localize on active genes. To elucidate PCGFs 
functions and role in transcriptional regulation, we decided to investigate which PRC1 sub-
complex localized on active or repressed genes. To do so, we compared PCGFs ChIP seq 
performed in intestinal crypts to RNA-seq obtained from ISCs of LGR5 ctrl mice.   
PCGF3 and PCGF6 localize on actively transcribed genes, suggesting a role in active 
transcription regulation also in intestinal epithelium. This is true also for PCGF1 targets 
genes which are enriched for medium-active genes. Strikingly, while PCGF2, consistently 
Figure 4.31 PCGFs proteins binds both expressed and repressed genes 
Box plot representing PCGFs targets genes, retrieved by ChIP-seq analyses and their relative 
expression in ISCs, showing that single and combinations of PCGFs binds both active and 
repressed genes.   
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with reported literature is found on transcriptionally repressed gene, PCGF4 seems to 
localize on active genes. Importantly, peaks containing PCGF2 and PCGF4 or PCGF1/2/4 
are on totally silenced genes, suggesting that PCGF2 is the main effector in gene silencing 
in intestinal crypts (Fig 4.31).    
 
However, to better characterize the epigenetic changes induced by specific PCGFs loss, and 
to elucidate to which extent PCGFs are able to compensate for each other, we are now 
breeding our conditional PCGFs KOs mice with AhCre transgenic mice, in order to perform 
ChIP sequencing analyses on PcG proteins and histone modifications among all PCGFs KO 
mice. These mouse models allow the deletion of PCGFs exons in all intestinal populations, 
with the only exception being Paneth cells. Moreover, these mice will be used for 
phenotypical analyses and transcriptomic analyses at single cell level, as well as in bulk.  
 
 
4.7  PRC1-NULL PHENOTYPE IN ISCs IS A SUM OF DIFFERENT 
SUB-COMPLEXES ACTIVITY. 
Intestinal tissue homeostasis and heterogeneity of intestinal cell populations arise from ISCs. 
Due to the fundamental role of PRC1 in adult stem cell identity maintenance we were 
interested in defining if a single PRC1 subcomplex or, alternatively, which combinations of 
complexes, were responsible for the loss of PRC1 activity phenotype.  
To investigate PCGFs function in governing ISCs self-renewal and identity maintenance, we 
bred all the previously described mouse models (Fig 4.25) with the LGR5-GFP-ires-
CreERT2 /Rosa26Lox-stop-Lox LacZ mouse strain (hereof LGR5 ctrl or LGR5 PCGFx KO 
after tamoxifen treatment), to obtain PCGFs excision only in LGR5 expressing stem cells. 
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The obtained strains, give us the possibility to carry out lineage tracing analysis and 
molecular analyses specifically in stem cells, allowing the definition of the phenotypic and 
transcriptomic changes arising from specific PCGF loss in the stem population. 
 
To this purpose, we began with the generation and analyses of LGR5-PCGF1, LGR5-
PCGF2/4, LGR5-PCGF3/5 and LGR5-PCGF6 conditional KO mice, focusing first on their 
ability to affect or impair stem cell self-renewal by performing a lineage tracing analysis. 
Importantly, in intestinal tissue, differently from hair follicle, the expression of LGR5-GFP-
ires-CreERT2 /Rosa26Lox-stop-Lox LacZ construct is not homogeneous. Within the crypts 
base, different ISCs that randomly inactivate the transgene, always compete with other stem 
cells, resulting in crypt clonality (Gehart and Clevers 2019). Indeed, this leads to crypts that 
express GFP and CreERT2, that are capable to elicit recombination between LoxP sites of 
PCGF and Rosa26Lox-stop-Lox LacZ transgenes, and crypts that do not express the enzyme. 
Therefore, LacZ staining does not occur homogeneously in the tissue.  
 
To verify whether PCGFs KOs are able to affect stem cell maintenance and tissue 
regeneration during homeostasis, mice were treated with four daily IP injection of tamoxifen 
and the intestine were harvested 30 days after the first injection, time point that showed a 
complete loss of traced cells derived from LGR5-PRC1 depleted stem cells (Chiacchiera, 
Rossi et al. 2016) . In fact, in our previous report, the ablation of all PRC1  subcomplexes, 
through the depletion of both catalytic subunits Ring1a and Ring1b, results in the loss of 
progeny derived from PRC1 defective ISCs, due to stem cell self-renewal impairment, as 
highlighted by the loss of LacZ staining in the tissue (Fig 4.32 top panel left). On the 
contrary, KOs for PCGF1, PCGF6, PCGF3, PCGF5 and the double KO for PCGF3/5 
redundant subunits do not affect stem cell ability to maintain the tissue (Fig 4.32), as 
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demonstrated by the presence of LacZ staining, thus proving that the depletion of a single 
PRC1 subcomplex is not sufficient to phenocopy the loss of the entire Polycomb complex.  
 
To define the role of PRC1 canonical subcomplexes we plan to perform the same lineage 
tracing experiment. However, preliminary data obtained by lineage tracing at 7 days post 
injection, suggest that also PRC1.2 and PRC1.4 concomitant ablation is not sufficient to 
phenocopy Ring1a/b dKO. In fact, while PRC1 loss of activity at 8 days display intestinal 
units that are only stained at the crypt base (Fig 4.33 left), while LGR5-PCGF2/4 KO derived 
progeny are found also in villi (Fig 4.33 right). This is due to the fact that impaired stem 
cells, are counter selected from the high competition at the crypt base, and the arising 
progeny, migrates in the villi is finally lost in lumen. LGR5-PCGF2/4 KO, are continuously 
generating progeny without being counter-selected, indicating that these mutations do not 
Figure 4.32 Lineage tracing analyses of non-canonical LGR5-PCGFs KO at 30 dpi  
Lineage tracing analyses of non-canonical PRC1 subcomplexes KOs, showing that the depletion 
of these subcomplexes do not affect stem cell capability to maintain the tissue.  
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confer disadvantages in terms of self-renewal and proliferation. However, longer time point 
are needed to better define the phenotype. 
 
These results together suggest that single PRC1 subcomplex depletion is not sufficient to 
phenocopy the drastic phenotype observed in PRC1 deficient mice, indicating that more than 
one complex is involved in the maintenance of cellular identity and stem cell self-renewal. 
 
 
4.8  TRANSCRIPTOMIC ANALYSES OF ISCs REVEALS THAT 
PRC1 SUBCOMPLEXES GOVERN SPECIFIC CELLULAR 
PROCESSES 
To elucidate the molecular functions of the different PCGFs proteins in ISCs, we decided to 
evaluate the transcriptional changes arising from PCGF1, PCGF2/PCGF4, PCGF3/PCGF5 
and PCGF6 depletion. To do this, we induced Cre-mediated excision of the transgenes in 
LGR5-ISCs by four daily intraperitoneal injection of Tamoxifen and we harvested the 
intestinal tissue after 7 days from the first injection (Fig 4.34A) and processed the crypts to 
single cells prior to sorting. 3000 to 5000 of sorted GFP-positive ISC from LGR5 ctrl mice, 
Figure 4.33 Lineage tracing analyses of canonical LGR5-PCGFs KO at 7 dpi 
Lineage tracing analyses of canonical PRC1 subcomplexes KOs, showing that the depletion 
of these subcomplexes do not affect stem cell capability to maintain the tissue.  
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2 biological replicates for LGR5-PCGF1 KO, LGR5-PCGF6 KO and LGR5-PCGF2/4, and 
2 technical replicates for PCGF3/5 KO were processed with Smart-Seq2 protocol and the 
floxing efficiency for every PCGF was evaluated on the pre-amplified cDNA (Fig 4.34B-
E).  
 
Figure 4.34 LGR5-PCGFs KO validation 
A) Schematic representation of the experiment workflow. 
B-E) RT-qPCR analyses of different PCGFs KO in pre-amplified cDNA obtained from 3-to-5 
thousand sorted ISCs subjected to SMART-seq2 protocol. Bar plots represent mRNA relative 
expression plus Standard Deviation. 
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Sequencing analyses revealed that overall LGR5-PCGF2/4 KO, consistent with their known 
important role as transcriptional regulators, leads to the upregulation of more than 2000 
genes and the downregulation of 1700 genes (Fig 4.35). Similarly, loss of PCGF1 in LGR5 
stem cell causes the downregulation of 617 gene and almost an equal number of genes 
upregulated (437) (Fig 4.35). Conversely, consistent with the activatory roles reported for 
PCGF3/5 and PCGF6 PRC1 containing complexes (Morey, Aloia et al. 2013, Zhao, Huang 
et al. 2017, Cohen, Zhao et al. 2018, Fursova, Blackledge et al. 2019, Scelfo, Fernandez-
Perez et al. 2019), their loss leads to a massive amount of genes downregulation, compared 
Figure 4.35 Volcano plots of different PCGFs KO showing the up and downregulated 
genes  
Volcano plot analyses of PCGF1, PCGF2/4, PCGF3/5 and PCGF6 KO ISCs showing the 
different expressed genes of KOs compared to LGR5 ctrl ISCs. (tresholds: p-value < 0.05, 
absolute log2(fold change)>1). 
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to gene activation with respectively 931 vs 499 and 993 and 386 genes deregulated (Fig 
4.35). 
To define which pathways are altered upon different PCGFs KO in ISCs, we interrogated 
GO analyses for up and downregulated genes (Fig 4.36). Genes that decrease their 
expression upon PCGFs depletion are involved in different metabolic, transcriptional, cell 
cycle-related and viral response processes, that are only partially overlapping among 
different sub complexes, suggesting that their loss impairs specific cellular functions. 
Figure 4.36 GO term analyses of deregulated genes in ISCs upon different PCGFs KO  
Gene ontology analyses of ISCs PCGFs KOs deregulated genes, showing their involvement in 
different cellular processes. 
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On the other hand, ISCs abrogated for canonical PRC1 complexes activity shows up 
regulation of genes related to development and differentiation, further proving their classical 
PRC1 functions, biological processes that are partially shared with LGR5-PCGF1KO altered 
transcriptome. Moreover, PCGF1 loss also induces alteration in transport and microbial 
related processes. Differently from PCGF1 and PCGF2/4 KO, PCGF3 and PCGF6 do not 
share any biological process, in accordance with their ability to binds different targets.   
 
 
4.9 FUTURE PERSPECTIVE AND ON-GOING 
CHARACTERIZATION 
To date, we show that in vivo PRC1 complexes maintenance is necessary to regulates stem 
cell identity in different stem cells, and that this function is accomplished by the sum of 
different PRC1 subcomplexes activities, that remains to be defined, that acts together on 
different cellular processes. We showed that in the intestinal epithelium, PRC1-
subcomplexes govern several different pathways and functions that are only partially shared 
among different PCGFs. This has to be proved also in HF-stem cell compartment, in order 
to dissect whether PRC1 subcomplexes features are similar or different in the two tissues.  
To complement the phenotypic analyses of ISCs, we are investigating also the effect of 
PCGFs deletion in the whole intestinal epithelium, through the controlled induction of Cre-
recombinase under CYP1A1 promoter, that is activated upon lipophilic xenobiotic 
administration. Preliminary analyses of single KO in epithelial tissue of intestine, showed 
that, consistent with their specific gene regulation, no major effects are evident when PCGFs 
are ablated in homeostatic conditions (Fig 4.37), further highlighting their interdependency. 
 
Polycomb proteins are important cell identity regulators, and their alteration in cancer is well 
documented. Among the different PCGFs, Mel18 and Bmi1, despite their great overlapping 
features, are known as tumor suppressor and oncogene respectively (Zhang, Sheng et al. 
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2010). However, nothing is known about the other PCGFs proteins constituting the non-
canonical complexes in both pathological and homeostatic condition.     
Of note, PRC1.1 subcomplex seems to be related to canonical-PRC1 regulation, that together 
with the lack of phenotypic outcome of LGR5-PCGF2/4 KO leads to the hypothesis that 
PCGF1 is able to co-regulate canonical PRC1 genes. To validate this theory, we are now 
breeding PCGF1 and PCGF2/4 mouse models to ablate the three complexes together in 
LGR5 expressing stem cells and intestinal epithelium, in order to study the phenotypical 
addiction of PRC1.1 loss in PRC1.2 and PRC1.4 KO. These three PcG proteins are reported 
in literature as transcriptional repressors, and we showed that, when they colocalized, target 
gene transcription is completely absent. On the other hand, PCGF3/5 and PCGF6 containing 
PRC1 are reported as activatory-Polycomb complexes, and we show that they share the 
ability to bind BHLH motifs on different genes. To deeply investigate the activatory 
Figure 4.37 Single deletion of PRC1 subcomplexes does not affect intestinal 
homeostasis 
Hematoxylin and Eosin staining of duodenum from AhCre-PCGF1, AhCre-PCGF6 and AhCre-
PCGF3/5 KOs and their floxing efficiency, showing that single PRC1 subcomplexes ablation 
does not affect intestinal homeostasis. Tissues were collected after 15days from first beta-
napthoflavon intraperitoneal injection. Graph represent the relative expression plus Standard 
Deviation of PCGFs transcripts in the respective ctrl and KOs mouse. 
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properties of PRC1 complex we are creating mice strains where PRC1.3/5 and PRC1.6 are 
concomitantly ablated from LGR5 expressing stem cells and whole intestinal epithelium.  
These conditional KOs for repressive and activatory PRC1 subcomplexes will be used to 
perform both phenotypical and molecular analyses in order to dissect the functions in 
homeostasis and their contribution to PRC1-loss-of-activity phenotype.  
 
As the last part of our characterization we aim to address the ability of the different PCGFs-
containing subcomplexes in tissue regeneration upon damage, and in oncogenic 
transformation.  
To address PCGFs role in regeneration we are planning to perform phenotypic and molecular 
analyses of PCGFs conditional KOs upon different damage induction, such as inflammation 
and irradiation.  
On the other hand, to address the oncogenic potential of PRC1 we will focus on PCGF6-
containing PRC1 subcomplex, due to its interaction with MGA and MAX proteins, which 
are involved in the c-Myc pathway. Of note, c-Myc overexpression is not sufficient to induce 
tumorigenesis in intestinal epithelium, but it has the ability to expand the staminal 
compartment during its upregulation (Finch, Soucek et al. 2009). We hypothesize that 
PCGF6 is able to restrain c-Myc transforming capability in intestinal epithelium, preventing 
c-myc binding on important genes necessary for transformation. To validate this model, we 
are breeding AhCre-PCGF6 conditional KO mouse model with Rosa26-LSL-MYCERT2 
that allow Myc translocation in the nucleus upon tamoxifen delivery, in this way we can 
couple PCGF6 KO with active nuclear c-myc function. We first analyzed the oncogenic 
potential of PCGF6 alone in a protocol of colon cancer induction, that exploits a carcinogen 
(Azoxymethane) and sequent cycles of colon inflammation with DSS molecule, allowing us 
to obtain colon adenomas in 60 days (Fig 4.38A). Preliminary results shows that PCGF6 KO 
is maintained during the whole protocol (Fig 4.38B), suggesting that depleted crypts are not 
counter selected and it does not have a major effect in tissue maintenance, as demonstrated 
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by the similar weight curve between AhCre ctrl and PCGF6 KO mice (Fig 4.38C) and from 
colon cancer adenomas histological sections that were similar in number and dimension 
along the colon (Fig 4.38D). However, deeper investigation of histological sections and 
Figure 4.38 PCGF6 KO does not affect adenomas onset and progression 
A) schematic view of AOM-DSS protocol used for AhCre WT and PCGF6 mice.  
B) Western blot analyses (up) and mRNA RT-qPCR (bottom) of intestinal crypts to validate 
PCGF6 KO at the end of the protocol. 
C) Weight curve showing the percentage of weight loss during the DSS cycles. 
D) Hematoxylin and Eosin staining of AhCre ctrl and AhCre-PCGF6 KO mice at the end of 
the AOM-DSS protocol, showing adenoma formation in the two conditions. 
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molecular studies are required, as well as is necessary to increase the number of experimental 
animals, and to carefully monitor the number and the volume of the tumors arising in the 
two conditions  Moreover, we aim to compare the effect of Myc overexpression in the 
presence or absence of PRC1.6, to validate our hypothesis, thus further analyses will be 
performed with the Myc inducible mice strains.  
 
 





5.1 PROJECT OVERVIEW 
Polycomb Groups of Proteins are epigenetic factors involved in development and 
differentiation. PcG proteins assemble to form two main complexes named PRC1 and PRC2 
which roles are widely studied in ESCs and other cultured cell lines since 40 years (Aloia, 
Di Stefano et al. 2013, Aranda, Mas et al. 2015, Scelfo, Piunti et al. 2015, Poynter and 
Kadoch 2016). However, a deep characterization of Polycomb complexes function in vivo 
has begun just few years ago, and a comprehensive view of their roles is still missing. The 
first studies demonstrated that Polycomb complexes were linked to embryonic development 
and their alteration leads to several different phenotypic defects spanning from homeotic 
transformation to pre-implantation death.  
Instead, the role of the PcG proteins roles in adult tissue homeostasis is still not known. 
Importantly tumors are strictly related to adult cells dedifferentiation and loss of identity 
(Friedmann-Morvinski and Verma 2014, Roy and Hebrok 2015). Adult tissues are 
maintained throughout life from adult stem cell pools that drive organs regeneration, and, in 
the past 5 years, it starts to be clear that Polycomb proteins are important regulator of stem 
cell identity and differentiation also in adult context. We recently reported that PRC1 and 
PRC2 play crucial roles in supporting intestinal homeostasis governing two different 
functions, by sustaining stem cell identity and self-renewal, and surveilling the balance 
among enterocytes and secretory cells by regulating lineage-differentiation genes 
respectively (Chiacchiera, Rossi et al. 2016, Chiacchiera, Rossi et al. 2016, Chiacchiera and 
Pasini 2017). 
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 Particularly, PRC1 is critical to maintain ISC and the loss of both RING1A and RING1B 
catalytic subunits leads to stem cells exhaustion driven by a massive upregulation of different 
non-lineage-specific transcription factors.  
Additionally, PRC1 is composed of several subunits, that generate different subcomplexes 
which are able to govern different aspects of stem cell maintenance, and these complexes 
are not studied in adult tissue homeostasis. Indeed, their contribution to PRC1-loss-of-
activity phenotype is still obscure. The discovery of their biological function in both 
homeostatic and pathological condition could also be important to develop novel therapeutic 
approaches. In fact, deregulation of all complexes could be dangerous for the whole 
organism, while targeting specific subcomplexes could be more specific and effective to 
overwhelm tumor growth without influencing healthy tissue. To this end we want to deeply 
investigate PRC1 subcomplexes in different compartments, in order to have a 
comprehensive view of their regulation and functions. Nevertheless, from new emerging 
literature, mostly related to cancer, is clear that the same proteins can behave differently 
depending from the context. Without going too far from Polycomb proteins, PRC2 complex 
is found to be mutated in opposite manners depending on the tumoral context (Scelfo, Piunti 
et al. 2015), highlighting that it is necessary to study proteins in a context dependent manner.  
 
In order to overcome the reported functional and biochemical redundancy, we exploited the 
use of a mouse model in which both catalytic subunits of PRC1 complexes could be 
abrogated (del Mar Lorente, Marcos-Gutierrez et al. 2000; de Napoles, Mermoud et al. 2004; 
Roman-Trufero, Mendez-Gomez et al. 2009). Until tamoxifen delivery our mouse model 
LGR5-GFP-ires-CreERT2/Ring1a-/-/Ring1bfl/fl/Rosa26Lox-stop-LoxLacZ only harbor the 
homozygous excision of Ring1a gene. In these conditions we do not notice any severe 
impairment in hair follicle morphogenesis and regeneration, as demonstrated by their ability 
to maintain the fur, during development and first anagen, however, we cannot formally 
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exclude that at least part of the phenotype observed during hair regeneration could be due to 
Ring1a depletion in the surrounding environment. 
 
5.2  PRC1 IS NECESSARY TO MAINTAIN ANAGEN 
PROGRESSION   
Using the LGR5-GFP-ires-CreERT2/Ring1a-/-/Ring1bfl/fl/Rosa26Lox-stop-Lox LacZ mouse 
strain we had the unique opportunity to deeply investigate PRC1s role in hair follicles and 
intestinal adult tissue contexts, which share common features, such as the rapid division of 
LGR5 stem cell population. These compartments arise from distinct embryonic layers (de 
Santa Barbara, van den Brink et al. 2003, Liu, Zhang et al. 2013), ectoderm and endoderm 
respectively, allowing us to analyze whether this fundamental complex plays the same role 
exploiting the same mechanism or the context influence PRC1 function. Our data revealed 
that PRC1 is able to repress a common set of genes in ISC and HFSCs, suggesting that its 
role is fundamental throughout different tissues despite the different embryonic origins. 
However, in adult life the pools of transcription factors present in a specific cell type, is able 
to shape the molecular outcome of PRC1 loss. 
 
Differently from ISC, that continuously divide to regenerate the tissue, LGR5-HFSCs 
encounter cycles of proliferation and resting during their lives. In order to minimize the 
differences among different HFs related to the cell cycle stages we decided to induce anagen. 
Loss of PRC1 activity in this context leads to the same phenotypic effect previously observed 
in the intestinal compartment. We faced an impairment of proliferation that inhibits the 
correct formation of all the structures that will develop the hairs, ultimately affecting tissue 
regeneration.  
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PRC1 is a known epigenetic repressor of Ink4a-ARF genomic locus that encode for p16 and 
p19 mouse proteins that are able to block Cyclin D and MDM2 negative regulator of RB and 
p53, leading to cell cycle inhibition. However, despite the relief of the transcriptional 
repression of this locus, it has been demonstrated, both in adult stem cells, in our ISC work, 
and from a new HF-related paper carried out during morphogenesis, that PRC1-loss-of-
activity phenotype is independent from Ink4a-ARF locus activation, suggesting that also in 
our context the early anagen proliferative blocks is induced by other factors apart from p16-
p19 pathways (Chiacchiera, Rossi et al. 2016, Cohen, Zhao et al. 2018). 
Whether these alternative pathways, which leads to a phenotypic convergence in the absence 
of PRC1, are the same in different tissues was investigated at molecular levels by comparing 
ISCs and HFSCs data. 
Even though, we faced a great impairment of anagen progression, we could see some anagen 
features in a reduced number of follicles that partially express beta-galactosidase protein. It 
has been demonstrated that upon LGR5-HFSCs depletion, CD34-HFSCs, residing in the 
upper bulge region, start to express LGR5 stemness marker and the follicles are able to 
correctly proceed through anagen (Hoeck, Biehs et al. 2017). However, it is possible that 
this mechanism is not happening in our model. In fact, we are not losing LGR5 expression 
in quiescent follicles, but only the PRC1 associated histone mark, suggesting that, rather 
than disrupt LGR5-HFSCs population within the hair follicle, PRC1 ablation is able to 
induce a massive deregulation of the transcriptional landscape without affecting stem cell 
viability but only their self-renewal potential and identity. In this view, PRC1 depleted cells 
are still able to divide once, or just a few times, giving rise to LacZ positive progeny but, 
lacking essential self-renewal related genes and other hair follicle specific transcripts, these 
cells are not able to sustain the correct hair follicle cycle progression and regeneration. 
Analyzing RNA-seq data obtained from LGR5-HFSCs Ring1a/b ctrl and dKOs, we found 
that PRC1 depleted cells show reduced expression of the Shh gene. SHH pathway is 
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necessary to sustain several processes in HF, first of all anagen progression. Remarkably, it 
has been demonstrated that ablation of the Shh gene in K15 expressing cells, that specify for 
both bulge and HG-HFSCs, leads to the generation of Mx cells that are impaired in anagen 
progression and failed to proceed after Anagen phase II (Hsu, Li et al. 2014, Zhang, Tsai et 
al. 2016). Therefore, we hypothesize that PRC1 activity is necessary to sustain Shh active 
transcription and hair follicle cycle progression.  
  
5.3 PRC1 IS NECESSARY FOR TISSUE IDENTITY 
MAINTENANCE  
PRC1 loss induces the deregulation of several different genes, both directly and indirectly. 
We confirmed that, also in this tissue context, PRC1 activity is necessary to preserve the 
expression of genes necessary for cell identity maintenance. This is in accordance with 
Cohen and colleagues (Cohen, Zhao et al. 2018), that observed that PRC1 ablation in 
epidermal progenitors downregulates epidermal and hair follicle related genes.  
Upregulated genes upon PRC1 loss of activity in HFSCs mostly comprise homeotic and 
development-related transcription factors, and the same is true for the intestinal 
compartments. Overall, almost the 25% of the upregulated genes were common among the 
two stem cell populations and, more importantly, in both cases the deregulated transcripts 
were not specifically expressed in peculiar tissues, but they were widely expressed among 
an extensive panel of tissues and cell lines, highlighting the crucial role of PRC1 in defining 
lineage-specificity. The same results were obtained also in epidermal progenitors (Cohen, 
Zhao et al. 2018) where the Ring1a/b dKO shows the upregulation of various genes involved 
in development and differentiation. These results together underlie the common role in 
governing identity maintenance that is accomplished by PRC1 in different stem cells, 
temporally spanning from embryonic stem cells, through more differentiated progenitor 
stem cells, to adult stem cells.   
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PRC1 and its PCGFs subunits are mainly studied in mESCs and during embryonic 
development. Recently Cohen and colleagues investigated PCGFs role in hair follicle 
morphogenesis. Importantly, they did not identify any defects in hair follicle formation in 
PCGF1, PCGF3/5 and PCGF6 KO. On the other hand, consistently with PRC1 catalytic 
mutant, that leads to the upregulation of only few genes and to an increase of Merkel cells 
within the developing hair follicle and epidermis, PCGF2/4 KO leads to the same phenotype, 
without affecting hair follicle features. Importantly LGR5 stem cells arise after 
morphogenesis and they do not address any feature of adult stem cell maintenance.              
Remarkably, nothing is known about the specific contribution of different PRC1 sub-
complexes in adult homeostasis preservation. To fill this void, we crossed different PCGFs 
conditional KOs in order to investigate their specific involvement in different homeostatic 
processes, evaluating both their phenotypic and transcriptional outcome upon loss-of-
activity induction. We showed that, consistently with hair follicle morphogenesis, single 
PCGFs KOs in adult LGR5-ISC, are not sufficient to impair homeostasis. This is highlighted 
also by the different transcriptomic changes arising from PCGFs depletion, showing how 
single PRC1 subcomplexes are specifically involved in minor processes, that are not 
sufficient to induce stem cell self-renewal failure. However, based on transcriptomic and 
genomic data, we hypothesize that a combination of different PRC1 subcomplexes ablation 
could phenocopy the drastic Ring1a/b dKO previously described.  
Additionally, our and Dr. Klose laboratories precisely shown that different combinations of 
PCGFs KOs are necessary to phenocopy Ring1a/b loss and that a single PCGF loss is not 
sufficient to induce a significative transcriptional deregulation to induce phenotype changes 
in vitro (Fursova, Blackledge et al. 2019, Scelfo, Fernandez-Perez et al. 2019).  
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5.4 PROFILING PRC1 BINDING IN STEM CELLS  
Carrying out this project we could also compare the binding profile of RING1B in different 
LGR5 stem cell population. In both hair follicle and intestinal stem cells population PRC1 
is mainly found at gene promoters. Comparing RING1B peaks among ISCs and HFSCs, we 
found that only a subset were common among the two population, meaning that RING1B 
binds to different genes in different adult stem cells. Remarkably, the shared peaks are 
related to genes involved in development and differentiation, further highlighting that PRC1 
role in cell fate determination and stem cell maintenance is common among different stem 
cells.  
By ChIP-seq experiments in HFSCs, we proved that PRC1 is able to bind both active 
H3K4me3-marked genes and repressed genes decorated with the H3K27me3 histone mark. 
Repressed genes were bound by Canonical PRC1 complexes, as demonstrated by the 
presence of CBX8 subunit, while active target genes display the presence of RYBP, defining 
the non canonical part of the complexes. Interestingly, we showed that canonical target genes 
are also marked by high levels of H2AK119Ub1 histone modification compared to non 
canonical sites that, instead, show only low levels of PRC1 mark, suggesting that non 
canonical complexes could exert their function independently from their ability to 
ubiquitinate histone H2A on K119. Importantly this histone modification distribution has 
been described also in murine ESCs, where PRC1-mediated ubiquitination and PRC2-
mediated methylation co-exist at gene promoters bound by CBX7 and RING1B, while 
RYBP/RING1B co-occupied genes are largely devoid of H2AK119Ub1 (Morey, Aloia et al. 
2013). We have also shown that this ability of PRC1 to binds both active and repressed genes 
is not a peculiar behavior of HFSCs and ESCs but is found also in ISCs. Moreover, this latter 
observation has also been confirmed by Cohen and colleagues (Cohen, Zhao et al. 2018) 
indeed expanding the evidence of PRC1 role on active genes also in epidermal progenitors.      
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In accordance with the recent emerging literature (Zhao, Huang et al. 2017, Cohen, Zhao et 
al. 2018, Fursova, Blackledge et al. 2019, Scelfo, Fernandez-Perez et al. 2019), we provide 
further evidences that PRC1 is able to bind active genes in vivo, and that this is achieved in 
the context of RYBP containing non-canonical complexes. However only few of those active 
PRC1 genes scored among the down-regulated transcripts upon PRC1 loss, both in HFCSs 
and ISCs, thereby suggesting a marginal role of non-canonical subcomplexes in maintaining 
the expression of those targets. Therefore, their specific role on active genes remains to be 
addressed.  
This latter observation suggests that stem cells loss of identity and self-renewal impairment, 
firstly shown in ISCs and now described for HFSCs, could be primarily ascribed to the 
repressive canonical activity of PRC1. We described that several Polycomb targets become 
derepressed upon PRC1 depletion, and those upregulated genes can be directly linked to the 
phenotypic convergence observed in the two stem cells populations, highlighting the general 
role of PRC1 in maintaining transcriptional repression of non-lineage specific genes. 
Additionally, we define that, in intestinal crypts, all non-canonical PRC1 subcomplexes can 
binds transcriptionally active genes and. Of note, PCGF4, that in the context of PRC1 has 
been always associated with gene repression, when localized on the chromatin alone is found 
on active genes. Remarkably, canonical subunit PCGF2 binds only repressed genes, and the 
concomitant genomic localization of PCGF2 and PCGF4, as well as PCGF1, PCGF2 and 
PCGF4 is found on transcriptionally silenced genes, leading to the hypothesis that PCGF2 
canonical subunits could be primarily involved in gene silencing. Moreover, it is possible 
that these differences in genomic localization could be part of the dissimilar behavior 




5.5 PRC1 GENERAL ACTIVITY IS INFLUENCED BY TFs POOLS. 
Importantly, both in ISCs and HFSCs, not all PRC1 repressed targets are transcriptionally 
activated upon Ring1a/b dKO. This evidence points out that, despite the general role of 
PRC1 previously described is shared among different stem cells of different tissues and 
arising from different embryonic layers, PRC1 transcriptional outcome is influenced by the 
tissue context, resulting in a cell type dependent upregulation of different PRC1 target genes. 
Likely, this specificity is conferred by the TFs repertoire available in the given cells.  
Accordingly, while in ISCs we did not found any specifics TFs able to drive a differentiation 
program, in Ring1a/b dKO HFSCs we could appreciate the de-repression of ASCL2, that is 
known to be sufficient and required for epidermal differentiation (Moriyama, Durham et al. 
2008). Deeper analyses of transcriptomic data from PRC1 deficient HFSCs confirmed the 
activation of an epidermal-specific transcriptional program, that involves the upregulation 
of different epidermal genes, which could, at least in part, contribute to the loss-of-identity 
phenotype arising from Ring1a/b depletion in HFSCs. 
 
 
5.6 PRC1 AS A STEM CELL IDENTITY GUARDIAN AND 
CLINICAL IMPLICATION  
Our data sustain the existence of a general role of PRC1, in different populations of adult 
stem cell, in the preservation of cell identity. PRC1 loss deregulates different genes, which 
are only partially overlapping in different stem cell populations, that ultimately converge to 
the same phenotypic effect through different cell-type specific mechanisms.  
This observation is particularly important non only to elucidate PRC1, and more in general 
Polycomb proteins, roles in shaping adult tissues and homeostasis maintenance, but also to 
analyze these epigenetic factors in several pathological conditions, primarily in cancer, in 
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which Polycomb complexes are directly involved and play different roles. Several reports 
show how PcG are required for tumor development and progression, as well as for its 
prevention depending on the contexts (Richly, Aloia et al. 2011, Scelfo, Piunti et al. 2015) 
and some new molecules that act as Polycomb inhibitors have already entered clinical trials 
(Richly, Aloia et al. 2011, Pasini and Di Croce 2016). Taking into account the context 
dependency highlighted from our works in adult stem cells, it is possible that the efficacy 
and the consequences of PcG inhibition could be cell type specific, linked to the TF pools 
and the signaling pathways of the different cells, underlying the necessity to carefully 
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Loss of PRC1 activity in different stem cell 
compartments activates a common transcriptional 
program with cell type–dependent outcomes
Silvia Pivetti1, Daniel Fernandez-Perez1, Alessandro D’Ambrosio1, Caterina Maria Barbieri1, 
Daria Manganaro1, Alessandra Rossi1, Laura Barnabei1*, Marika Zanotti1, Andrea Scelfo1, 
Fulvio Chiacchiera1,2†‡, Diego Pasini1,3†‡
Polycomb repressive complexes are evolutionarily conserved complexes that maintain transcriptional repression 
during development and differentiation to establish and preserve cell identity. We recently described the 
fundamental role of PRC1 in preserving intestinal stem cell identity through the inhibition of non–lineage-specific 
transcription factors. To further elucidate the role of PRC1 in adult stem cell maintenance, we now investigated its 
role in LGR5+ hair follicle stem cells during regeneration. We show that PRC1 depletion severely affects hair 
regeneration and, different from intestinal stem cells, derepression of its targets induces the ectopic activation of 
an epidermal-specific program. Our data support a general role of PRC1 in preserving stem cell identity that 
is shared between different compartments. However, the final outcome of the ectopic activation of non– 
lineage-specific transcription factors observed upon loss of PRC1 is largely context-dependent and likely related 
to the transcription factors repertoire and specific epigenetic landscape of different cellular compartments.
INTRODUCTION
Cellular identity is preserved by different layers of transcriptional 
control. Among the factors and molecular circuits involved in estab-
lishing and maintaining cell type–specific transcriptional profiles, 
epigenetic regulators play a pivotal role. Alterations in these mecha-
nisms are one of the leading causes of different pathologies, such as 
cancer (1, 2). Polycomb group (PcG) proteins are a class of evolu-
tionarily conserved molecules required to maintain transcriptional 
repression during development and differentiation (3). PcG proteins 
assemble into two major complexes named Polycomb repressive 
complex 2 (PRC2) and PRC1. PRC1 and PRC2 share the vast majority 
of their targets, characterized by CpG-rich regions at promoters, 
where they are recruited sequentially. The core of PRC2 is composed 
of the mutually exclusive catalytic subunits EZH1 and EZH2, which 
deposit the mono-, di-, and trimethylation on lysine 27 of histone 
H3 (H3K27me3), and of two structural proteins SUZ12 and EED, 
which are necessary for complex formation and stabilization (4, 5). 
PRC1 is responsible for the deposition of a single ubiquitin moiety on 
lysine 119 of histone H2A (H2AK119Ub1) through the catalytic sub-
units RING1A or RING1B. In addition, it has been described that 
PRC1 exists in several different forms characterized by the presence 
of different mutually exclusive Polycomb group ring finger (PCGF) pro-
teins (6). These different complexes have been defined as “canonical” 
or “noncanonical” depending on their ability to associate with chro-
mobox (CBX) proteins. While CBX-containing canonical PRC1 com-
plexes are tethered to chromatin by PRC2-dependent deposition of 
H3K27me3, the recruitment of noncanonical complexes remains 
independent of PRC2 activity.
The activity and biological function of PRC1 and PRC2 has been 
intensively investigated in the past 20 years during embryonic 
development and using embryonic stem cells (ESCs) (3, 5), while 
their role in adult stem cells and tissue homeostasis has only recently 
attracted attention (7–14). Adult tissues are constantly regenerated 
and maintained by a pool of stem cells, which are able to compen-
sate for cell loss and tissue damage while preserving stem cell pools 
(15). We recently uncovered the central role of PRC1 activity in pre-
serving intestinal stem cell (ISC) identity through the transcriptional 
repression of non–lineage-specific transcription factors (TFs), which 
are able to interfere with the transcriptional program stimulated by 
the Wnt pathway required for the maintenance of the ISC pool (9). 
With the aim to uncover whether this is a general PcG role in adult 
stem cells, we now investigated the consequences of PRC1 loss of 
activity in a stem cell compartment from a different tissue with a 
distinct developmental origin—hair follicle stem cells (HFSCs).
The skin is the largest organ of the body. It is the first barrier 
against external insults such as bacteria and virus infections, toxic 
agents, and ultraviolet radiation, preserving, at the same time, water 
and temperature homeostasis. In mammals, the epidermis comprises 
the interfollicular epidermis and the pilosebaceous unit composed 
of the hair follicle (HF) and the sebaceous gland. During morpho-
genesis, which begins after delivery, HFs grow downward in the 
dermal compartment of the skin from the hair bulge and its associ-
ated germ (16). Hair regeneration is fueled by two different stem cell 
pools located in the bulge and hair germ. The bulge contains both CD34+ 
and LGR5+ (Leucine Rich Repeat Containing G Protein-coupled- 
receptor-5) stem cells, while the hair germ is exclusively colonized by 
LGR5+ stem cells (17, 18). Throughout life, HFs cycle between prolifera-
tion (anagen), destruction (catagen), and resting (telogen) phases (19). 
Anagen onset is activated when WNT proliferative signals overcome 
a bone morphogenetic protein threshold (20, 21), and LGR5+ HFSCs are 
essential during anagen to sustain HF growth (22). These cells first prolif-
erate to form multipotent progenitors that briefly divide and give rise to 
matrix cells that will generate all the inner layers of the differentiating 
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HF (23, 24). During anagen progression, LGR5+ stem cells expand 
downward to constitute the outer root sheet (ORS) that delimitates the 
follicle. During anagen phase, LGR5+ HFSCs appear to be functionally 
similar to LGR5+ ISCs, being actively proliferating stem cells supporting 
a renewing tissue. For these reasons, they represent a good system to 
uncover general, stem cell–specific PRC1 activities.
Here, we report that the activity of PRC1 is essential to sustain 
LGR5+ HFSC and general HF regeneration. We further characterized 
the direct molecular circuits triggered by PRC1 loss of function and 
found that, despite the fact that a large part of PRC1 activity is associated 
with active gene expression, the phenotypic outcome of its loss of func-
tion can be primarily ascribed to its canonical repressive functions. 
In this context, PRC1 is directly involved in suppressing an epidermal 
transcriptional program maintaining silencing of the master epidermal 
regulator Ascl2. Taking advantage of parallel data generated in ISCs, 
we further show that, despite the fact that PRC1 retains a general role 
in suppressing developmental programs across tissue and stem cell 
compartments, the molecular phenotypes triggered by PRC1 loss of 
function are strongly dependent on the cellular context, and there-
fore, by the repertoire of the expressed TFs in any given cell.
RESULTS
PRC1-dependent H2AK119Ub1 is required for HF regeneration
To uncover the general mechanisms by which PRC1 activity contrib-
utes to lineage identity in different adult stem cell populations, we 
took advantage of the LGR5-GFP-ires-CreERT2/Ring1a−/−/Ring1b f l/fl/
Rosa26lox-stop-lox LacZ compound model (hereof Ring1a/b ctrl or 
dKO upon tamoxifen treatment) that we have previously generated 
(fig. S1A) (9). The Lgr5 transgene is homogenously expressed in a 
population of actively cycling and long-lived HFSCs that, from the 
base of the hair bulb, gradually expand through the ORS, contributing 
to the regeneration of the follicle (18). We used this genetic model 
to acutely abrogate PRC1 activity in 8 to 12 weeks, sex-matched mice 
and showed that four daily tamoxifen injections are sufficient to 
abolish PRC1 activity in LGR5+ [green fluorescent protein–positive 
(GFP+)] HFSCs, as shown by the loss of H2AK119Ub1 in GFP+ cells of 
telogen HFs (Fig. 1, A and B).
HF regeneration in adult mice is a critical mechanism through 
which fur is maintained during the entire life span. HFs cycle syn-
chronously during the first 10 to 11 weeks of age and then gradually 
loose synchrony, despite maintaining the same regenerating capa-
bilities (fig. S1B) (18, 19, 25). To investigate the role of PRC1 in 
adult HFSCs during HF regeneration, we exploited the possibility 
to resynchronize HFs by means of follicles plucking. As soon as the 
hair is removed, follicles rapidly and synchronously enter into ana-
gen phase and start to cycle (25). To abrogate PRC1 activity from 
the first phases of HF regeneration, we administered tamoxifen 
in adult mice 1 day before waxing the back skin (Fig. 1C). After 
12 days from waxing, while the fur of Ring1a/b ctrl mice was com-
pletely regenerated (Fig. 1D, top), we severely delayed follicle 
regeneration in Ring1a/b dKO mice in the absence of PRC1 activity 
(Fig. 1D, bottom). We further confirmed this result by lineage-tracing 
analyses, taking advantage of a Rosa26lox-stop-lox LacZ allele to 
follow LACZ expression in the progeny of LGR5+ stem cells. 
Twelve days after waxing, we markedly reduced the number of 
-galactosidase (-Gal)–expressing HFs in Ring1a/b dKO animals, 
suggesting that the residual hair growth is derived from wild-type 
HFs (Fig. 1E).
PRC1 depletion affects the onset of anagen phase and  
the HF cycle
To elucidate whether PRC1 activity is required for entering into or 
to progress through the anagen phase, we activated Cre-mediated 
recombination at P49 to induce Ring1b loss of function during the 
long telogen period. After 2 weeks from tamoxifen exposure, we 
synchronized HFs by waxing and then collected the back skin after 
8 and 12 days (Fig. 2A and fig. S2A) to perform histological analyses 
and -Gal staining to trace PRC1-null progeny. After 8 days from 
waxing, we observed a substantial delay in hair growth in Ring1a/b 
dKO mice (fig. S2B). This was further confirmed by histological 
analysis showing shorter HFs, blocked in the early anagen phases 
(I and II) [fig. S2, C (top) and D] (25). At 8 days from waxing, the 
total number -Gal+ HFs was strongly reduced in Ring1a/b dKOs 
[fig. S2, C (bottom) and E]. It is well established that the hypodermal 
adipocyte layer fluctuates in thickness during the hair cycle (25, 26). This 
increases during anagen and reduces throughout catagen to reach a 
resting phase until a new hair cycle begins. Ring1a/b dKOs displayed 
a clear imbalance of hypodermis fat (fig. S2F) and dermis thickness 
(fig. S2G), despite the fact that the total skin showed a similar width 
(fig. S2H). This reinforces evidence that PRC1 loss severely affects 
HF regeneration. This phenotype was confirmed and enhanced after 
12 days from waxing (Fig. 2B). According to Müller-Röver et al. (25) 
classification, at this time point, while Ring1a/b ctrl mice showed all 
features of full anagen (anagen phase VI), Ring1a/b dKO follicles still 
resembled primary stages of the hair cycle (anagen phases II and III; 
Fig. 2C, top). Lineage tracing of LGR5+ stem cell progeny showed a 
marked reduction of cells derived from Ring1a/b dKO stem cells, as demon-
strated by the severe lack of -Gal staining compared to ctrl follicles 
[Fig. 2, C (bottom) and D]. Consistently, the differences in follicles 
length, hypodermis, and dermis thickness were further increased at 12 
versus 8 days after waxing, with a similar reduced number of HFs 
(Fig. 2, E to H, and fig. S2, I to L). Together, these data suggest that the 
loss of PRC1 activity does not fully prevent entry into the anagen phase 
but rather impairs the regenerative potential of LGR5+ stem cells.
Conserved PRC1-repressed transcriptional programs are 
required to preserve HFSCs and ISCs
Our results suggest that the loss of PRC1 induces similar phenotypic 
outcomes in HFSCs compared to our previous results with ISCs (9). 
Whether this involves common or cell type–specific pathways remains 
an important open question. To investigate the transcriptional changes 
induced by PRC1 loss of function in anagen-activated LGR5+ stem 
cells, we collected the skin of Ring1a/b dKO and ctrl adult mice 
8 days from waxing (Fig. 3A). HFs were isolated and reduced at single 
cells, and LGR5+ cells were isolated by fluorescence-activated cell 
sorting (FACS) to perform RNA sequencing (RNA-seq) analyses. FACS 
analysis on the same cells stained for H2AK119Ub1 demonstrated 
that tamoxifen treatment results in >70% loss of PRC1 activity in 
LGR5+ (GFP+) cells (Fig. 3B). RNA-seq analysis in these cell popu-
lations revealed a >5-fold bias in genes up-regulation (1066 up- 
regulated versus 187 down-regulated genes) that is consistent with 
the general PRC1 role as transcriptional repressor also in the HF 
compartment (Fig. 3C). Gene ontology (GO) analysis on differentially 
expressed genes showed that up-regulated genes are primarily 
associated with general developmental processes (Fig. 3D). In con-
trast, down-regulated genes were specifically enriched by factors 
involved in HF morphogenesis, HFSC maintenance, and hair cycle 











Pivetti et al., Sci. Adv. 2019; 5 : eaav1594     15 May 2019
S C I E N C E  A D V A N C E S  |  R E S E A R C H  A R T I C L E
3 of 11
functional annotation revealed that DNA binding TFs, and par-
ticularly homeotic TFs, were overrepresented among the genes up- 
regulated in Ring1a/b dKO (fig. S3A). The additional comparison 
in respect to transcriptional data obtained from several tissues 
(ENCODE; fig. S3B, bottom) highlighted that the loss of PRC1 
activity results in the transcriptional activation of non–lineage-specific 
genes that are preferentially expressed in distinct tissue compartments. 
In contrast, down-regulated genes were primarily expressed in acti-
vated LGR5+ HFSCs (fig. S3B, top), further corroborating impaired 
activation of HFSC regenerative capabilities in the absence of PRC1 
activity. These data are in agreement with our previous finding in 
ISCs (9), further highlighting the conserved essential role of PRC1 in 
maintaining lineage identity within adult tissues. Whether this involves 
common or specific mechanisms remains an open question. Thus, we 
searched for common classes of genes that could be potentially involved 
with the loss of cell identity in ISCs versus HFSCs upon PRC1 in-
activation. We compared RNA-seq profiles in both stem cell com-
partments and found that none of the down-regulated genes were in 
common in accordance with the distinct identity of the two stem cell 
populations (fig. S3C). In contrast, we found approximately one-fourth 
of the up-regulated genes (255 genes, ≈25%) in common between ISC 
and HFSC (fig. S3D). This group of genes was enriched by mainly 
homeobox-containing TFs involved in regulating general developmental 
processes (fig. S3E). Several ZIC (Zinc finger protein of the cerebellum) 
TFs (Zic1, Zic4, and Zic5; fig. S3F), as well as Sox7, Hoxa10, and Hoxb13 






















































































Fig. 1. PRC1 activity is required to sustain HF regeneration. (A) Immunostaining using H2AK119Ub1 (red) and 4′,6-diamidino-2-phenylindole dihydrochloride (DAPI; 
blue) of HF from LGR5-eGFP-ires-CREERT2 HFSCs in Ring1a/b+/+ and Ring1a/b−/− mice . Scale bars, 50 m. (Photo credit: F.C. and S.P., European Institute of Oncology). 
(B) Quantification of H2AK119Ub1+ HFSCs in Ring1a/b+/+ and Ring1a/b−/− mice. ****P < 0.0001 (P values were calculated with two side t test). TAM, tamoxifen. (C) Sche-
matic representation of the protocol used in (D) and (E). (D) Representative pictures of Ring1a/b+/+ and Ring1a/b−/− mice immediately after hair removal and after 12 days. 
(Photo credit: F.C., European Institute of Oncology). (E) In vivo lineage tracing of HFSCs. Mice were treated as described in (C), and skin was collected at indicated time 
point. Samples were stained with X-Gal. Whole tissues were imaged before paraffin embedding, and the sections obtained were counterstained using neutral red. (Photo 
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PRC1 plays a common general role in distinct stem cell compartments to 
prevent activation of non–lineage-specific, homeobox-containing TFs.
Transcriptional repression of a subset of canonical PRC1 
targets preserves stem cell identity
Recently, two major classes of PRC1 complexes have been de-
scribed (6) on the basis of their biochemical composition. Canonical 
PRC1, which contains CBX proteins, is recruited on their targets in 
a PRC2- dependent manner. Noncanonical PRC1 complexes do not 
contain the CBX-containing subunits and are recruited independently 
from PRC2. They are characterized by the presence of different PCGF 
subunits and share the subunits RYBP (RING1 and YY1 Binding Protein) 
or YAF2 (YY1 Associated Factor 2). Different components of canonical 
and noncanonical PRC1 complexes are expressed in HFSCs (fig. S4A). 
To investigate the ability of RING1B to enter both canonical and non-
canonical complexes in HFSCs, we performed proximity ligation assay 
(PLA). Wild-type and dKO LGR5+ HFSCs from waxed mice have 
been sorted (fig. S4, B and C) and used to investigate the ability of 
RING1B to interact with RYBP (Fig. 3, F and G) or BMI1 (Fig. 3, H and I). 
Our data indicate that in HFSCs, both canonical and noncanonical 
complexes assemble, suggesting that the phenotype observed in dKO 
HFSCs could be the result of the impaired activity of different 
complexes.
To identify the common mechanisms through which PRC1 regu-
lates cell fate determination in different stem cell populations, we 
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Fig. 2. PRC1 activity is required for anagen onset and progression. (A) Schematic representation of the experiment. Tamoxifen was delivered intraperitoneally once 
a day for four consecutive days during the long telogen phase. At 63 days, postdelivery hairs were removed, and samples were collected after 12 days. (B) Representative 
pictures of Ring1a/b+/+ and Ring1a/b−/− mice immediately after hair removal and after 12 days. (Photo credit: S.P., European Institute of Oncology). (C) Histological analysis 
and in vivo lineage tracing of HFSCs. Mice were treated as described in (A). Skin was collected at the indicated time points. All collected sample were paraffin-embedded 
and stained with either X-Gal or hematoxylin and eosin (H&E). Scale bars, 250 m. (Photo credit: S.P., European Institute of Oncology). (D) Quantification of -Gal+ HFs, 
(E) HF length, (F) hypodermis, (G) dermal height, and (H) total section thickness at 12 days after waxing in Ring1a/b+/+ and Ring1a/b−/− mice. All P values were calculated 
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Fig. 3. Loss of PCR1 activity affects HFSCs transcriptional landscape. (A) Schematic view of the experiment. (B) Quantification of H2AK119Ub1+ HFSCs used 
for RNA-seq experiments in Ring1a/b+/+ and Ring1a/b−/− mice. HFs were collected 8 days after waxing. Single-cell suspension was stained using anti-H2Ak119Ub1 and 
analyzed by FACS. (C) Volcano plot of differentially expressed genes between Ring1a/b+/+ and Ring1a/b−/− mice. Log2 fold change, ≥1. (D) GO analysis of up-regulated and 
(E) down-regulated genes in Ring1a/b−/− mice (log2 fold change, ≥1) representative snapshots of modulated genes is shown. Shh, Sonic hedgehog. (F) PLA between 
RING1B and RYBP on Ring1a/b+/+ and Ring1a/b−/− HFSCs. (Photo credit: S.P. and A.D., European Institute of Oncology). (G) Quantification of RING1B-RYBP PLA dots per cell 
in Ring1a/b+/+ and Ring1a/b−/− HFSCs. (H) PLA between RING1B and BMI1 on Ring1a/b+/+ and Ring1a/b−/− HFSCs. (Photo credit: S.P. and A.D., European Institute of Oncology). 
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analysis for RING1B in FACS-sorted activated LGR5+ stem cells 
purified 8 days from waxing (Fig. 4, A and B). This analysis identified 
nearly 3900 RING1B significant peaks that were mainly associated 
with promoter regions (Fig. 4C). This distribution closely resembles 
the RING1B chromatin association that we have found in ISCs 
(Fig. 4D). Since RING1A or RING1B can form distinct functional 
complexes that may localize differently along the genome (6), we 
first compared the genomic localization of RING1B in both HFSCs 
and ISCs in respect to the deposition of H3K27me3 to define 
Polycomb-repressed domains (9, 28). We restricted the extent of 
overlap with the canonical PcG-repressed domains only to 20% of 
RING1B sites in HFSCs (Fig. 4E) and to 10% in ISCs (Fig. 4F), 
suggesting that a large fraction of RING1B activity is exerted inde-
pendently of PRC2. In ESCs, H3K27me3 is enriched at promoters of 
developmental-related genes concomitantly with the deposition of 
the transcriptional activatory modification H3K4me3. This promoter 
status has been defined as “bivalent” or “poised” (29). Bivalency is 
resolved when ESCs are triggered to differentiate by the acquisition 
of a purely active (H3K4me3 only) or repressed (H3K27me3 only) 
state. We found that, while only 30% of H3K27me3 sites in HFSC 
are bivalent (coenriched with H3K4me3), this proportion expands 
in ISCs where it reaches 80% of all RING1B target promoters 
enriched for H3K27me3 (Fig. 4, G and H). We also observed a large 
fraction of RING1B-bound sites that lacks H3K27me3 but presents 
H3K4me3 deposition (Fig. 4, I and J). Accordingly, with the ability 
of RING1B to interact with subunits of both canonical and non-
canonical complexes, we observed that in HFSCs, nearly 70% of 
RYBP peaks colocalize with RING1B (Fig. 4K), but only a small 
percentage (11%) of the co-occupied regions harbor H2AK119Ub 
(Fig. 4L). Those regions characterized by the presence of RING1B 
and H2AK119Ub are also occupied by CBX8, a canonical PRC1 
subunit, and are decorated by PRC2-dependent H3K27me3 mark 
(Fig. 4, M and N). These data suggest that both canonical and non-
canonical PRC1 activities, which are not associated with H3K27me3 
and H2AK119Ub, could contribute in the maintenance of stem 
cell identity.
To address this issue, we ranked all RING1B target promoters 
based on their expression in wild-type cells, and we compared their 
expression in PRC1-defective HFSCs and ISCs (Fig. 4O and fig. S5A). 
This analysis identified four classes of genes. Repressed genes in 
wild-type cells defined cluster 1 and were enriched for transcrip-
tionally activated genes in Ring1a/b dKO HFSCs and ISCs. Genes 
with intermediate expression (clusters 2 and 3) showed no difference 
(Fig. 4O) or slightly decreased expression (fig. S5A) in Ring1a/b 
dKO cells. Highly expressed genes (cluster 4) were slightly down- 
regulated in Ring1a/b dKO HFSC. The distribution of H3K27me3, 
H2AK119Ub, and H3K4me3 (Fig. 4P and fig. S5B) identified genes 
belonging to cluster 1 as fully silenced through canonical Polycomb 
activities, as demonstrated by the presence of CBX8 (Fig. 4P). These 
sites are devoid of H3K4me3, which is instead enriched at all the 
other clusters (Fig. 4P and fig. S5B) where colocalizes with RING1B 
and RYBP (Fig. 4P). Accordingly, genes involved in development and 
differentiation were only enriched in cluster 1 (Fig. 4Q and fig. S5, 
C, E, and F). Despite the fact that these data support a prominent 
role for canonical versus noncanonical activities in maintaining cell 
identity in HFSCs and ISCs, it is important to stress that only a subset 
of RING1B+/H3K27me3+/H2AK119Ub targets become derepressed 
upon the loss of PRC1 activity in HFSCs and ISCs (Fig. 4R and 
fig. S5D). This suggests, first, that H3K27me3 is largely sufficient to 
prevent TF accessibility and activation of PcG targets and, second, 
that only a small proportion of PcG target genes contribute to the 
observed phenotypes.
Loss of PRC1 activity activates epidermal-specific program
To uncover direct mechanisms associated with PRC1 loss of activity, 
we focused our attention on RING1B targets that became dere-
pressed in Ring1a/b dKO. This includes Ascl2 (Fig. 5A), which 
encodes for a TF previously shown to be sufficient and required to 
drive epidermal differentiation (30). To investigate whether a spe-
cific differentiation program is initiated upon PRC1 activity loss, we 
performed gene set enrichment analysis (GSEA) comparing signa-
tures from different cells belonging to distinct skin compartments 
(31) against Ring1a/b dKO versus ctrl transcriptional outcome in 
HFSCs. This analysis showed that, together with the stem cell signa-
ture, genes involved in epidermal-specific transcriptional program 
became enriched in Ring1a/b dKO mice (Fig. 5B). Among them, 
Satb1, Krtdap, Calm5, Itgam, and Gdpd2, together with Ascl2, were 
some of the known epidermal markers that are highly activated 
(Fig. 5, A, C, and D). We further scanned the Ascl2 promoter with 
LASAGNA-Search 2.0 (32) for putative TFs responsible for its acti-
vation and found several binding motifs that are recognized by the 
family of ZIC TFs (Fig. 5E). Note that different members of this TF 
family are also directly bound and derepressed in Ring1a/b dKO 
HFSCs (fig. S3F), establishing a positive feedback loop driving epi-
dermal identity. Together, these results support a model in which PRC1 
directly suppresses an epidermal-specific transcriptional program 
via suppression of master regulators of lineage specification, thus 
contributing to preserve HF identity.
DISCUSSION
The role of Polycomb complexes in maintaining adult stem cell iden-
tity has been investigated by several groups during the past 5 years. 
We recently reported that PRC1 and PRC2 play a crucial role in 
supporting intestinal homeostasis (8–10). Along the crypt-to-villus 
axis, the balance between secretory cells and enterocytes differentia-
tion, transit-amplifying cell proliferation and stem cell maintenance 
are preserved by Polycomb complexes. In particular, PRC1 is criti-
cally required for ISC maintenance, and the loss of RING1A/B sub-
units leads to stem cell exhaustion. Its activity is required to maintain 
repressed non–lineage-specific TFs, some of which are able to inter-
fere with the ISC-specific transcriptional programs. Stem cell loss 
observed in RING1A/B-deficient intestinal epithelium can therefore 
be ascribed not to the initiation of a defined transcriptional program 
but to the loss of stem cell–specific ones. To unveil general mecha-
nisms underlying PRC1-dependent adult stem cell maintenance, we 
extended its analysis in proliferating HFSCs. Similar to what we 
previously described for ISCs, the loss of RING1A/B in HFSCs 
markedly affects HF regeneration. This phenotypic convergence 
is mirrored at a transcriptional level by the up-regulation of non–
lineage-specific genes, enriched for DNA binding TFs. We provide 
evidence that PRC1 associates at H3K27Me3+ promoters of re-
pressed genes in the context of canonical complexes, characterized 
by the presence of CBX8 subunit and H2AK119Ub. At promoters 
of active genes, RING1B occupancy coincides with RYBP and low 
or undetectable H2AK119Ub levels, suggesting that noncanonical 
PRC1 complexes could play a role at these promoters that is largely 
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Fig. 4. Genomic distribution of PRC1 binding in HFSCs and ISCs. (A) Schematic view of ChIP-seq experiment. (B) Gating strategy used to sort HFSCs used in ChIP-seq 
experiments. (C) Genomic distribution of RING1B-bound sites in LGR5+ HFSCs. (D) Genomic distribution of RING1B-bound sites in LGR5+ ISCs. (E) Bar plots showing the 
fraction of RING1B-bound promoters marked by H3K27me3 in HFSCs. (F) Bar plots showing the fraction of RING1B-bound promoters marked by H3K27me3 in ISCs. (G) Bar 
plots showing the fraction of RING1B-bound H3K27Me3+ promoters marked by H3K4Me3 in HFSCs. (H) Bar plots showing the fraction of RING1B-bound H3K27Me3+ 
promoters marked by H3K4Me3 in ISCs. (I) Bar plots showing the fraction of RING1B-bound promoters marked by H3K4me3 in HFSCs. (J) Bar plots showing the fraction of 
RING1B-bound promoters marked by H3K4me3 in ISCs. (K) Bar plot showing the fraction of RYBP peaks overlapping with RING1B peaks in HFSCs. (L) Bar plot representing 
the percentage of promoters occupied by RYBP and RING1B marked by H2AK119Ub1 in HFSCs. (M) Bar plot showing the percentage of promoters occupied by RING1B 
and H2AK119Ub marked by H3K27Me3 in HFSCs. (N) Bar plot showing the percentage of CBX8 peaks overlapping with RING1B, H3K27Me3, and H2AK119Ub triple-positive 
peaks in HFSCs. (O) Quartile-based gene expression clustering performed using Ring1a/b+/+ RNA-seq data, showing expression variations between Ring1a/b+/+ and 
Ring1a/b−/− HFSCs. (P) Heatmap representing normalized RING1B, H3K27me3, H3K4Me3, H2AK119Ub1, CBX8, and RYBP ChIP-seq intensities of ±8 kb from TSS of RING1B 
target genes in HFSCs. Clusters were made according to Fig. 4O. bp, base pair. (Q) GO analyses of genes belonging to cluster 1. (R) Venn diagram showing the overlap 
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distribution has also been reported in murine ESCs, where H2AK119Ub1 
and PRC2 co-occupy genes bound by CBX7/RING1B and are largely 
excluded by those regions exclusively bound by RYBP/RING1B 
(33). Note that, similar to ESCs, PRC1 localized on both repressed 
(canonical PcG targets) and active genes in both ISCs and HFSCs. 
This latter observation is in line with another recent report demon-
strating a pivotal role of PRC1 during skin development (11). How-
ever, despite the fact that RYBP-containing PRC1 localizes to active 
promoters in both ISCs and HFSCs, very few of those active PRC1 
targets score among the down-regulated genes, suggesting a marginal 
role of noncanonical complexes in preserving the expression of these 
target genes. This further restricts the specific phenotypes firstly de-
scribed in ISCs and now documented in HFSCs to a more canonical 
PRC1 repressive activity. Our data demonstrate that several PcG 
direct targets became derepressed upon PRC1 loss of function and 
several of these targets can be directly linked to the observed pheno-
typic convergence. However, in HFSCs and ISCs, not all the PRC1 
bound targets became activated upon RING1A/B loss. This suggests 
that, despite the idea that a general PRC1 role in maintaining repres-
sion of non–lineage-specific genes is, to some extent, conserved in 
cells of different developmental origin and tissues (i.e., HFSC, ESCs, 
and ISC), the transcriptional program triggered by its loss of func-
tion remains cell type dependent. This is likely due to the repertoire 
of available TFs in any given cell. Accordingly, among the different 
derepressed genes in Ring1a/b dKO HFSC, we found ASCL2, a DNA 
binding TF sufficient and required for epidermal differentiation (30). 
Further analysis of the transcriptome of PRC1-deficient HFSCs con-
firmed the activation of an ectopic, epidermal-specific, transcriptional 
program that could likely contribute for the observed phenotype.
Together, our data ultimately support the existence of a general 
role played by PRC1 to maintain adult stem cell identity that con-
verge into a common phenotype with distinct cell type–specific 
mechanisms. This observation is of crucial importance not only to 
understand the role of Polycomb complexes in shaping adult tissues 
but also in different pathological settings, such as cancer, in which 
PcG is directly involved. The requirement of PcG during tumor de-
velopment and progression, where a high level of cell heterogeneity 
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Fig. 5. PRC1 activity is required to maintained repressed the epidermal-specific transcriptional program in HFSCs. (A) RING1B occupancy at ASCL2 locus and 
transcriptional activation of ASCL2 in Ring1a/b−/−. (B) GSEAs performed on Ring1a/b−/− HFSCs using signatures specific for 14 major skin and HF cell populations (31). FDR, 
false discovery rate; NES, normalized enriched stone; EPI, epidermis. (C) Heatmap representing epidermal-specific genes differentially regulated in Ring1a/b−/− 
HFSCs (log2 fold change). (D) Genomic snapshots of RNA-seq for Calm5 and Itgam genes that are involved in epidermal differentiation. Chr13, chromosome 13. (E) 
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inhibitors entered clinical trials (1, 34). In this context, the efficacy 
(i.e., the consequences) of PcG inhibition could be cell type specific, 
as we describe for adult stem cells, and possibly dependent on the 




Lgr5-specific conditional knockout mice were generated by crossing 
Ring1A−/− Ring1Bfl/fl (35), with LGR5-eGFP-IRES-CreERT2 mice (36). 
These mice were crossed with Rosa26lox-stop-lox LacZ transgenic 
mice for in vivo lineage tracing (37). Genotyping was confirmed by 
polymerase chain reaction (PCR) of tail skin DNA. Cre-dependent 
recombination was induced performing three intraperitoneal injec-
tions of tamoxifen (Sigma-Aldrich) at 75 mg/kg.
Mice were maintained accordingly to the guidelines set out in Com-
mission Recommendation 2007/526/EC, 18 June 2007, on guidelines 
for the accommodation and care of animals used for experimental and 
other scientific purposes. All experiments were performed in accor-
dance with the Italian Laws (D.L.vo 116/92 and following additions), 
which enforces EU Directive 86/609 (Council Directive 86/609/EEC of 
24 November 1986 on the approximation of laws, regulations, and 
administrative provisions of the member states regarding the protec-
tion of animals used for experimental and other scientific purposes).
HF purification
LGR5+ cells were purified from back skin of treated mice at different 
time points. Subcutaneous fat and the blood vessels were removed, and 
the skin was digested using collagenase (2.5 mg/ml) in Dulbecco’s 
modified Eagle’s medium (DMEM) for 45 min. HFs were scraped off 
and incubated for 10 min at 37°C with 2.5% trypsin in phosphate- 
buffered saline (PBS) and deoxyribonuclease 1 (DNase1; 1600 U/ml). 
Fetal bovine serum was added to neutralize trypsin. Cells were washed 
with PBS and filtered with 70-m cell strainer.
Flow cytometry and FACS
Single-cell suspension were washed and resuspended in sorting me-
dium [DMEM; 1:100 penicillin and streptomicin (17-602F, Lonza), 
1:100 l-glutamine (17-605E, Lonza), Hepes, 2 mM EDTA, DNase1 
(800 U/ml), and 10 uM Y27632 (Selleck Chemicals)]. Single GFP+ 
cells were FACS-sorted using either FACSMelody or FACSJazz cell 
sorters (BD Biosciences). Living cells were discriminated by propidium 
iodide exclusion staining.
Immunofluorescence
Back skin was harvested at the described time points, fixed with 
4% paraformaldehyde (PFA) for 3 hours at 4°C, and cryopreserved in 
30% sucrose overnight, followed by O.C.T. embedding (Tissue-TEK 
4583). Embedded tissues were cut at 7 m in thickness. Sections were 
washed in tris-buffered saline–0.1% Tween 20 (TBS-T) and blocked with 
5% donkey serum at room temperature for 1 hour. Section were in-
cubated with anti-H2AK119Ub (D27C4, Cell Signaling Technology) 
overnight at 4°C, washed in TBS-T, incubated for 1 hour at room 
temperature with secondary antibody [715-165-147, Cy3 AffiniPure 
Donkey Anti-Rabbit IgG (H+L), Jackson ImmunoResearch] and 
4′,6-diamidino-2-phenylindole dihydrochloride (32670, Sigma-Aldrich), 
and mounted with Mowiol 4-88 (81381, Sigma-Aldrich). Images were 
taken with Leica Sp8 confocal microscope.
Proximity ligation assay
Anagen-induced sorted LGR5 HFSCs were spotted in Cell-Tak 
(Corning)–coated coverslip, and PLA was performed using Sigma- 
Aldrich Duolink In Situ Orange Starter Kit Mouse/Rabbit follow-
ing the manufacturer’s instruction protocol. Anti-RING1B 
antibody (homemade), anti-RYBP (AB3637, Millipore), and anti-BMI1 
(homemade) primary antibodies were used.
Histology and lineage tracing
Freshly obtained back skin samples were collected at the indicated 
time point and were immediately prefixed for 30 min at room tem-
perature in PBS containing 0.2% gluteraldehyde, 0.02% NP-40, and 
2% PFA. Samples were washed three times for 10 min each with 
PBS and incubated for 30 min with the equilibration buffer (2 mM 
MgCl2, 0.02 NP-40, and 0.1% sodium deoxycholate in PBS). 
Samples were stained overnight at room temperature using 5 mM 
K3Fe(CN)6, 5 mM K4Fe(CN)6, and X-Gal (1 mg/ml) in equilibration 
buffer. Stained skin were washed abundantly with PBS at room 
temperature and then fixed overnight in 4% PFA in PBS before paraf-
fin embedding. Five-micrometer sections were obtained, rehydrated, 
and nuclei-counterstained with Nuclear Fast Red solution for 
10 min at room temperature. For histological analysis, freshly iso-
lated back skin samples were fixed in 4% formaldehyde overnight, 
paraffin-embedded, and stained with hematoxylin and eosin Y. 
Images were acquired using Olympus BX51 or Leica DM6 widefield 
microscope.
RNA sequencing
FACS-sorted cells were collected in 0.5-ml tubes and processed di-
rectly following Smart-seq2 protocol (38) with minor modifications. 
Briefly, 3000 cells per sample were collected directly and lysed in 2 l 
of lysis buffer [0.2% Triton X-100 and ribonuclease inhibitor (4 U/l)]. 
One microliter of 10 M oligo-dT30Vn and 1 l of 10 mM deoxy-
nucleotide triphosphate were added, and the samples were incu-
bated for 3 min at 72°C. Reverse transcriptase step was performed 
using SuperScript III reverse transcriptase enzyme (Invitrogen). 
Preamplification of the obtained complementary DNA (cDNA) was 
performed using KAPA Taq HotStart enzyme with High-Fidelity 
Buffer. Preamplified cDNA was purified using AMPure beads 
(Agencourt AMPure XP, Beckman Coulter), and the quality was 
checked using Bioanalyzer (Agilent). Two nanograms of cDNA was 
tagmented with 100 ng of homemade Tn5 enzyme and further 
amplified using KAPA HiFi HotStart Kit. Tagmented, amplified 
DNA was sequenced using Illumina HiSeq2000.
ChIP sequencing
LGR5+ HFSCs were purified as previously described from anagen- 
synchronized HFs of Ring1a/b+/+ mice and were extracted following 
the protocol previously described. A total of 2.5 million cells 
were used for ChIP-seq as previously described (9). Sonicated 
chromatin was incubated with 10 g of rabbit anti- RING1B 
antibody (homemade), anti-H2AK119Ub1 (8240, Cell Signaling 
Technology), anti-RYBP (AB3637, Millipore), and anti-CBX8 (39) 
overnight, and the immunocomplexes recovered using protein A–
conjugated magnetic beads (Dynabeads, Life Technologies). Purified 
chromatin was decross-linked overnight in 0.1 M NaHCO3 and 
1% SDS. Decross-linked DNA was purified. ISC-specific H3K4me3 
ChIP-seq profile was obtained as previously described (9) using 5 g 
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RNA-seq analysis
Reads were aligned to the mouse reference genome mm9 using TopHat 
v2.1.1 (40) with parameters --no-coverage-search and --library-type 
fr-unstranded. PCR duplicates were removed using Picard (http://
broadinstitute.github.io/picard/). Gene counts were calculated using 
HTSeq-count v0.8.0 (41) with parameters --stranded=no --mode= 
intersection-nonempty using RefSeq mm9 annotation downloaded from 
the University of California, Santa Cruz. Differential expression 
analyses were performed using the R package DESeq2 v1.20 (42) 
using default parameters. Genes with an absolute log2 fold change of 
1 and false discovery rate of <0.1 were considered as differentially 
expressed. Gene enrichment analysis on down- and up-regulated genes 
was performed using DAVID 6.8 (43). A preranked GSEA (44) was 
performed using gene lists (Signature Gene Lists) from multiple 
skin cell populations obtained from (31). The analysis was performed 
using default parameters (weighted as enrichment statistic) and ranking 
the input gene list using log2 fold-change data obtained from DESeq2.
To assess the expression of differentially expressed genes in Ring1A/
B−/− versus wild-type HFSC in other mouse tissues, we used public 
RNA-seq data (bam files) deposited by ENCODE at (http://hgdownload.
soe.ucsc.edu/goldenPath/mm9/encodeDCC/wgEncodeLicrRnaSeq/). 
Bam files were processed with the pipeline described previously, and 
RPKM (Read Per Kilobase of Milion Mapped Reads) data were normal-
ized with the function normalize.quantiles() from the R package 
preprocessCore (https://github.com/bmbolstad/preprocessCore).
ChIP-seq analysis
Reads were aligned to the mouse reference genome mm9 using 
Bowtie v1.2.2 (45) with default parameters and not allowing 
multimapping (-m1). PCR duplicates were removed using Picard 
(http://broadinstitute.github.io/picard/). Peaks were called using 
MACS2 v2.1.1 (46) with parameters -g mm --nomodel -p 1e-10 –B. 
Genomic peak annotation was performed using the R package 
ChIPpeakAnno v3.15 (47), considering the promoter region of ±2.5 kb 
around the TSS (Transcription Start Site). Overlaps of ChIP-seq targets 
were performed as following: Genes with peaks in their promoter re-
gions (±2.5 kb around TSS) were considered as targets. Then, the 
overlap between target gene lists was performed using the R package 
VennDiagram v1.6.20 (48).
For heatmap representation of ChIP-seq signal, bigwig files, 
with input signal subtracted, were generated using the function 
bamCompare from deepTools 2.0 (49) with parameters --ratio 
subtract –bs 30 --extendReads 200. To normalize for differences in 
sample library size, a scaling factor for each sample was calculated 
as (1/total mapped reads) × 1 million and applied during bigwig file 
generation with the parameter –scaleFactors from bamCompare.
Ring1b ChIP-seq targets were clustered in four groups ac-
cording to their RPKM expression using the dplyr function ntile(). 
Tracks for H3K27me3 from ISC and HFSC were obtained from (9) 
and (28), respectively, and processed with the pipeline described 
previously.
SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/5/5/eaav1594/DC1
Fig. S1. Mouse model of PRC1 activity abrogation.
Fig. S2. PRC1 loss severely affects anagen onset and progression.
Fig. S3. PRC1 loss has different transcriptional effects among tissues.
Fig. S4. Expression of core PRC1 subunits in HFSCs.
Fig. S5. Genomic distribution of PRC1 in ISCs resembles HFSCs.
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“One, remember to look up at the stars and not down at your feet. Two, never 
give up work. Work gives you meaning and purpose and life is empty without it. 
Three, if you are lucky enough to find love, remember it is there and don't throw 
it away.” 
― Stephen Hawking 
 
“The important thing is not to stop questioning. Curiosity has its own reason for 
existence. One cannot help but be in awe when he contemplates the mysteries of 
eternity, of life, of the marvelous structure of reality. It is enough if one tries 
merely to comprehend a little of this mystery each day.” 
 
—"Old Man's Advice to Youth: 'Never Lose a Holy Curiosity.'" LIFE Magazine (2 
May 1955) p. 64” ― Albert Einstein 
 
 
